Curriculum Vitae - Pubtexto...University/University-Hospital/Courses Affiliations: 1981-1989...

1

2018-11-15/ta

Curriculum Vitae Trevor Cornelius Stuart Archer

Born: 25th October 1949

Nationality: British + Swedish [since 20051219] citizenship. Education [to certificate/diploma] and Appointments:

1967 General Certificate of Education, ‘O’ levels - Wallington Grammar School, Surrey, England; 1969 Ordinary National Certificate, ONC, Applied Biology, Cambridgeshire College of Arts and Technology, Cambridge, England; 1971 Higher National Certificate/Diploma [BA], HNC/D, Applied Biology, Cambridgeshire College of Arts and Technology (now Cambridge Polytechnical College), Cambridge, England;

1974 Bachelor of Science, Single Honours ‘Psychology’, University of Newcastle-Upon-Tyne, Newcastle, England; 1979 Doctor of Philosophy, ‘Psychology’, Uppsala University, Uppsala, Sweden. 1981-Docent (Psychology), Uppsala University, Uppsala, Sweden. 1982. Docent (Psychiatric & Neurophysiologic Department), Ulleråkers Hospital, Uppsala. 1985. Professor (Psychology), Umeå University; Göteborg University (main affiliation); Guest Professorships: Karlstad University; Örebro University; Madrid Complutense, Spain; Kalmar University, Sweden; Visiting Professor, University of Hawaii at Manoa, USA; Madrid University, Spain; La Sapienza University, Rome, Italy. 1978 Behavior Therapy Course (10-points). Course Supervisor. P-O Sjödén, Bengt Andersson. Lectures: animal learning and motivation C-course, Dept. Psychology, Uppsala University. 1983, 1985, 1987 Leadership Techniques and Training with Negotiating Techniques. (Arranged by Astra Läkemedel AB). Stockholm, Södertälje & Åtvidaberg). 1989-1992: Leadership courses, Gothenburg university, for Heads of Department and Deans of Faculty. 2013. Honorary Doctor and Professor, Honorary Member (23rd member, 8th foreign member) of the Polish Pharmacological Society.

2

Positions: UK: 1967-1971 Assistant Scientific Officer, Institute of Animal Physiology, Babraham, Cambridge, England; BSc Single Honours ('71-'74: University of Newcastle-upon-Tyne). Sweden: 1974-1976 Laboratory Assistant, Neurophysiology Laboratory, Ulleråkers Hospital, Uppsala, 1976-1978 Mental Nurse ('heltid'), Geriatric Ward, Ullersåkers Hospital, Uppsala, Sweden; 1978-1983 Research Scientist, Pharmacology Department, Astra Läkemedel AB, Södertälje, Sweden; 1983-1988 Head of Department for Psychoneuropharmacology, Astra Läkemedel AB, Södertälje, Sweden; Projektleader-Antidepressants-anxiolytics 1985-1988. 1985-1988 ‘Extraordinary’-professor (Adjunct), Umeå University, Umeå, Sweden. 1989[1st jan] - Professor, Department of Psychology, Göteborg University, Sweden. 1989-1996 Ordförande, Forskarutbildningsnämnden [Chairman, PhD-program Committee]. 1989- present. Founder and Member of PHD-program Committee [FUN and FUB]. 2016(dec)- Senior Professor, Dept. of Psychology, University of Gothenburg. 1991-1993 Head (prefekt) of Department of Psychology, Göteborg University, Sweden. 1993-1995 Dean of Faculty of Social Sciences, Göteborg University, Sweden.[1993/4-both Head of Department and Dean-of-Faculty]. 1995-1996 Committee for Assurance of Teaching Quality and Standards, University of

Göteborg. University/University-Hospital/Courses Affiliations: 1981-1989 Associate Professor, Psychology, Associate Professor, Ulleråker Psychiatry, Uppsala University, Sweden. 1988. 'Extra'-ordinary Professor, Biological Psychology, Umeå University, Sweden. Lab. Association Dept.Of Pharmacology. 1993-present Visiting Professor - Substance abuse, schizophrenia and PTSD clinical studies -

University Hospital of the 12th October, Madrid, Spain.

3

1994-jun-aug Visiting Professor, University of Hawaii at Manoa, Honolulu, Hawaii. Summer school - 2 postgraduate + 1 graduate courses [seven-week courses]. 1996-present Psychobiology [basic neurobiology, stress and health, drug abuse] course for socionom students, two terms/year, at the University of Orebro, Sweden. [Organiser]. 1998 One-month course on Nootropic Drugs and Memory Models, for trainee

psychiatrists, University of Madrid, Madrid, Spain. 2000-2004 Guest Professor at the University of Karlstad, Sweden. 2000-2001 Biopsychology (10 points) and Neuropsychology (5 points) postgraduate courses at the Universities of Örebro and Karlstad. [Organiser + Lecturer]

2000-2001

Neuropsychology postgraduate course (10 points) at University of Örebro. [Organiser + Lecturer]

2002. Neurobiology of Cognition & Memory (5 points) postgraduate

2001-2002 ” ” Emotion, Stress & Personality (5 + 5 points)

2001-2005 Examiner [Examinator] - Degree of Master’s Examination - Karlstad University. 2005. Guest Professor at the University of Örebro, Examiner: C-kurs/D-kurs. 2003-8; 2010- Guest Professor at the University of Kalmar (Linne).Research Coordinator

[Psychology]; Examiner – sports and health. 8. Research Coordinator [Sports and Health]. Examiner: C-kurs/D-kurs. 2006-2009

Assessor [together with Professor emeritus Sven Carlsson], ranking the National Clinical Psychology Final Reports [Psykolog examensarbete]. Professional Invited Affiliations [Editorships] - International journals/societies: - Founding Member of European Behavioural Pharmacology Society, 1984 - “ of Neurotoxicity Society, 2000. Editor & Editorial Board

- (1) Editor, Scandinavian Journal of Psychology, 1988-96.

- (2) Editorial Board member of the Journal, Experimental Animal Behaviour, 1985-

Treasurer and Executive Committee of the European Behavioral Pharmacology Society,

1986-92.

4

- Committee of European Brain & Behaviour Society, 1988-90.

- (3) Editorial Board member of the Journal, Behavioral Pharmacology, 1989-2010.

- Re-elected to EBPS full committee, 19th May, 1996-, Cagliari, Sardinia.

-(4) Editorial Board member of the Journal, Neurotoxicity Research, 1999-

Founding Member of the Neurotoxicity Society, 1999.

-Council for the Neurotoxicity Society, 2001.

-(5) Editorial Committee of The European Journal of Psychiatry, 2004-

President, Neurotoxicity Society, 2005-2007.

-(6) Regional Editor, The Open Toxinology Journal, 2008-

-(7) Editorial Board member of the Journal, Acta Neurologica Scandinavica, 2008-

- (8) Editorial Board member of the Journal, Advances in Integrative Omics and Applied

Biotechnology, 2011-.

-(9) Editorial Board member, and Co-Editor, of the Journal, PSYCH JOURNAL, 2011-.

-(10) Editorial Board member of the Journal, World Journal of Trauma and Critical

Care.

-(11) Co-Editor and Editorial Board member of the Journal, Journal of Symptoms and

Signs.

-(12) Editorial Board member, and Co-Editor, of the Journal, Dataset Papers in Cells

Biology.

-(13) Editorial Board member of the Journal, Journal of Neurological Disorders.

-(14) Editorial Board member of the Journal, Intellectual Disability Diagnosis Journal.

-(15)Editorial Board Member of the Journal, Journal of Neurology and Neurophysiology.

-(16) Editorial Board Member of the Journal, International Journal of School and

Cognitive Psychology.

-(17) Guest Editor of the Journal, Personality Science and Individual Differences:

Character, Responsibility and Well-Being.

-(18) Editorial Board Member of the Journal, Autoimmune Disease and Theoretical

Approaches.

-(19) Lead Guest Editor of the Journal, BioMed Research International Special Issue:

Brain Toxicology and Disease States.

-(20) Editorial Board Member of the Journal, Pharmacologia

-(21) Editorial Board Member of the Journal, the Open Conference Proceedings Journal

5

-(22) Editorial Board Member of the Journal, Journal of Health Science

-(23) Associate Editor of the Journal, Clinical Medicine, OMICS.

- (24) Editorial Board Member of the Journal, The Open Access Journal of Science and

Technology.

- (25) Editorial Board Member of the Journal, Journal of Reward Deficiency Syndrome

(JRDS).

-(26) Editorial Board Member of the Journal, International Journal of Autoimmune

Disorders and Therapy (IJADT).

-(27) Editorial Board Member of the Journal, SM Journal of Neurology and

Neuroscience.

- (28) Editorial Board Member of the Journal, Archives of Depression and Anxiety.

- (29) Editorial Board Member of the Journal, Psychiatry, open access.

- (30) Editorial Board Member of the Journal, Journal of Psychological Sciences.

- (31) Editor-in-Chief and Editorial Board Member of the Journal, Clinical and Experimental

Psychology.

- (32) Editorial Board Member of the Journal, Clinical Depression.

- (33) Editorial Board Member of the Journal, Journal of Trauma & Acute Care.

- (34) Associate Editor, Cellular and Molecular Biology.

- (35) Editor-in-Chief and Editorial Board Member of the Journal, Journal of Psychiatry and

Psychology Research: Well-being, Empowerment and Affective Profiles.

- (36) Editorial Board Member of the Journal, Bio Accent Open Access Journals Psychology.

- (37) Editorial Board Member of the Journal, The Scientific Pages of Addiction and

Rehabilitation.

- (38) Editorial Board Member of the Journal, Acta Psychopathologica.

- (39) Editorial Board Member of the Journal, Journal of Traumatic Stress Disorder and

Treatment.

- (40) Editorial Board Member of the Journal, Allergy.

- (41) Editorial Board Member of the Journal, Psychiatry and Psychology.

- (42) Editorial Board Member of the Journal, International Journal of Nutritional Studies.

- (43) Editorial Board Member of the Journal, HIV Current Research.

- (44) Editorial Board Member of the Journal, Journal of Chronic Diseases and Management.

- (45) Editorial Board Member of the Journal, JSM Schizophrenia.

6

- (46) Editorial Board Member of the Journal, JSM Anxiety and Schizophrenia.

- (47) Editorial Board Member of the Journal, International Journal of Nutritional Sciences.

- (48) Editorial Board Member of the Journal, The Scientific Pages of Physical Medicine.

- (49) Editorial Board Member of the Journal, International Journal of Brain Disorders

Therapy.

- (50) Editorial Board Member of the Journal, Neuropsychology & Stress Management.

- (51) Editorial Board Member of the Journal, Sports Medicine and Rehabilitation Journal.

- (52) Editorial Board Member of the Journal, Nutrition & Food Science Journal.

- (53) Editorial Board Member of the Journal, Physical Medicine & Rehabilitation Journal.

- (54) Editorial Board Member of the Journal, International of Nutritional Sciences.

- (55) Editorial Board Member of the Journal, EC Neurology Journal.

- (56) Editorial Board Member of the Journal, Journal of Transmitted Diseases and Immunity.

- (57) Editorial Board Member of the Journal, The Open Medicine Journal.

- (58) Editorial Board Member of the Journal, Annals of Burns and Trauma.

- (59) Editorial Board Member of the Journal, Nutrition and Food Toxicology (NUFT).

- (60) Editorial Board Member of the Journal, Journal of Addiction Disorder and

Rehabilitation (JADR).

- (61) Editor-in-Chief for Proceedings of the International Seminar on Social Science and

Humanities Research (SSHR 2017).

- (62) Editorial Board Member of the Journal, Annals of Sleep Medicine Research.

- (63) Editorial Board Member of the Journal, Global Journal of Allergy.

- (64) Editorial Board Member of the Journal, Journal of Integrative Food Sciences and &

Nutrition.

- (65) Editorial Board Member of the Journal, General Medicine Journal.

- (66) Editorial Board Member of the Journal, SM Journal of Autism and Epilepsi.

- (67) Editorial Board Member of the Journal, Alzheimer’s and Parkinsonism: Research and

Therapy.

- (68) Editor and Editorial Board Member of the Journal, Journal of Child Psychology.

- (69) Editor and Editorial Board Member of the Journal, Journal of Mental Health and Aging.

- (70) Editorial Board Member of the Journal, Journal of Pediatric Neurology and

Neuroscience.

7

- (71) Editorial Board Member of the Journal, International Journal of Emerging Diseases and

Preventative Medicine.

- (72) Editorial Board Member of the Journal, Journal of Nutrition and Human Health (JNHH).

- (73) Editorial Board Member of the Journal, International Journal of HIV and AIDS Research.

- (74) Editorial Board Member of the Journal, Neuroscience and Psychiatry. - (75) Editor-in-Chief and Editorial Board Member of the Journal, Journal of Psychology Research & Review (PRR). - (76) Editorial Board Member of the Journal, International Journal of Psychology & Behavior Analysis. - (77) Editor-in-Chief and Editorial Board Member of the Journal, Neuropsychology and Stress Management. - (78) Editorial Board Member of the Journal, Journal of Medicines Development Sciences. - (79) Editorial Board Member of the Journal, Online Journal of Neurology and Brain Disorders. - (80) Editorial Board Member of the Journal, Global Journal of Internal Medicine. - (81) Editorial Board Member of the Journal, Journal of Medicines Development Sciences. - (82) Editorial Board Member of the Journal, Cancer and Tumor Review. - (83) Editorial Board Member of the Journal, Integrative Neuroscience Research. - (84) Chief Editor of the journal, Archives of Addiction and Rehabilitation. - (85) Editorial Board Member of the Journal, Neurology and Neurosurgery. - (86) Editorial Board Member of the Journal, International Journal of Psychiatry Research. - (87) Editorial Board Member of the Journal, Physical Medicine & Rehabilitation Studies. - (88) Editorial Board Member of the Journal, Journal of Public Health and General Medicine. - (89) Editorial Board Member of the Journal, Journal of Spine and Neurological Disorders. - (90) Editorial Board Member of the Journal, Journal of Psychiatry and Mental illness. - (91) Editorial Board Member of the Journal, Current Insights in Schizophrenia Research. - (92) Editorial Board Member of the Journal, PLOS ONE. - (93) Editorial Board Member of the Journal, Japanese Journal of Physical Medicine & Rehabilitation. - (94) Editorial Board Member of the Journal, International Journal of Anesthesiology Research.

- (95) Editorial Board Member of the Journal, Archives in Neurology and Neuroscience.

- (96) Editorial Board Member of the Journal, Journal of Ageing and Restorative Medicine.

Doctoral/Postgraduate Supervision: - Abdul K. Mohammed - Umeå University - Examined October, 1986. - Bruce G. Minor - Karolinska Institute - Examined March, 1987

- Johan Luthman1 - Karolinska Institute - Examined October, 1989. - Anders Fredriksson - Uppsala University - Examined September, 1994. - Torsten Norlander2 - Göteborgs Universitet - Examined May, 1997. - Nadja Schröder3 - University of Porto Alegro, Brazil - Examined 9th September, 1999. - Anki Nordmarker - Göteborgs Universitet – Psychology, examined for Master's degree, October, 2010, examined doctoral dissertation, december 2016.

8

Henrik Bergman- Göteborgs Univ. – Psychology - Master's(Lic), Examined 23rd october 2008

Anette Kjellgren- Göteborgs Universitet – PhD examined, 21 November, 2003. Överläkare Madeleine Zöller - Göteborgs University – Psychology, examined Masters 2009, examined doctoral dissertation, december 2016. Erik Wästlund - Göteborgs University – Psychology, examined 23rd February, 2007. Ulla Karilampi- Göteborgs University – Psychology, examined Masters 2009, Doctoral Dissertation examined 14th October, 2011. Thomas Theorin - Örebro University - Psychology

Cristina Diaz Berciano - Madrid University [Complutense] – examined Masters, 2004. Eva Johansson - Göteborgs university – Psychology, examined 2002. Per Kristiansson – Göteborgs university – PhD Examined 12th September, 2003. Nina Svensson – Göteborgs university- Psychology, examined Masters, October, 2010. Ann-Christine Andersson-Arntén – Göteborgs univ. – Masters’(Lic), Examined,9th may 2008

Caroline Wass6-Göteborgs university, Med.Fac Pharmacol, PhD,examined 14th December

2007

Lars Helldin4 – Uppsala university (Med.Fac.) – Psychiatry

Frank Stenman7 - Göteborgs university- Psychology

Erica Karlsson - Göteborgs university- Psychology – Masters (Lic), Examined, 9th may 2008; [Doctoral Dissertation examined 8th May (see below) ]. Erica Schütz, Göteborgs university- Psychology, Doctoral dissertation, 8th may, 2015. Per Hellström8 - Göteborgs university – Clinical Neuroscience, examined Doctoral Dissertation, May, 2011. Anders Hedin – Örebro universitet – Idrottsvetenskap, Stage I (75%) examination 2012-05-05; doctorsexamination 2012-05-25. Danilo Garcia9 – Göteborg university – Psychology, examined Doctoral Dissertation, 15th

March 2012. Sigvard Lingh – Uppsala universitet - Psychology

Kjell Svensson10 – Linnea university – Sports and Health Science. Ali Al Nima – Göteborg university – Masters in Psychology. 1assistent-supervisor (Behav.Pharm.) to Doc. G. Jonsson (Astra Arcus AB) 2with Dr. R. Gustafsson as assisting supervisor (Örebro University) 3with Dr. I. Izquierdo as joint-supervisor (University of Porto Alegro, Brazil) 4assistent supervisor with Doc. L. Ekselius (Uppsala university) 5assistent supervisor with Doc. L. Svensson (Med. Fac., GU) 7with Doc. I. Thylefors (Psychology), 8with Carsten Wikkelsöö 9with Anwer Siddiqui 10with Marie Alaricsson

External Examiner (Fakultetsopponent vid doktorsdisputation):

-Tapani Korhonen - Jyväskylää Universitet, Finland, 1987. -Per Kristian Ejde - Bergen Universitet, Faculty of Medicine, Norway, 1989. -Arto Hiltunen - Uppsala Universitet, Sverige, 1990. -Anders Lund - Bergen Universitet, Faculty of Medicine, Norway, 1992.

9

- Jonas Ahlbom - Uppsala Universitet, Faculty of Medicine, Uppsala, Sweden, 1995. -Riina Haidkind – University of Tartu, Tartu, Estonia, 2004. -Patrik Millet – University of Luleå, Sweden, 2005. -Pia Leppänen – University of Åbo, Åbo, Finland, 2009. Assignments to Committees for Decisions concerning Academic Positions:

Assessed Professorships, Deans, Readers, Lecturers.[University-position-recommendation]. Bergen-Professor-Dr. Håkan Sundberg, 1989, later appointed Dean of Social Sciences, 1990

Cambridge university-Reader-Barry Everitt, 1989

Uppsala University-Professor-Dr. Bo Ekehammer, 1992, Stockholm University-Professor-Dr. Lars-Göran Nilsson, 1993, Umeå University-Professor-Dr. Claes von Hofstein, 1995, Lund University-Professor-Dr. Kenneth Hugdahl [Proposed], 1994, Trondheim University-Professor-Dr. David Benton[Proposed], 1995, Trondheim University-Professor-Dr. S. Hansen[Proposed], 1995, Liverpool University-Professor-Dr. Steven Cooper [Proposed], 1994, Nottingham University-Professor-Dr. Steven Cooper[Proposed], 1993, Leeds University – Professor - Dr. Steven Cooper[Proposed], 1991, Leeds-Professor-Dr. R. John Rodgers, 1997, University of California at Irvine-Distinguished (Outstanding level & Academy of Science)-

Professor-Dr. James L. McGaugh, 1988, Liverpool-Professor-Dr. Everard Thornton, 1992, Åbo University- Professorship in the Humanities at the Swedish Language - Åbo Academy

University [Åbo Akademi, Humanistiska fakulteten], Matti Lainen, 2000, Göteborg- Assoc. Professor-Ulf Berggren [Faculty of Dentistry], 1995, Göteborg - Full Professor-Ulf Berggren [Faculty of Dentistry], 2003, Uppsala - Full Professor-Mona Eliasson [Faculty of Social Sciences], 2003, Mittuniversitet, Östersund – Full Professor-Stig Vinberg [hälsovetenskap med inriktning mot arbetsliv]. 2011. Karlstad Universitet, Institutionen för Sociala och Psykologiska studier, Professor i Psykologi – Anna Stigsdotter Neely, feb., 2015. Hawaii-Fellow for Center of Advanced Studies in Behavioural Sciences-Professor Caroline Blanchard, 1995, Tel Aviv,Isreal-Assistent Professor-Dr. Ina Weiner, 1991, 1993, Institute of Neurology, University of London-Reader-Dr. J.L. Herberg, 1990, Liverpool-Reader-Dr. Everard Thornton, 1989, Lancashire Polytechnic-Dean of Nursing Faculty-Dr. Everard Thornton, 1993, Newcastle, NSW, Australia-Associate Professor- Dr. H. Peter Pfister, 1990, again 1992, and again 1993. Tel Aviv, Israel-Senior Lecturer+Fellow- Dr. Ina Weiner, 1990, again 1992. Tuebingen, Germany – Prof. Werner Schimdt – Career assessment for MaxPlanck Institute, 2006. Örebro-Lecturer-Dr. Pia Wennerholm, 2002,

10

Örebro-Lecturer-Dr. Annika Lantz, 2002, University of the West Indies-Senior Lecturer- Dr. E. Thornton, 2002

London-Psychiatric Consultant-Dr. Madeleine Zöller, 2002, East Anglia- Psychiatric Consultant-Dr. Madeleine Zöller, 2002, Exeter- Psychiatric Consultant-Dr. Madeleine Zöller, 2002, Thames region- Psychiatric Consultant-Dr. Madeleine Zöller, 2002, University of West Indies, Trinidad-Senior Lecturer-Everard Thornton, 2003, Örebro-Lecturer-Dr. Anna Karen Andersson, 2003, Örebro-Lecturer-2005

Örebro-Lecturer- Clinical Psychology-2006

Örebro-two lectureships-Psychology(developmental)-2008

Linné University lectureship-Clinical and Neuropsychology – Karin Grip – 2014. Karlstad University lectureship-Psychology-2015-Anna Neely-

Umeå University Lectureship-Sports Psychology-2015-6 - Uppsala-Docent-Dr. Mona Eliasson, 1989, Professorship, 2007. Stockholm-Docent-Dr. Marie-Louise Wadenberg, 1998, Luleå-Docent-Dr. Karl W. Sandberg, 1998, Jyväskylä-Docent-Dr. Tapani Korhonen, 1990, Göteborg-Docent-Dr. Lena Nordholm, 1994, Göteborg-Docent-Dr. Torsten Klint, 1993, Göteborgs University, Social Sciences Faculty, Docent, Danilo Garcia, 2015. Göteborgs University, Social Sciences Faculty, Docent, Max Rapp-Ricciardi, 2016. Göteborgs University, Social Sciences Faculty, Docent, Lillemor Adrinson, 2016. Between 20-22 other senior lectureships/professorships (e.g. von Hofstein, Erneling, Lyxell, Hemlin, Öhlund, Molander, Lundquist, Persson, Gustafsson, etc,) lectureships, and 'forskarassistent-ships' (e.g. Nyberg, Gustafsson) not listed above have been carried out for Swedish and foreign universities. Books/Edited Journal Issues: 1. Perspectives on Learning and Memory, coedited by L.G. Nilsson and T. Archer, LEA, New Jersey, 1985. 2. Aversion, avoidance and Anxiety: Perspectives on aversively motivated behavior, coedited by T. Archer and L.G. Nilsson, LEA, New Jersey, 1989. 3. Attention Deficit Disorder: Clinical and Basic Research, coedited by T. Sagvolden and T. Archer, LEA, New Jersey, 1989. 4. Behavioral Pharmacology of 5-HT, coedited by P. Bevan, A. Cools and T. Archer, LEA, New Jersey, 1989. 5. Behavioral Biology: Neuroendocrine Axis, coedited by Trevor Archer and Stefan Hansen, Lawrence Erlbaum Assoc. Publ., New Jersey, 1991. 6. Strategies for Studying Brain disorders: Affective Disorders and Drug Abuse, Vol. 1, coedited by Tomás Palomo and Trevor Archer, Farrand Press and Complutense, London and Madrid, 1994. 7. Strategies for Studying Brain disorders: Schizophrenia, Movement and age related

11

cognitive disorders, Vol. 2, coedited by T. Palomo, T. Archer and R. J. Beninger, Farrand Press and Complutense, London and Madrid, 1994. 8. Dopamine Disease States.Edited by R.J. Beninger, T. Palomo and T. Archer, Madrid

University Press, 1996. 9. Estados Patológicos De La Dopamina, Edited by R.J. Beninger, T. Palomo and T. Archer, Madrid University Press, 1997. 10. Interactive Monoaminergic Disorders. Edited by T. Palomo, R.J. Beninger and T. Archer, Madrid University Press-Editorial Sintesis, 1999. 11. Avances Neurocientificos y Realidad Clinica.I TRASTORNOS AFECTIVOS. [Advances in Neurosciences and Clinical Realities. I Affective Disorders], Edited by T. Palomo, R.J. Beninger, M.A. Jiménez-Arriero and T. Archer, Editorial Sintesis, 1999. 12. Avances Neurocientificos y Realidad Clinica. II TRASTORNOSESQUIZOPSICÓTICOS. [Advances in Neurosciences and Clinical Realities.II Schizopsychotic Disorders], Edited by T. Palomo, R.J. Beninger, M.A. Jiménez-Arriero and T. Archer, Editorial Sintesis, 2000. 13. Avances Neurocientificos y Realidad Clinica.III ALCOHOLISMO Y

TOXICOMANIAS. [Advances in Neurosciences and Clinical Realities.III Substance Abuse

Disorders], Edited by T. Palomo, R.J. Beninger, M.A. Jiménez-Arriero and T. Archer, Editorial Sintesis, 2001. 14. Catecholamines in Brain Disorders. Edited by T. Palomo, R.J. Beninger and T. Archer, Madrid University Press, 2001, in press. 15. Neurodegenerative Brain Disorders. Edited by T. Palomo, R.J. Beninger and T. Archer, Editorial Sintesis, Madrid, 2001. 16. Neurotoxicity Research: Neurotoxicological Aspects of Drug Abuse. Edited by R.M. Kostrzewa and T. Archer, Harwood Academic Publications, London, 2000. 17. Neurotoxicity Research: Neuroprotection and Restoration. Edited by R.M. Kostrzewa

and T. Archer, Harwood Academic Publications, London, 2000, Volume 2. 18. Avances Neurocientificos y Realidad Clinica.IV TRASTORNOS COGNITIVOS. [Advances in Neurosciences and Clinical Realities.IV Cognitive Disorders], Edited by T. Palomo, R.J. Beninger, M.A. Jiménez-Arriero and T. Archer, Editorial Sintesis, 2001. 19.Neurodevelopmental Liabilities Underlying Brain Disorders. Edited by T. Palomo, R.J. Beninger, R.M. Kostrzewa and T. Archer, Graham Publishing, Graham Publishing, Mountain View, 2003. 20.Avances Neurocientificos y Realidad Clinica. V NEUROIMAGEN EN

PSIQUIATRIA,[Advances in Neurosciences and Clinical Realities. v Neuroimaging

in psychiatry], Edited by T. Palomo, R.J. Beninger, M.A. Jiménez-Arriero and T. Archer, Editorial Sintesis, 2002. 21. Neurotoxicity Research: Neurodevelopmental liabilities in Drug Abuse. Edited by R.M. Kostrzewa, T. Palomo, R.J. Beninger, & T. Archer, Harwood Academic Publications, London, 2002. 22. Neurotoxicity Research: Neurodevelopmental liabilities in Schizophrenia and Affective Disorders. Edited by R.M. Kostrzewa, T. Palomo, R.J. Beninger, & T. Archer, Harwood Academic Publications, London, 2002. 23. Neurotoxicity Research: Neurodevelopmental liabilities in Movement disorders. Edited by T. Archer, Graham Academic Publications, London, 2003. 24. Gene-Environment interplay in Alcoholism and Substance Abuse Disorders. Edited

12

by T. Palomo, R.J. Beninger, R.M. Kostrzewa and T. Archer, Graham Publishing, Mountain View, 2004. 25. Gene-Environment interplay in Affect and Dementia. Edited by T. Archer, Graham

Academic Publications, Mountain view, 2004. 26. Gene-Environment interplay in Neurogenesis and Neurodegeneration, .Edited by T. Palomo, R.J. Beninger, R.M. Kostrzewa and T. Archer, Graham Publishing, Mountain View, 2004. 27. Gene-Environment interplay in Schizopsychotic Disorders, Edited by T. Palomo, T. Archer, R.M. Kostrzewa and R.J. Beninger, Graham Publishing, Mountain View, 2005. 28. Gene-Environment interplay in Neuropsychiatric Disorders, Edited by RJ Beninger, T

Palomo, RM Kostrzewa and T Archer, Graham Publishing, Madrid and Mountain View, 2005. 29. Implications of Co-morbidity for Neuropsychiartic Disorders, Edited by T Palomo, RJ

Beninger, RM Kostrzewa and T Archer, Graham Publishing, Madrid and Mountain View, 2007. 30. Neuronal Substrates of Co-morbidity, Edited by T. Archer, Volume 12, Graham

Publishing, Madrid and Mountain View, 2007. 31. Beyond Neuropsychiatric Diagnostics: Symptoms not Disorders, Edited by T Palomo, RJ Beninger, RM Kostrzewa and T Archer, Graham Publishing, Madrid and Mountain View, 2009. 32. Handbook of Neurotoxicity: Neurologic and Psychiatric Disease, Edited by T. Archer

and U. Sailer, Springer, 2014. 33. Book Series: Frontiers in Personality Science and Individual Differences, with Danilo

Garcia. Nature Publishing Group and Frontiers. 34. Neurotoxin Modelling of Brain Disorders – Life-long Outcomes in Behavioral Teratology.

RM Kostrzewa and T Archer, Springer, 2016.

35. Immunolgy and Psychiatry, book authors: Muller, Myint & Schwartz, series editors: RM

Kostrzewa and T Archer, Springer, 2016.

36. Toxicity and Autophagy in Neurodegenerative Disorders, book author: Fuentes, JM;

series editors: RM Kostrzewa and T Archer, Springer, 2018.

37. Pituitary Adenylate Cyclase Activating Polypeptide – PACAP, book authors: Reglodi, D &

Tamas, A; series editors: RM Kostrzewa and T Archer, Springer, 2018.

38. Personality and Brain Disorders: associations and interventions, book authors: Garcia D,

Kostrzewa RM & Archer T, Springer, 2018.

39. Synthetic Cathinones, book author: Zawilska, JB; series editors: RM Kostrzewa and T

Archer, Springer, 2018.

TEXTBOOK OF PSYCHOLOGY: Psychology and Life

13

Gerrig, R.J., Zimbardo, P.G., Svartdal, F., Brennen, T., Donaldson, R., Archer, T. Psychology and Life, Pearson Publishing, 2012. TEXTBOOK of PSYCHOLOGY: Comer and Gould “Psychology Around US”. Chapter 5: Behavioural Neuroscience.Adaptation. Wiley: Chichester, 2013. PhD Program Department of Psychology Course: Scientific Writing. Grant Assessments

Fonds Wetenshappelijk Onderzoek – Research Foundation Flanders: “Levenslijn”

HSFR - Sweden [3-year committee]

Riksbanks Jubileum Fond - Sweden [7 + 1 major projects]

MFR - Sweden

FRN - Sweden

National Science Foundation - USA

National Institute of Drug Abuse - USA

Natural Sciences & Engineering Research Council of Canada

Medical Research Council–Swindon, UK [3 occasions]

Adlerbrecktskafond

Lundgrensfond

Wallenbergsfond

European Behavioural Pharmacology Society – Travel Grant awards. Foundation for Polish Science (x 2)

Estonian Science Foundation (x 2)

Health Research Board of the Republic of Ireland (x 3). Medical Research Council. Programma Nazionale di Ricerche in Antartide (PNRA)Italian Scientific Committee for Antarctic

Research

Italian Medical Research Council. Polish Science Foundation. Successful Nominations for the Award of Honorary Doctorships - University of

Göteborg

Professor Robert Hinde, Master of St. John’s College, University of Cambridge, UK.[Faculty of

Social Sciences], 1991. Professor Gary Olson, University of Toronto, Department of Psychology, Canada.[Faculty of Social Sciences], 1994.

14

Professor Lewis S. Seiden, Founder of the Seiden Laboratory of Physiological and

Pharmacological Sciences and Psychiatry, University of Chicago, USA. [Faculty of Medicine], 1999. Professor Steven Cooper, University of Liverpool, UK.[Örebro University], 2002. Nomination Pending: Professor Thomas N Chase, NIH [Faculty of Medicine, Göteborg

university]. Professor C. Robert Cloninger, University of Washington at St. Louis at Missouri, USA. 2012. Conferences, Symposia and Meetings

1. 1984 Perspectives on Animal Learning and Human Memory, Umeå, Sweden, June

16-21, with L.G. Nilsson. 2. 1986 Inaugural Meeting of the European Behavioural Pharmacology Society, Antwerp, Belgium, June 29-July 5, with F.C Colpaert, T.W Robbins, M. Lyon and I. Stolerman. 3. 1987 Neurotoxins in Mental Disorders, Kuopio, Finland, May 28-29, with C. Fowler. 4. 1987 Perspectives on Aversively Motivated Behaviour, Umeå, Sweden, June 17-21, with L.G. Nilsson. 5. 1987 Attention Deficit Disorder: Basic and Clinical Issues, Oslo, Norway, with T. Sagvolden. 6. 1987 Behavioural Pharmacology of 5-HT, Amsterdam, Netherlands, October 27-31, with P. Bevan, C. Broekkamp and A.R. Cools. 7. 1988 First Polish-Swedish Meeting on Structure and Function in

Neuroharmacology, Zoborow, Warsaw, Poland, May 4-8, with W. Kostowski. 8. 1988 The Neurobiology of Memory, Umeå, Sweden, June 5-7, with L-G Nilsson. Among the Invited Speakers: Eric Kandel, Endel Tulving, Larry Weiskrantz, Dick Thompson. Eric Kandel was Nobel Prize Laureate 2000. 9. 1988 Second Meeting of the European Behavioural Pharmacology Society, Athens, Greece, September 2-5, with F.C. Colpaert, R. Dantzer, C. Spyraki, and I. Stolerman. 10. 1989 International Meeting in Honour of Knut Larsson: Neuroendocrine Axis in

Behavioural Biology, Göteborg, Sweden, December 13-16, with S. Hansen. 11. 1990 Symposium in Memorium of Conrad Lorenz ”International Symposium on

Evolutionary Aspects of Behavioural Sciences”, Göteborg, Sweden, May 21-24, with Percy

Löwenhardt (deceased). 12. 1990 Third Meeting of the European Behavioural Pharmacology Society, Noordwuitkahout, Netherlands, June 29-July 4, with F.C. Colpaert, A.R. Cools, M. Kruk, and I. Stolerman. 13. 1991 Second Polish-Swedish Meeting on Structure and Function in

Neuropharmacology, Zacopane, Poland, September 16-21, with Edmund Przegalinski.

15

14. 1992 International Meeting on Strategies for Studying CNS Active Compounds:

Models, Screens and Clinical Syndromes, April 26-May 3, Madrid, Spain, with T. Palomo, and

L.S. Seiden. 15. 1992 Fourth Meeting of the European Behavioural Pharmacology Society, Cambridge, England, August 7-11, with F.C. Colpaert, A.R. Cools, T.W. Robbins, and I. Stolerman

16. 1992 Developmental Toxicology - Preclinical and clinical data in retrospect, August

27-28, Stockholm, Sweden. 17. 1993 3rd International Congress on Amino Acids and Analogues, August 23-27, Vienna, with W. Danysz. 18. 1995 International Symposium on Dopamine Disease States, October 18-21, Mojacar, Spain, with T. Palomo and R.J. Beninger. 19. 1996 World Congress of Psychiatry - Symposia organised by T. Palomo and T. Archer: I. Some aspects of movement disorders

II. Dopamine dysfunction in psychiatric disorders

III. Schizophrenia: Dopamine - serotonin interactions

IV. Dopamine - serotonin interactions in disorders of affect

V. Sensitization in drug addiction

VI. Brain imaging in psychiatric disorders

Aspects of molecular biology in psychiatric disorders relating to memory and aging. 20. 1996 Symposium Organiser: "Neurodegenerative Bases of Movement Disorders" at

the Fifth Meeting of the European Behavioural Pharmacology Society, Cagliari, Sardinia, 16th-21st May. 21. 1997 Estadios Patológicos de la Dopamina, Maj 29-30, Madrid, Spain, with J. Marechal and T. Palomo. 22. 1997 Interactive Monoaminergic Basis of Brain Disorders, October 8-12, Mojacar, Spain, with T. Palomo. 23. 1998 Catecholamines in Brain Disorders, November 20-21, Madrid, Spain, with T. Palomo. 24. 1999 Neurotoxicology, Degeneration and Protection in Brain Disease States, October

15-19, Mojacar, Spain, with T. Palomo and J. Borrell. 25. 2000 Advances in Neuroscience: Affective Disorders, January, 27-30, Madrid, Spain, with T. Palomo. 26. 2000 Advances in Clinical Neuroscience: Schizopsychotic Disorders, June, 7-10, Madrid, Spain, with T. Palomo. 27. 2001 Advances in Clinical Neuroscience: Substance Abuse Disorders, January, 25-28, Madrid, Spain, with T. Palomo. 28. 2001 Advances in Clinical Neuroscience: Cognitive Disorders and Dementia, June, 21-23 Madrid, Spain, with T. Palomo. 29. 2001 Joint Meeting of the Royal Medical Society (London) and Cerebro y Mente

(Madrid) on Neurologic and Psychiatric Brain Disorders with T. Palomo and R. Guiloff, May

2-6, Madrid, Spain. 30. 2001 (Proposal) Third Polish-Swedish Meeting on Structure and Function in

16

Neuropharmacology: Neurotoxicity and Neurodegeneration, With W. Danysz, R. Kostrzewa

& J. Vetulani, Zacopane, Poland. 31. 2001 NATO Conference on Etiologic Auto-toxic Cellular Processes in

Neurodegenerative and Neuropsychiatric Disorders: Neuroprotective Strategies, to be held in Padua, Italy, in July, with Richard M. Kostrzewa, East Tennessee State University, Quillen

School of Medicine. 32. 2001 Neurodevelopmental Liabilities in Brain Disease States, October 18-22, Mojacar, Spain, with T. Palomo. 33.2001 Advances in Clinical Neuroscience: Movement and Neurodegenerative

disorders, January, 21-23 Madrid, Spain, with T. Palomo. 34. 2002 Advances in Clinical Neuroscience: neuroimaging in psychiatry, January

24-26, Madrid, Spain, with T. Palomo. 35. 2003 Mechanisms for Neurodegenerative Disorders, April, 25-27, La Serena, Chile, with J. Segura-Aguilar and R. Kostrzewa. 36. 2003 Neurovulnerabilty for Brain Disease Due to Genetic-Environment Agents, October 15-19, Mojacar, Spain, with T. Palomo. 37. 2005 World Congress of Parkinsonism and Related Disorders, June 5-9, Berlin, with

P. Riederer and M. Youdim. 38. 2005 Implications of Comorbidity for Etiology and Treatment of Neuropsychiatric

Disorders, October 19-23, Mazagon, Spain, with T. Palomo. 39. 2005 Advances in Clinical Neuroscience: Dopaminergic systems in psychiatric

disorders, May 12-15, Madrid, Spain, with T. Palomo. 40. [Under planning] 2008 Congress on the Brain in Health and Ill-health, October, North

Point, Darjeeling, India, with the Rector, Headmaster and Principle of St. Joseph’s College and School. 41. 2007 World Congress of Parkinsonism and Related Disorders, 9-13 December, Amsterdam, with E. Wolters. 42. 2007 Progress in Alzheimer’s disease and Parkinson’s disease: Meeting in Honour

of Moussa Youdim’s 45 years in Science. 3-6th October, Haifa, Isreal. 43. 2007 III Neurotoxicity Society Meeting: Mechanisms of Neurodegenerative

Disorders, 23-27 March, Pucon, Chile. 44. 2007 Beyond Neuropsychiatric Diagnostics: Symptoms not Disorders, October

17-21, Mazagon, Spain, with T. Palomo. 45. 2009 Staging in Neuropsychiatric Disorders: Etiopathogenesis and Treatment, October 14-19, Mojacar, Spain, with T. Palomo. BIT’s 4th Annual World Congress of NeuroTalk-2013

Theme: Advances and Challenges in Neurosciences, Xi’an, China

Advisory Board Member. 46. Symposium Organiser: “ADHD: Diagnosis, Incidence and Intervention”; International Academy of Law and Mental Health, Vienna, 13-17 July, 2015. Springer Book Series on “HANDBOOK OF NEUROTOXICITY”

Series Editors: RM Kostrzewa and T Archer

17

Volumes number: 1. (Mal)adaptive Aspects of Developmental Stress. Eds: G Laviola & S Macri. 2. Isoquinolines and Beta-carbolines as Neurotoxins and Neuroprotectants. Eds. L

Antkiewicz-Michaluk & H Rommelspacher. 3. Methylmercury and Neurotoxicity. Eds: S Ceccatelli & M Aschner. 4. Immunology and Psychiatry: from Basic to Clinic. Eds. N Müller & AM Myint. Award 2010

Lifetime Achievement Award from St. Joseph’s College, North Point.

Diploma (Phillip Khan-Panni, Chairman Alumnus Society) and NP Shield. Award 2013

Honorary Member of the Polish Pharmacological Society 2013

To be Conferred may, 23-25, 2013. Awards 2013

Honorary Professor and Honorary Professor in Pharmacology, Polish Science Academy and Pharmacological Society

23rd May, 2013. Invitation 2014

Sansone Lecture on Well-being.University of Washington at St. Loius, Missouri.8thApril, 2014

Award 2014

The Sansone Award, University of Washington, St. Louis, Missouri, USA. Judicial assignments

Expert Witness: Mål nr 27370-10, Socialnämnden I Gotlands kommun (Lagman Peter

Freudenthal) Datum: 2010-09-02. Expert Witness: Mål nr T 1058-11 27370-10, Socialnämnden I Gotlands kommun

(Rådmannen Kristina Wirdemark)Datum: 2012-05-30. Journals for which manuscripts have been reviewed 2000-2014

Abnormal & Behavioral Psychology

Acta Neurologica Scandinavica (15+)

Acta Psychiatrica Scandinavica

18

Addiction Research & Therapy [OMICS]

Aging Science

Alcoholism & Drug Dependence

Alzheimer’s Disease & Parkinsonism

American Journal of Psychiatry

Annals of Sports Medicine and Research

Annual Research and Review in Biology

Anxiety, Stress & Coping

Appetite

Archives of Physical Medicine and Rehabilitation (5)

Asian Journal of Social Psychology

Autism-Open access

Basic and Clinical Pharmacology and Toxicology

Behavioural Brain Research

Behavioural Pharmacology (30+)

Behavioral & Neural Biology

Biological Psychiatry

BMC Neuroscience

BMC Psychiatry

Brain

Brain & Behavior

Brain, Behavior & Immunity

Brain Disorders & Therapy

Brain Research

Brain Research Bulletin

Brain Sciences

British Journal of Education, Society & Behavioural Science

British Journal of Pharmacology

Cell & Molecular Biology x 5

Chemico-Biological Interactions

Clinical and Experimental Psychology

Clinical Depression

Clinical Epigenetics

Clinical Medical Journals

Cognitive, Affective and Behavioral Neuroscience

Current Neuropharmacology

Contemporary Clinical Trials

Degenerative Neurological and Neuromuscular Disease

Epigenetics in Creativity

Current Psychiatry Reviews

Early Child Development and Care

Environmental Toxicology & Pharmacology

European Child & Adolescent Psychiatry

European Journal of Oral Science

European Journal of Parapsychology

European Journal of Pharmacology

European Journal of Psychiatry

19

European Neuropsychopharmacology

Frontiers in Aging Neuroscience

Future Medicine: Clinical Practice

General Pharmacology

General Hospital Psychiatry

Global Journal of Allergy

Healthy Aging Research

Health and Quality of Life Outcomes

Intellectual Disability Diagnosis Journal International Journal of Developmental Neuroscience

International Journal of Educational Policy Research and Review

International Journal of Emergency Mental Health and Human Resilience

International Journal of Mental Health and Psychiatry

International Journal of Molecular Sciences: Neurological Injuries

International Journal of Molecular Sciences: Biochemistry, Molecular Biology and

Biophysics

International Journal of Emergency Mental Health and Human Resilience

International Journal of Neuropsychopharmacology

International Journal of Psychology

International Journal of School and Cognitive Psychology

Journal of Addiction Research & Therapy (5)

Journal of AIDS and Clinical Research

Journal of the American Aging Association

Journal of Clinical Medicine and Research

Journal of Cross-Cultural Psychology

Journal of Depression and Anxiety Journal of Education and Learning

Journal of Health Education Research & Development

Journal of Health Science

Journal of Intellectual Disability-Diagnosis and Treatment

Journal of Neural Transmission

Journal of Neurological Disorders

Journal of Neurology

Journal of Novel Physiotherapies

Journal of Positive Behavior Interventions

Journal of Psychopharmacology

Journal of Physical Activity and Health

Journal of Research and Development

Journal of Signs and Symptoms

Learning & Memory

Learning & Motivation Medical Journals

Molecules

Molecular Psychiatry

Naunyn-Schmiedeberg’s Archives of Pharmacology

Neurodegenerative Disease Management

Neurology and Neurophysiology

20

Neuropsychiatric Disease and Treatment

Neurorehabilitation

Neuroscience

Neuroscience and Biobehavioral Reviews (5)

Neuroscience Letters

Neuropharmacology

NeuroReport

Nordic Journal of Psychiatry

Nordic Psychology

Nutritional Journal OMICS PUBLISHING GROUP/ACR

OMICS General Medicine

Open Toxinology Journal Neurotoxicity Research (30+)

Personality Science and Individual Differences: Character, Responsibility and Well-Being

Pharmacology, Biochemistry & Behavior

Pharmacology & Toxicology

Physiology & Behaviour

PLOS ONE

Progress in Neuro-psychopharmacology & Biological Psychiatry

Psychoneuroendocrinology

Psychopharmacology

PsychJournal Psychological Reports: Perceptual & Motor Skills

Psychology and Psychotherapy

Psychology Research and Behavior Management

Scandinavian Journal of Psychology

Scandinavian Journal of Medical Science & Sports

Schizophrenia Bulletin

Schizophrenia Research

ScienceAsia

Scientific Research and Essays

Social Behavior and Personality

Stress & Health (10+) – Reviewer Runner-up Commendation Award 2012 –

Cary L Cooper, CBE, Editor-in-Chief, Stress and Health Journal, Wiley

Blackwell. The World Journal of Biological Psychiatry

Trends in Cognitive Sciences

Series Volume Reviews: Neuropathology of Drug Addictions and Substance Misuse, Editor: V. Preedy, three volumes. Prepublication textbook reviews: Worth Publishers [Kolb & Wishaw: Biological Psychology; Gray: Psychology]. Harwood Academic Publications. Sinauer Associates.

21

Lawrence Erlbaum Associates. McGraw-Hill [Passer & Smith: Psychology]

Thompson publications

Pearson Group

John Wiley & Sons

Elsevier: Proposal V. Preedy “Neuropathology of Drug Addictions and Substance Misuse.”

TREVOR ARCHER -LIST OF PUBLICATIONS

* 1. Sjödén, P.O. & Archer, T. Conditioned taste-aversion to saccharin induced by

2,4,5-Trichlorophenoxyacetic acid in rats. 5th Scandinavian Meeting on "Physiology

and Behavior", 1977, p. 40.

* 2. Sjödén, P.O. & Archer, T. Conditioned taste-aversion to saccharin induced by

2,4,5- Trichlorophenoxyacetic acid in albino rats. Physiology and Behavior, 1977, 19,

157-161.

* 3. Sjödén, P.O., Archer, T., Nilsson, L.G., & Carter, N. The role of environmental

context in taste-aversion conditioning as measured during extinction: Implications for

a cognitive theory. 5th Scandinavian Meeting on "Physiology and Behavior", 1977, p.

41.

* 4. Sjödén, P.O., Archer, T., & Söderberg, U. Effects of 2,4,5 Trichlorophenoxyacetic

acid (2,4,5-T) on radioiodine distribution in rats. Bulletin of Environmental

Contamination and Toxicology, 1977, 17, 670-678.

* 5. Doctoral Dissertation: Archer, T. Associative and non-associative processes in

taste-aversion learning: Exteroceptive context and neophobic responses. Acta

Universitatis Upsaliensis, 18, 1979.

6. Archer, T. & Sjödén, P.O. Positive correlation between pre- and post-conditioning

saccharin intake in taste-aversion learning. Animal Learning and Behavior, 1979, 7,

144-148.

* 7. Archer, T. & Sjödén, P.O. Novel vs familiar exteroceptive contexts in tasteaversion

conditioning and extinction. Report No. 246, Dept. of Psychology, Uppsala University,

1979.

8. Archer, T. & Sjödén, P.O. Neophobia in taste-aversion conditioning: Individual

differences and effects of contextual changes. Physiological Psychology, 1979, 7, 364-

369.

22

9. Archer, T., Sjödén, P.O., & Carter, N. Control of taste-aversion extinction by

exteroceptive cues. Behavioral and Neural Biology, 1979, 25, 217-226.

10. Sjödén, P.O., Archer, T., & Carter, N. Conditioned taste-aversion induced by

2,4,5-Trichlorophenoxyacetic acid: Dose-response and pre-exposure effects.

Physiological Psychology, 1979, 7, 93-96.

11. Archer, T., Sjödén, P.O., Nilsson, L-G., & Carter, N. Role of exteroceptive background

context in taste-aversion conditioning and extinction. Animal Learning and

Behavior, 1979, 7, 17-22.

1980

12. Archer, T. & Sjödén, P.O. Context-dependent taste-aversion learning with a

familiar conditioning context. Physiological Psychology, 1980, 8, 40-46.

13. Archer, T., Sjödén, P.O., Nilsson, L-G., & Carter, N. Exteroceptive context in

taste-aversion conditioning and extinction: Odour, cage and bottle stimuli. Quarterly

Journal of Experimental Psychology, 1980, 32, 197-214.

14. Archer, T., Ögren, S.O., Fuxe, K., & Johansson, G. Studies on the functional role

of brain noradrenaline with the NA neurotoxin N-2-chloroethyl-N-ethyl-2-bromobenzyl

amine hydrochloride (DSP4). Neuroscience Letters, 1980, Suppl. 5, p. 458.

15. Rönnberg, J., Archer, T., & Ohlsson, K. Temporal factors in audition and vision: A

functional emphasis. Scandinavian Journal of Psychology, 1980, 21, 241-247.

16. Ögren, S.O., Archer, T., Holm, A-C., & Johansson, G.Acute and long-term effects

of p-chloroamphetamine in one-way and two-way avoidance learning. Neuroscience

Letters, 1980, Suppl. 5, p. 466.

17. Ögren, S.O., Archer, T., & Ross, S.B.Evidence for a role of the locus coeruleus

noradrenaline system in learning. Neuroscience Letters, 1980, 20, 351-356.

18. Ögren, S.O., Fuxe, K., Archer, T., Hall, H., Holm, A-C., & Köhler, C. Studies on

the role of central 5-HT neurons in avoidance learning: A behavioral and biochemical

analy sis. In: Serotonin: Current Aspects of Neurochemistry and Function, B. Haber

and S. Gabay (Eds.), Plenum Press, 1980, pp. 681-705.

1981

19. Archer, T. & Sjödén, P.O. Environment-dependent taste-aversion extinc

23

tion: A question of stimulus novelty at conditioning. Physiological Psychology, 1981, 9,

102-108.

20. Archer, T., Ögren, S.O., Fuxe, K., Agnati, L., & Eneroth, P. On the interactive role

of central noradrenaline neurons and corticosterone in two-way active avoidance

acquisition in the rat. Neuroscience Letters, 1981, 27, 341-346.

21. Archer, T., Ögren, S.O., & Johansson, C. The acute effect of p-chloroam

pheta-mine on the retention of fear conditioning in the rat: Evidence for a role of

serotonin in memory consolidation. Neuroscience Letters, 1981, 25, 75-81.

22. Archer, T., Ögren, S.O., & Ross, S.B. N-2-chloroethyl-N-ethyl-2-bromoben

zyl-amine hydrochloride (DSP4), a new selective noradrenaline neurotoxin, and taste

neophobia in the rat. Physiological Psychology, 1981, 9, 197-202.

23. Archer, T., Ögren, S.O., Ross, S.B., & Johansson, G. DSP4, a selective noradrenaline

neurotoxin, and avoidance learning in the rat. In: Quantification of Steady-State

Operant Behavior, C.M. Bradshaw, E. Szabadi and C.F. Lowe (Eds.), Elsevier/North-

Holland Biomedical Press, 1981, pp. 445-448.

24. Sjödén, P.O. & Archer T. Associative and non-associative effects of exter-oceptive

context in taste-aversion conditioning with rats. Behavioral and Neural Biology, 1981,

33, 74-92.

* 25. Toneby, M., Archer, T., Hall, H., & Magnusson, O. Behavior teratological effects of

prenatal haloperidol treatment on rat offspring. 2nd International Meeting of the

Society for Developmental Neuroscience, 1981, p. 88.

26. Ögren, S.O., Archer, T., Fuxe, K., & Eneroth, P. Glucocorticoids, catechola-mines

and avoidance learning. In: Steroid Hormone Regulation of the Brain, K. Fuxe, J-Å.

Gustafsson and L. Wetterberg (Eds.), Pergamon Press, 1981, pp. 355-377.

* 27. Ögren, S.O., Archer, T., Fuxe, K., Johansson, G., & Holm, A-C. Behavioral and

biochemical studies on the effects of chronic administration of antidepressant drugs

on central serotonergic receptor mechanisms. Symposium Abstract from New Vistas

on Depression, 1981, Japan.

* 28. Ögren, S.O., Archer, T., Holm, A-C., & Johansson, G.5-HT depletion and

avoidance acquisition as a function of shock intensity. 5th European Neuro

science Congress, 1981, p. 523, Liege, Belgium.

29. Ögren, S.O., Archer, T., Holm, A-C., & Ross, S.B.Separating the associative

24

effects of serotonin depletors on active avoidance learning. In: Quantification of

Steady-State Operant Behavior, C.M. Bradshaw, E. Szabadi and C.F. Lowe (Eds.),

Elsevier/North-Holland Biomedical Press, 1981, pp. 449-452.

1982

30. Archer, T. DSP4-(N-2-chloroethyl-N-ethyl-2-bromobenzylamine), a new

noradrenaline neurotoxin, and stimulus conditions affecting acquisition of two-way

active avoidance. Journal of Comparative and Physiological Psychology, 1982, 96,

476-490.

31. Archer, T. Serotonin and fear retention in the rat. Journal of Comparative and

Physiological Psychology, 1982, 96, 491-516.

32. Archer, T. The role of noradrenaline in learned behaviors: Studies using DSP4.

Scandinavian Journal of Psychology, 1982, Suppl. 1, 61-71.

33. Archer, T., Cotic, T., Järbe, T.U.C. Attenuation of the context effect and lack of

unconditioned stimulus-preexposure effect in taste-aversion learning following

treatment with DSP4, the selective noradrenaline neurotoxin. Behavioral and Neural

Biology, 1982, 35, 159-173.

* 34. Archer, T., Ross, S.B., Johansson, G., & Jonsson, G. Systemic DSP4, a selective

noradrenaline neurotoxin, and two-way avoidance acquisition in the rat: Parametric

relationships. 5th European Neuroscience Congress, 1982, p. 177, Liege, Belgium.

* 35. Archer, T., Ross, S.B., Ögren, S.O., Johansson, G., & Johansson, C.Serotonin and

avoidance acquisition and retention. 6th European Neuroscience Congress, 1982, p.

283, Torremolinos, Spain.

36. Archer, T. & Sjödén, P.O. Higher-order conditioning and sensory preconditioning

of a taste-aversion with an exteroceptive CS1. Quarterly Journal of Experimental

Psychology, 1982, 34, 1-17.

37. Archer, T., Ögren, S.O., Johansson, G., & Ross, S.B. DSP4-induced two-way

active avoidance impairment in rats: Involvement of central but not peripheral

noradrenaline depletion. Psychopharmacology, 1982, 76, 303-309.

38. Archer, T., Ögren, S.O., & Ross, S.B. Serotonin involvement in aversive

conditioning: Reversal of the fear retention deficit by long-term p-chloroamphetamine

but not pchlorophenylalanine. Neuroscience Letters, 1982, 34, 75-82.

25

* 39. Archer, T., Ögren, S.O., Ross, S.B., Johansson, G., & Johansson, C.Acute

pchloroamphetamine and aversive conditioning in the rat. 1st International Congress

of Brain and Behavior, 1982, p. 472, Lausanne.

* 40. Ögren, S.O., Archer, T., Johansson, C., & Johansson, G.Stress-induced analgesia

and avoidance behavior - possible interactions with serotonergic neurotransmission.

13th C.I.N.P. Congress, 1982, p. 553, Israel.

41. Ögren, S.O., Fuxe, K., Archer, T., Johansson, G., & Holm, AC. Behavioral and

biochemical studies on the effects of acute and chronic administration of anti-

depressant drugs on central serotonergic receptor mechanisms. In: Advances in the

Biosciences: Vol. 40, New Vistas in Depression, S.Z. Langer et al. (Ed.), Pergamon

Press, 1982, pp. 11-19.

42. Ögren, S.O., Johansson, G., Johansson, C., & Archer, T. Serotonin neurons and

aversive conditioning in the rat. Scandinavian Journal of Psychology, 1982, Suppl. 1, 7-

15.

* 43. Ahlenius, S., Archer, T., Tandberg, B., & Hillegaart, V. Effects of (-)3-(3Hydroxyphenyl)-

Nn-propylpiperidine (3-PPP), alone and in combination with haloperidol (HPD), on

conditioned avoidance behavior, catalepsy and tread-mill performance in the rat. 5th

Catecholamine Symposium, 1983, Göteborg, Sweden.

44. Archer, T. Signalled and unsignalled avoidance impairments following noradrenaline

depletion with DSP4: An hypothesis incorporating an associative and non-associative

factor. Scandinavian Journal of Psychology, 1983, 24, 75-87.

* 45. Archer, T. The use of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine

hydro-chloride (DSP4) as a pharmacological tool for studying the role of noradre-naline

in learned behaviors. In: Drugs as Tools, G. Lowe (Ed.), 1983, Abstract.

* 46. Archer, T., Jonsson, G., & Ross, S.B. Dose- and time-dependent effects of the nor

adrenaline neurotoxin, DSP4, and comparison with other selective nor-adrenaline

neurotoxins. 5th Catecholamine Symposium, 1983, Göteborg, Sweden.

47. Archer, T., Mohammed, A.K., Forsberg, B., & Siddiqui, A. Neophobia to novel

taste and novel exteroceptive stimulus following DSP4 administration. Experimental

Animal Behaviour, 1983, 2, 19-36.

48. Archer, T., Mohammed, A.K., & Järbe, T.U.C. Latent inhibition following

26

systemic DSP4: Effects due to presence and absence of contextual cues in taste-

aversion learning. Behavioral and Neural Biology, 1983, 38, 287-306.

49. Archer, T., Mohammed, A.K., Ross, S.B., & Söderberg, U. T-maze learning,

spontaneous activity and food intake recovery following systemic administ-ration of

the noradre naline neurotoxin, DSP4. Pharmacology, Biochemistry & Behavior, 1983,

19, 121-130.

50. Archer, T., Ögren, S.O., Ross, S.B., & Magnusson, O. Retention deficits induced

by acute p-chloroamphetamine following fear conditioning in the rat.

Psychopharmacology, 1983, 82, 14-19.

* 51. Mohammed, A.K. & Archer, T.Behavioral effects of DSP4, a selective noradrenaline

neurotoxin.First European Meeting on Experimental Analysis of Behavior, 1983,

Liege, Belgium.

52. Mohammed, A.K., Everitt, B.J., Robbins, T.W., Dunn, L.T., Kilbourn, A., &

Archer, T. Noradrenaline and the latent inhibition effect in rats. 5th International

Catechola mine Symposium, 1983, Göteborg, Sweden.

53. Sjödén, P.O. & Archer, T. Potentiation of a bottle aversion by taste in compound

conditioning with rats. Experimental Animal Behaviour, 1983, 2, 1-18.

54. Söderberg, U., Fredriksson, A., Mohammed, A.K., Jonsson, G., Ross, S.B., &

Archer, T. The role of olfactory bulbectomy and DSP4 treatment in avoidance learning

in the rat. Neuroscience Letters, Suppl. 14, 1983.

* 55. Ögren, S.O., Archer, T., & Ross, S.B. Noradrenaline in learning and memory - the

status of the cognitive deficit. 5th International Catecholamine Symposium, 1983,

Göteborg, Sweden.

56. Ögren, S.O., Ross, S.B., Hall, H., & Archer, T. Biochemical and behavioral

effects of antidepressant drugs. In: Drugs in Psychiatry: Volume I, Antidepressants,

G.D. Burrows, T.R. Norman and B. Davis (Eds.), Elsevier/North-Holland Biomedical

Press, 1983, pp. 13-34.

57. Ögren, S.O., Archer, T., & Johansson, C. Evidence for a selective brain nor-adrenergic

involvement in the locomotor stimulant effects of amphetamine in the

rat. Neuroscience Letters, 1983 43, 327-331.

1984

27

58. Ahlenius, S., Archer, T., Tandberg, B., & Hillegart, V. Effects of (-)3-PPP on

acquisition and retention of a conditioned avoidance response in the rat.


59. Archer, T. Spontaneous recovery from damage to specific neurotransmitter

systems. Trends in Pharmacological Sciences, 1984, 7, 263-264.

60. Archer, T., Jonsson, G., & Ross, S.B. A parametric study of the effects of the

noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurones

in the CNS of the rat. British Journal of Pharmacology, 1984, 82, 249-257.

61. Archer, T., Ross, S.B., & Minor, B.G. Attenuation of the post-decapitation

convulsions after repeated treatment of rats with desipramine, imipramine and

maprotiline. Acta Pharmacol. et Toxicol., 1984, 54, 372-378.

62. Archer, T., Sjödén, P.O., & Nilsson, L-G. The importance of contextual elements

in taste-aversion learning. Scandinavian Journal of Psychology, 1984, 25, 251-257.

63. Archer, T., Söderberg, U., Mohammed, A.K., Fredriksson, A., & Ross, S.B.

Active and passive avoidance performance following bilateral olfactory

bulbectomy. Scandinavian Journal of Psychology, 1984, 25, 179-188.

64. Archer, T., Söderberg, U., Ross, S.B., & Jonsson, G. Role of olfactory

bulbectomy and DSP4 treatment in avoidance learning in the rat. Behavioral

Neuroscience, 1984, 98, 496-505.

65. Archer, T. & Tandberg, B. Effects of acute administration of 5-Methoxy-

N,Ndimethyltryptamine upon the latency and duration of post-decapitation

convulsions. Acta Pharma col. et Toxicol., 1984, 55, 224-230.

66. Archer, T., Ögren, S.O., & Johansson, G. Stimulus conditions affecting rate of

acquisition in a computer-operated version of the two-way active avoidance

procedure. Scandinavian Journal of Psychology, 1984, 25, 89-95.

67. Archer, T., Ögren, S.O., & Ross, S.B. The effect of acute zimelidine and

alaproclate administration of two-way active avoidance: Comparison with other

antidepressant agents, test of selectivity and sub-chronic studies.


68. Fowler, C.J. & Archer, T. Brain injury and early catecholamine

mobilization. Trends in Pharmacological Sciences, 1984, 5, 86-87.

69. Mohammed, A.K., Archer, T., & Järbe, T.U.C. Noradrenaline loss and the

28

disruption of between-CS stimulus generalisation effects in aversion learning.

Scandinavian Journal of Psychology, 1984, 25, 79-88.

* 70. Mohammed, A.K., Fredriksson, A., Archer, T., Söderberg, U., & Lewander, T.The

effects of DSP4 and 6-hydroxydopamine on amphetamine-induced activity in rats.

IUPHAR International Congress of Pharmacology, 1984, London, U.K.

71. Nilsson, L-G. & Archer, T. A cognitive theory to accommodate taste-aversion data.

Umeå Psychological Reports, No. 180, 1984.

* 72. Söderberg, U., Mohammed, A.K., & Archer, T. Thermoregulation and water

balance in rats after central noradrenaline depletion compared with effects of

olfactory bulbectomy. First Symposium of the European Neuroendocrine Association,

1984.

73. Ögren, S.O., Archer, T., & Johansson, C. Stress-induced analgesia and avoidance

behaviour: possible interactions with serotonergic neurotransmission. In: Stress

Induced Anal gesia, M.D. Tricklebank and G. Curzon (Eds.), John Wiley & Sons, Ltd.,

1984, pp. 165-183.

74. Ögren, S.O., Archer, T., & Ross, S.B. Norepinephrine in learning and memory -

The status of the cognitive deficit. In: Catecholamines: Neuropharmacology and

Central Nervous System-Theoretical Aspects, A. Dahlström (Ed.), Alan R. Liss, Inc.,

New York, 1984, pp. 285-292.

1985

75. Ahlenius, S. & Archer, T. Normal and abnormal animal behaviour: Importance of

catecholamine release by nerve impulses for the maintenance of normal behaviour. In:

Neuro biology, R. Gilles and J. Balthazart (Eds.), Springer- Verlag Berlin Heidelberg,

1985, 329-343.

76. Archer, T., Arweström, E., Jonsson, G., Minor B.G., & Post, C. Complete

blockade and attenuation of 5-hydroxytryptamine induced analgesia following NA

depletion in rats and mice. Acta Pharmacol.et Toxicol., 1985, 57, 255-261.

77. Archer, T. & Fowler, C.J. Towards an animal model for the cholinergic lesion in

Alzheimer's disease. Trends in Pharmacological Sciences, 1985, 61-62.

78. Archer, T., Fowler, C.J., Fredriksson, A., Lewander, T., Magnusson, O., Mohringe,

29

B., & Söderberg, U. Increased total activity in the rat after L-tryptophan plus the

monoamine oxidase-A inhibitor amiflamine but not after L-tryptophan plus clorgyline.

British Journal of Pharmacology, 1985, 85, 581-590.

79. Archer, T., Jonsson, G., & Ross, S.B. Active and passive avoidance following the

administration of systemic DSP4, xylamine or p-chloroamphetamine. Behavioral and

Neural Biology, 1985, 43, 238-249.

80. Archer, T., Järbe, T.U.C., Mohammed, A.K., & Priedite, G. The effect of stimulus

preexposure upon the context effect in taste-aversion learning in noradrenaline-

depleted rats. Scandinavian Journal of Psychology, 1985, 26, 158-169.

81. Archer, T., Minor, B.G., & Post, C. Blockade and reversal of 5-methoxy-

N,Ndimethyltryptamine-induced analgesia following noradrenaline depletion. Brain

Research, 1985, 333, 55-61.

82. Archer, T. & Sjödén, P.O. Effects of CS concentration in taste-aversion learning:

Problems in assessing aversion strength. Scandinavian Journal of Psychology, 1985,

26, 42-52.

83. Archer, T., Sjödén, P.O., & Nilsson, L-G. Contextual control of taste-aversion

conditioning and extinction. In: Context and Learning, P. Balsam and A. Tomie (Eds.),

Lawrence Erlbaum Associates, New Jersey, 1985, pp. 225-271.

84. Archer, T., Tandberg, B., Renyi, L., & Ross, S.B. Antagonism of 5-methoxy-N,N-

dimethyltryptamine-induced changes in postdecapitation convulsions in rats by

repeated treatment with drugs enhancing 5-hydroxytryptamine neurotransmission.

Journal of Pharmacological Pharmacology, 1985, 37, 648-650.

85. Danysz, W., Fowler, C.J., & Archer T. Electrical intra-cranial self-stimulation: A

potentially valid model for antidepressant action. Trends in Pharmacological Sciences,

1985, 6, 278-279.

86. Danysz, W., Jonsson, G., Mohammed, A.K., & Archer, T. The hindlimb extension

reflex is not a reliable marker of post-decapitation convulsions or spinal noradrenaline

depletion in rats. European Journal of Pharmacology, 1985, 116, 331-333.

87. Minor, B.G., Post, C., & Archer, T. Blockade of intrathecal 5-hydroxytryptamineinduced

antinociception in rats by noradrenaline depletion. Neuroscience Letters, 1985, 54, 39-

44.

88. Nilsson, L-G. & Archer, T. Perspectives on animal learning and human memory.

30

In: Perspectives on Learning and Memory, L-G. Nilsson and T. Archer (Eds.), Lawrence

Erlbaum Assoc., New Jersey, 1985, pp. 3-14.

89. Nilsson, L-G. & Archer, T. Basic theoretical concepts. In: Perspectives on

Learning and Memory, L-G. Nilsson and T. Archer (Eds.), Lawrence Erlbaum Assoc.,

New Jersey, 1985, pp. 15-18.

90. Nilsson, L-G. & Archer, T. Classification of concepts. In: Perspectives on


New Jersey, 1985, pp. 63-65.

91. Nilsson, L-G. & Archer, T. Connecting models. In: Perspectives on Learning and

Memory, L-G. Nilsson and T. Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey,

1985, pp. 147-149.

92. Nilsson, L-G. & Archer, T. Experimental paradigms and ecology. In: Perspectives

on Learning and Memory, L-G. Nilsson and T. Archer (Eds.), Lawrence Erlbaum Assoc.,

New Jersey, 1985, pp. 193-196.

93. Nilsson, L-G. & Archer, T. Short-term memory and attention. In: Perspectives on


New Jersey, 1985, pp. 115-117.

94. Nilsson, L-G. & Archer, T. General empirical laws. In: Perspectives on Learning

and Memory, L-G. Nilsson and T. Archer (Eds.), Lawrence Erlbaum Assoc., New

Jersey, 1985, pp. 243-245.

95. Post, C., Arweström, E., Minor, B.G., Wikberg, J.E.S., Jonsson, G., & Archer, T.

Noradrenaline depletion increases noradrenaline-induced antinocicep-tion in mice.

Neuroscience Letters, 1985, 59, 105-109.

96. Robbins, T.W., Everitt, B.J., Cole, B.J., Archer, T., & Mohammed, A.K.

Functional hypotheses of the coeruleocortical noradrenergic projection: A review of

recent experimentation and theory. Physiological Psychology, 1985, 13, 127-150.

1986

97. Archer, T. Possible indications of noradrenergic involvement in behavioral

plasticity. International Union of Physiological Sciences. xxth International Congress,

1986, p. 5.

31

98. Archer, T., Callenholm, N.E.B., Järbe, T.U.C., Minor, B., & Mohammed, A.K.

Taste/ tactile cue discrimination in taste-aversion learning following depletion of

noradrenaline. Scandinavian Journal of Psychology, 1986, 27, 39-51.

99. Archer, T., Cotic, T., & Järbe, T.U.C. Noradrenaline and sensory preconditioning

in the rat. Behavioral Neuroscience, 1986, 100, 704-711.

100. Archer, T., Danysz, W., Jonsson, G., Minor, B.G., & Post, C. 5-methoxy-

N,Ndimethyltryptamine-induced analgesia is blocked by a-adrenoceptor antagonists in

rats. British Journal of Pharmacology, 1986, 89, 293-298.

101. Archer, T., Fredriksson, A., Jonsson, G., Lewander, T., Mohammed, A.K., Ross, S.

B., & Söderberg, U. Central noradrenaline depletion antagonizes aspects of d-

amphetamine-induced hyperactivity in the rat. Psychopharmacology, 1986, 88, 141-

146.

102. Archer, T., Jonsson, G., Minor, B.G., & Post, C. Noradrenergic-serotonergic

interactions and nociception in the rat. European Journal of Pharmacology, 1986, 120,

295-307.

103. Archer, T., Mohammed, A.K., Danysz, W., Järbe, T.U.C., & Jonsson, G.

Attenuation of sensory preconditioning by noradrenaline depletion in the rat.

Behavioural Brain Research, 1986, 20, 47-56.

104. Archer, T., Mohammed, A.K., & Järbe, T.U.C. Context-dependent latent

inhibition in taste-aversion learning. Scandinavian Journal of Psychology, 1986, 27,

277-284.

105. Danysz, W., Jonsson, G., Minor, B.G., Post, C., & Archer, T. Spinal and locus

coeruleus noradrenergic lesions abolish the analgesic effects of 5-methoxy-N,N-

dimethyltrypta mine. Behavioral and Neural Biology, 1986, 46, 71-86.

106. Danysz, W., Minor, B.G., Jonsson, G., Post, C., & Archer, T. Spinal noradrenergic

neurotransmission and the analgesia induced by brief footshock. Brain Research, 1986,

365, 169-173.

107. Danysz, W., Minor, B.G., Post, C., & Archer, T. Chronic treatment with antidepressant

drugs and the analgesia induced by 5-methoxy-N,N-dimethyl-tryptamine: Attenuation

by desipramine. Acta Pharmacol.et Toxicol., 1986, 59, 103-112.

108. Fernandez-Guasti, A., Hansen, S., Archer, T., & Jonsson, G. Noradrenalineserotonin

interactions in the control of sexual behavior in the male rat: DSP4-induced

32

noradrenaline depletion antagonizes the facilitatory effect of sero-tonin receptor

agonists, 5MeODMT and lisuride. Brain Research, 1986, 377, 112-118.

109. Fowler, C.J., Danysz, W., Archer, T. Noradrenaline-stimulated inositol

phosphoipid breakdown as a measure of Alpha1-adrenoceptor function in rat hip-

pocampal miniprisms after repeated antidepressant treatment. Journal of Neural

Transmission, 1986, 66, 197-208.

110. Fowler, C.J., Magnusson, O., Mohammed, A.K., Danysz, W., & Archer, T. The

effect of selective noradrenergic lesions upon the stimulation by noradrenaline of

inositol phos pholipid breakdown in rat hippocampal miniprisms. European Journal of

Pharmacology, 1986, 123, 401-407.

111. Järbe, T.U.C., Callenholm, N.E.B., Mohammed, A.K., & Archer, T. Noradrenaline

and the context-dependent extinction effect. Physiology & Behavior, 1986, 38, 495-

501.

112. Minor, B.G., Archer, T., Post, C., Jonsson, G., & Mohammed, A.K. 5-HT agonist

induced analgesia modulated by central but not peripheral noradrenaline depletion in

rats. Journal of Neural Transmission, 1986, 66, 243-259.

113. Mohammed, A.K., Callenholm, N.E.B., Järbe, T.U.C., Swedberg, M.D.B., Danysz,

W., Robbins, T.W., & Archer, T. Role of central noradrenaline neurons in the contextual

control of latent inhibition in taste aversion learning. Behavioural Brain Research,

1986, 21, 109-118.

114. Mohammed, A.K., Danysz, W., Ögren, S.O., & Archer, T. Central noradrenaline

depletion attenuates amphetamine-induced locomotor behavior. Neuroscience

Letters, 1986, 64, 139-144.

115. Mohammed, A.K., Jonsson, G., & Archer, T. Selective lesioning of forebrain

noradrenaline neurons at birth abolishes the improved maze learning perfor-mance

induced by rearing in complex environment. Brain Research, 1986, 398, 6-10.

116. Mohammed, A.K., Jonsson, G., Sundström, E., Minor, B.G., Söderberg, U., &

Archer, T. Selective attention and place navigation in rats treated prenatally with

methyl azoxymethanol. Developmental Brain Research, 1986, 30, 145-155.

117. Mohammed, A.K., Jonsson, G., Söderberg, V., & Archer, T. Impaired selective

attention in methylazoxymethanol-induced microencephalic rats. Pharmacology,

Biochemistry & Behavior, 1986, 24, 975-981.

33

118. Post, C., Minor, B.G., Davies, M., & Archer, T. Analgesia induced by 5-

hydroxytryptamine receptor agonists is blocked or reversed by noradrenaline-

depletion in rats. Brain Research, 1986, 363, 18-27.

119. Renyi, L., Archer, T., Minor, B.G., Tandberg, B., Fredriksson, A., & Ross, S.B.

The inhibition of the cage-leaving response - A model for studies of the serotonergic

neuro transmission in the rat. Journal of Neural Transmission, 1986, 65, 193-210.

120. Archer, T. 5-Hydroxytryptamine antagonists and the 5-methoxy-

N,Ndimethyltryptamine-induced changes of postdecapitation convulsions.

Pharmacology & Toxicology, 1987, 60, 37-42.

121. Archer, T. Towards animal models of mental retardation. Trends in

Pharmacological Sciences, 1987, 8, 165-166.

122. Archer, T., Arweström, E., Minor, B.G., Persson, M-L., Post, C., Sundström, E., &

Jonsson, G. (+)-8-OH-DAPT and 5-MeODMT induced analgesia is antagonised by nor

adrenaline depletion. Physiology and Behavior, 1987, 39, 95-102.

123. Archer, T., Fredriksson, A., Lewander, T., & Söderberg, U. Marble burying and

spontaneous motor activity in mice: Interactions over days and effect of diazepam.

Scandinavian Journal of Psychology, 1987, 28, 242-249.

124. Danysz, W., Fowler, C.J., Ahlenius, S., & Archer, T. 'Selective' lesions of brain

neurotransmitters can be misleading. Trends in Pharmacological Sciences, 1987, 8, 45-

46.

125. Danysz, W., Fowler, C.J., & Archer, T. Experimental methods employed in

antidepressant research - critical review. New Trends in Experimental and Clinical

Psychiatry, 1987, 3, 59-88.

126. Danysz, W., Minor, B.G., Mohammed, A.K., Pucilowski, O., Plaznik, A.,

Kostowski, W., Post, C., & Archer, T. Chronic treatment with antidepressant drugs and

ECT differentially modifies the hypothermic action of clonidine and guanfacine.

Pharmacology & Toxicology, 1987, 60, 305-311.

127. Mohammed, A.K., Wahlström, G., Tiger, G., Björklund, P-E., Stenström, A.,

Magnusson, O., Archer, T., Fowler, C.J., & Nordberg, A. Impaired performance of rats in

the Morris swim-maze test late in abstinence following long-term sodium barbital

treatment. Drug and Alcohol Dependence, 1987, 20, 203-212.

128. Post, C., Archer, T., & Gordh Jr., T. Spinal a-adrenergic mechanisms for

34

analgesia. Schmertz - Pain - Doleur, 1987, 3, 107-114.

129. Post, C., Gordh Jr., T., Minor, B.G., Archer, T., & Freedman, J.Antinociceptive

effects and spinal cord tissue concentrations after intrathecal injections of guanfacine

or clonidine to rats. Anesthesia and Analgesia, 1987, 66, 317-324.

130. Post, C., Persson, M.L., Archer, T., Minor, B.G., Danysz, W., & Sundström, E. In

creased antinociception by Alpha-adrenoceptor drug after spinal cord nor-adrenaline

denervation. European Journal of Pharmacology, 1987, 137, 107-116.

131. Teiling, A.K.Y., Mohammed, A.K., Minor, B.G., Järbe, T.U.C., Hiltunen, A.J., &

Archer, T. Lack of effects of prenatal exposure to lidocaine upon development of

behavior in rats. Anesthesia and Analgesia, 1987, 66, 533-541.

1988

132. Archer, T. Possible indications of noradrenergic involvement in behavioral

plasticity. In: Cellular Mechanisms of Conditioning and Behavioral Plasticity, C.

Woody, D.L. Alkon, and J. McGaugh (Eds.), 1988, Plenum Publ. Corp., pp. 445-455.

133. Archer, T. Ethopharmacological approaches to aggressive behavior. Nordic

Journal of Psychiatry, 1988, 42, 471-477.

134. Archer, T., Danysz, W., Fredriksson, A., Jonsson, G., Luthman, J., Sundström. E.,

& Teiling, A. Neonatal 6-hydroxydopamine induced dopamine depletions: Motor

activity and performance in maze learning. Pharmacology, Biochemistry & Behavior,

1988, 31, 357-364.

135. Archer, T., Fredriksson, A., Sundström, E., Luthman, J., Lewander, T., Söderberg,

U., & Jonsson, G. Prenatal methylazoxymethanol treatment potentiates d-

amphetamine- and methylphenidate-induced motor activity in male and female rats.

Pharmacology and Toxicology, 1988, 63, 233-239.

136. Archer, T., Hiltunen, A.J., Järbe, T.U.C., Kamkar, M.R., Luthman, J., Sundström,

E., & Teiling, A. Hyperactivity and instrumental learning deficits in

methylazoxymethanoltreated rat offspring. Neurotoxicology and Teratology, 1988, 10,

341-347.

137. Danysz, W., Kostowski, W., & Archer, T. Some aspects of stress and

35

depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 1988, 12,

405-419.

138. Danysz, W., Plaznik, A., Kostowski, W., Malatynska, E., Järbe, T.U.C., Hiltunen,

A., & Archer, T. Comparison of desipramine, amitriptyline, zimel-dine and alaproclate

in six animal models used to investigate antidepressant drugs. Pharmacology and

Toxicology, 1988, 62, 42-50.

139. Fowler, C.J., Thorell, G., Sundström. E., & Archer, T. Norepinephrine-stimulated

inositol phospholipid breakdown in the rat cortex following serotoninergic lesion.

Journal of Neural Tranmission, 1988, 73, 205-215.

140. Järbe, T.U.C., Falk, U., Mohammed, A.K., & Archer, T. Acquisition and reversal

of taste/tactile discrimination after forebrain noradrenaline depletion. Behavioral

Neuroscience, 1988, 102, 925-933.

141. Minor, B.G., Danysz, W., Post, C., Jonsson, G., Sundström, E., & Archer, T. Nor

adrenergic and serotonergic involvement in brief shock-induced analgesia in rats.

Behavioral Neuroscience, 1988, 102, 915-924.

142. Minor, B.G., Persson, M.L., Post, C., Jonsson, G., & Archer, T. Intrathecal

noradrenaline restores 5-methoxy-N,N-dimethyltryptamine induced anti-nociception

abolished by intrathecal 6-hydroxydopamine. Journal of Neural Transmission, 1988,

72, 107-120.

143. Post, C., Archer, T., & Minor, B.G. Evidence for crosstolerance to the analgesic

effects between morphine and selective a2-adrenoceptor agonists. Journal of Neural

Transmission, 1988, 72, 1-9.

144. Sjödén, P.O. & Archer, T. Exteroceptive cues in taste-aversion learning, no

artifact: Reply to holder. Animal Learning & Behavior, 1988, 16, 235-239.

145. Sjödén, P.O. & Archer, T. Contextual cues in taste-aversion. Animal Learning &

Behavior, 1988, 16, 242-243.

146. Sundström, E., Archer, T., Melander, T., & Hökfelt, T. Galanin impairs acquisition but not

retrieval of spatial memory in rats studied in the Morris swim maze. Neuroscience

Letters, 1988, 88, 331-335.

1989

36

147. Archer, T. Neurotoxin-induced cognitive and motor activity modification: A

catecholamine connection. In: Attention Deficit Disorder: Clinical and Basic Research,

T. Sagvolden and T. Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp.

287-322.

148. Archer, T. Perspectives on the determinants of hedonic value. In: Aversion,

Avoidance & Anxiety: Perspectives on aversively motivated behavior, T. Archer and

L-G. Nilsson (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 41-44.

149. Archer, T. 5-HT, pain and anxiety. In: Behavioral Pharmacology of 5-HT, P.

Bevan, A. Cools and T. Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp.

299-300.

150. Archer, T., Beninger, R.J., Järbe, T.U.C., & Seiden, L.S. Latent learning in a radial

arm maze following neonatal dopamine depletion. Behavioral Pharmacology, 1989-90,

1, 191-199.

151. Archer, T. & Järbe, T.U.C. Neurobiological perspectives on aversively motivated

behavior. In: Aversion, Avoidance & Anxiety: Perspectives on aversively motivated

behavior, T. Archer and L-G. Nilsson (Eds.), Lawrence Erlbaum Assoc., New Jersey,

1989, pp. 223-229.

152. Archer, T. & Mohammed, A.K. Neurochemistry and behavior: Differential

postweaning housing and catecholamines. In: The Ethoexperimental Analysis of

Behavior, R.J. Blanchard and P. Brain (Eds.), Martinus Nijhoff Press, 1989, pp. 525-

537.

153. Archer, T. & Nilsson, L-G. Clinical perspectives on aversively motivated

behavior. In: Aversion, Avoidance & Anxiety: Perspectives on aversively motivated


1989, pp. 139-144.

154. Archer, T., & Nilsson, L.G. Catecholamine substrates of learned and spontaneous

behaviors: Relationships between attention and learning in cognition and behavioral

plasticity. In: Background Papers for the Workshop on Neural Mechanisms of

Learning and Memory, J. Delacour (Ed.). European Science Foundation, 1989.

155. Archer, T. & Sagvolden, T. Basic mechanisms of drug action: Catecholaminergic

issues. In: Attention Deficit Disorder: Clinical and Basic Research, T. Sagvolden, and T.

Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 191-197.

37

156. Archer, T. & Sagvolden, T. Model experiments of attention deficit disorder and

hyperkinetic syndrome. In: Attention Deficit Disorder: Clinical and Basic Research, T.

Sagvolden and T. Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 255-

259.

157. Beninger, R.J. & Archer, T. Neuroethological perspectives on aversively

motivated behavior. In: Aversion, Avoidance & Anxiety: Perspectives on aversively

motivated behavior, T. Archer and L-G. Nilsson (Eds.), Lawrence Erlbaum Assoc., New

Jersey, 1989 pp. 335-342.

158. Berge, O.G., Post, C., & Archer, T. The behavioral pharmacology of serotonin in

pain processes. In: Behavioral Pharmacology of 5-HT, P. Bevan, A. Cools and T. Archer

(Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp.301-319.

159. Bevan, P., Lorens, S., & Archer, T. Behavioural pharmacology of 5-HT: Possible

progress in the laterality of concepts. In: Behavioral Pharmacology of 5-HT, P. Bevan,

A. Cools and T. Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 459-

474.

160. Ferreira, A., Hansen, S., Nielsen, M., Archer, T., & Minor, B.G. Behavior of

§mother rats in conflict tests sensitive to antianxiety agents. Behavioral Neuroscience, 1989,

103, 193-201.

* 161. Fowler, C.J., Cowburn, R., Archer, T., Mohammed, A.K., & Cross, A.J.

§Alzheimer's disease is a multitransmitter disorder: Implications of "cholinergic" animal

models. Alzheimer Actualities, 7, 8.

162. Gärling, T. & Archer, T. Methodological and conceptual perspectives on aversive

§conditioning. In: Aversion, Avoidance & Anxiety: Perspectives on aversively motivated


1989, pp. 371-379.

163. Hiltunen, A.J., Järbe, T.U.C., Kamkar, M.R., & Archer, T. Behaviour in rats

maintained by low differential reinforcement rate: Efffects of ?1- tetrahydro-

cannabinol, cannabinol and cannabidiol, alone and in combination.

Neuropharmacology, 1989, 28, 183-189.

164. Järbe, T.U.C. & Archer, T. 5-HT, drug discrimination and aversion. In: Behavioral

Pharmacology of 5-HT, P. Bevan, A. Cools and T. Archer (Eds.), Lawrence Erlbaum

Assoc., New Jersey, 1989, pp. 397-406.

38

165. Kostowski, W., Plaznik, A., & Archer, T. Possible implications of 5-HT function

for the etiology and treatment of depression. New Trends in Experimental and Clinical

Psychiatry, 1989, 5, 91-116.

166. Luthman, J., Fredriksson, A., Lewander, T., Jonsson, G., & Archer, T. Effects of

d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-

hydroxydopamine treatment. Psychopharmacology, 1989, 99, 550-557.

167. Luthman, J., Fredriksson, A., Sundström, E., Jonsson, G., & Archer, T. Selective

lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor

behavior and monoamine alterations at adult stage. Behavioral Brain Reseach, 1989,

33, 267-277.

168. Minor, B.G., Danysz, W., Jonsson, G., Mohammed, A.K., Post, C., & Archer, T.

Adaptive changes in a-2 adrenoceptor mediated responses: Analgesia, hypothermia

and hypoactivity. Pharmacology & Toxicology, 1989, 65, 143-151.

169. Nilsson, L-G. & Archer, T. Aversively motivated behavior: Which are the

perspectives? In: Aversion, Avoidance & Anxiety: Perspectives on aversively

motivated behavior, T. Archer and L-G. Nilsson (Eds.), Lawrence Erlbaum Assoc., New

Jersey, 1989, pp. 437-465.

170. Overmier, J.B. & Archer, T. Historical perspectives on the study of aversively

motivated behavior: History and new look. In: Aversion, Avoidance & Anxiety:

Perspectives on aversively motivated behavior, T. Archer and L-G. Nilsson (Eds.),

Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 3-39.

171. Plaznik, A., Kostowski, W., & Archer, T. Serotonin and depression: Old problems

and new data. Progress in Neuro-Psychopharmacology and Biological Psychiatry,

1989, 13, 623-633.

172. Sagvolden, T. & Archer, T. Attention deficit disorder: Clinical issues. In: Attention

Deficit Disorder: Clinical and Basic Research, T. Sagvolden and T. Archer (Eds.),

Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 25-29.

173. Sagvolden, T. & Archer, T. Future perspectives on ADD research. An irresistible

challenge. In: Attention Deficit Disorder: Clinical and Basic Research, T. Sagvolden

and T. Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 369-389.

174. Sjödén, P.O. & Archer, T. Taste-aversion conditioning: The role of contextual

39

stimuli. In: Aversion, Avoidance & Anxiety: Perspectives on aversively motivated

behavior, T. Archer & L-G. Nilsson (Eds.), Lawrence Erlbaum Assoc., 1989, pp. 87-120.

1990

175. Eriksson, P., Archer, T., & Fredriksson, A. Altered behavior in adult mice exposed

to a single low dose of DDT and its fatty acid conjugate as neonates. Brain Research,

1990, 23, 514(1), 141-2.

176. Fredriksson, A., Plaznik, A., Sundström, E., Jonsson, G., & Archer, T. MPTPinduced

hypoactivity in mice: Reversal by L-Dopa. Pharmacology & Toxicology, 1990, 67,

295-301.

177. Gillberg, P.G., Hartvig, P. Gordh, T., Sottile, A., Jansson, I., Archer, T., & Post, C.

Behavioral effects after intrathecal administration of cholinergic receptor agonists in

the rat. Psychopharmacology, 1990, 100, 464-469.

178. Mohammed, A.K., Wahlström, G., Archer, T., & Nordberg, A. Learning deficits in

aged rats pretreated chronically with barbital and tested late in abstinence: Alleviation

by tetrahydroaminoacridine. Journal of Neural Transmission, 1990, 2, 285-294.

179. Post, C., & Archer, T. Interactions between 5-HT and noradrenaline in analgesia.

In: Serotonin and Pain, J-M. Besson (Ed.), Elsevier Science Publishers B.V. (Biomedical

Division), 1990, pp. 153-173.

180. Sundström, E., Fredriksson, A., & Archer, T. Chronic neurochemical and

behavioral changes in MPTP-lesioned C57 BL/6 mice: A model for Parkinson's disease.

Brain Research, 1990, 528, 181-188.

181. Archer, T. Animal models and drug screens in depression: Pragmaticism and the

validity requirement. In: "Animal models in psychopharmacology", B. Olivier, J. Mos

& J. Slangen (Eds.), Birkhaüser, Verlag AG, Basel, 1991, pp. 243-250.

182. Archer, T. Learning techniques to study memory processes in opiate and/ or

adrenergic systems. In: Peripheral Signaling of the Brain: Role in Neuronal-Immune

Interactions, Learning and Memory, R.C.A. Frederickson, J.L. McGaugh, and D.L.

Felten (Eds.). Hogrefe and Huber Publishers, Toronto, 1991, pp. 315-332.

183. Archer, T. & Nilsson, L.-G. Unitary concepts in behavioral biology. In:

40

Behavioral Biology: Neuroendocrine Axis, T. Archer and S. Hansen, (Eds.), L. Erlbaum,

Hillsdale, N.J., 1991, pp. 255-266.

184. Archer, T., Hård, E., & Hansen, S. Animal models of mental retardation. In:

Neuromethods Vol. 19 : Animal Models in Psychiatry, II, A. Boulton, G. Baker, and M.

Martin-Iverson (Ed.). The Humana Press., Clifton, N.J., 1991, pp. 273-314.

185. Danysz, W., Archer, T., & Fowler, C.J. Screening for new antidepressant

compounds. In: Behavioral Models in Psychopharmacology, P. Willner (Ed.),

Cambridge University Press, 1991 pp. 126-156.

186. Luthman, J., Fredriksson, A., Plaznik, A., & Archer, T. Ketanserin and mianserin

treatment reverses hyperactivity in neonatally dopamine-lesioned rats. Journal of


187. Teiling-Gårdlund, A., Archer, T., Danielsson, M., Danielsson, B., Fredriksson, A.,

Lindquist, N.G., Lindström, H., & Luthman, J. Effects of prenatal exposure to tribu

tyltin and trihexyltin on behaviour in rats. Neurotoxicology and Teratology, 1991, 13,

99-105.

1992

188. Archer, Trevor Functional and neuroendocrine correlates of memory in normal

and disease states: I. Putative neurotransmitters in animal models of depression and

dementia. Rapport HSFR , 1992.

189. Archer, T. & Fredriksson, A. Functional changes implicating dopaminergic

systems following perinatal treatments. Developmental Pharmacology and Therapy,

1992, 18, 201-222.

* 190. Archer, T. & Nilsson, L.G. Symposium i biologisk psykologi: minnets psykologi

och neurobiologi. Rapport 1992.

191. Fredriksson, A., Dahlgren, L., Danielsson, B., Eriksson, P., Dencker, L., & Archer,

T. Behavioural effects of neonatal metallic mercury exposure in rats. Toxicology, 1992,

74, 151-160.

192. Kostowski, W., Dyr, W. Krzascik, P., Järbe, T.U.C., & Archer, T. 5Hydroxytryptamine

1A receptor agonists in animal models of depression and

anxiety. Pharmacology & Toxicology, 1992, 71,24-30.

41

*193. Nilsson, L-G. & Archer, T. Neurobiologi av minne. Rapport 1992.

194. Nilsson, L.-G., & Archer, T. Biological aspects of memory and emotion: Affect

and cognition. In: "The Handbook of Emotion and Memory", S.-Å. Christiansson (ed.),

Lawrence Erlbaum Associates, 1992, 99.289-305.

195. Rönnberg, J. & Archer, T. Purposive Behaviour in cognition and perception:

Considerations of awareness in memory. Scandinavian Journal of Psychology, 1992,

33, 86-91.

196. Wahlström, G., Archer, T. & Lärkfors, L. Nerve growth factor (NGF) in rat brain

following long-term barbital treatment: relation to convulsions and cognitive function.

Neuroscience Letters, 1992, 137, 65-68.

1993

197. Archer, T. The antinociceptive efficacy of typical and atypical antidepressant

compounds: Further evidence for serotonergic function in analgesia. Nordic Journal of

Psychiatry, 1993, 47, 347-349.

198. Archer, T. Behavioural retardation in the neuropathology of mental

retardation. Acta Pathologica, Microbiologica et Immunologica Scandinavica, 1993,

101, 35-56.

199. Archer, T. & Fredriksson, A. Neuroleptics - Preclinical and mechanistic studies.

In: Developmental toxicology - Preclinical and clinical data in retrospect.. A.

Sundwall, B. R. Danielsson, O. Hagberg, E. Lindgren, P. Sjöberg & A. Victor (Eds).

Stockholm, 1993, pp. 123-136.

200. Archer, T. Use of antidepressants in pain: Chronic and acute studies in the

laboratory. Nordic Journal of Psychiatry, 1993, 47, 7-8.

201. Danielsson, B., Fredriksson, A., Dahlgren, L., Teiling-Gårdlund, L., Olsson. L.,

Dencker, L., & Archer, T. Behavioural effects of prenatal metallic mercury inhalation

exposure in rats. Neurotoxicology and Teratology, 1993, 15, 391-396.

202. Fredriksson, A., Teiling-Gårdlund, A., Bergman, K., Oskarsson, A., Ohlin, B., Danielsson,

B., & Archer, T. Effects of maternal dietary supplementation with selenite on the

postnatal development of rat offspring exposed to methyl mercury in utero.

Pharmacology and Toxicology, 1993, 72, 377-382.

42

1994

203. Archer, T. The role of conditioning in the use of placebo. Nordic Journal of

Psychiatry, 1994, 49, 43-53.

204. Archer, T. & Fredriksson, A. Functional effects of MPTP in mice: Studies on

parkinsonian validity. Polish Journal Pharmacology, 1994, 46, 197-198.

205. Archer, T. & Nilsson, L.-G. Context effects in learning and memory: Human and

animal perspectives. In: The Memory System of the Brain. J. Delacour (ed.), Vol.

4,.1994, pp. 153-181. London: World Scientific Press.

206. Archer, T. & Palomo, T. Introduction: Depressive, anxiety and drug abuse

disorders. In: Strategies for Studying Brain Disorders. Vol. I. Depressive, anxiety and

drug abuse disorders. (Eds. T. Palomo & T. Archer), Madrid, Farrand Press, 1994, pp.

1-8.

207. Beninger, R. J., Palomo, T. & Archer, T. Introduction: Schizophrenia, movement

disorders and age related cognitive disorders. In. Strategies for Studying Brain

Disorders (Eds. T. Palomo, T. Archer & R. J. Beninger), Madrid, Vol. 2, Farrand Press,

1994, p. 1-14.

208. Danysz, W. & Archer, T. Glutamate, learning and dementia - selection of

evidence. Journal of Amino Acids, 1994, 7, 147-163.

209. Erlandsson, S. I. & Archer, T. Tinnitus, pain and affective disorders. In: Strategies

for Studying Brain Disorders: Vol. I. Depressive anxiety and drug abuse disorders.

(Eds. T. Palomo & T. Archer), Madrid, Farrand Press, 1994, pp. 123-142.

210. Fredriksson, A. & Archer, T. MPTP-induced behavioural deficits in mice: validity

and utility of a model of parkinsonism. In: Strategies for Studying Brain Disorders. Vol.

II. Schizophrenia, movement disorders and age related cognitive disorders. (Eds. T.

Palomo, T. Archer & R. J. Beninger), Madrid, Farrand Press, 1994, 201-231.

211. Fredriksson, A. & Archer, T. MPTP-induced behavioural and biochemical

deficits: A parametric analysis. Journal of Neural Transmission, 1994, 7, 123-132.

212. Fredriksson, A., Gentsch, C. & Archer, T. Effect of the competitive NMDA

antagonist, CGP 40116, and low dose of L-Dopa on the motor activity deficit of MPTP-

treated mice. Behavioural Pharmacology, 1994, 5, 599-606.

213. Fredriksson, A., Gentsch, C. & Archer, T. Synergistic interactions between

43

NMDA antagonists and L-dopa on activity in MPTP-treated mice. Journal of Neural

Transmission, 1994, 97, 197-209.

214. Fredriksson, A., Platznik, A., Sundström, E. & Archer, T. Effects of D1 and D2

agonists on spontaneous motor activity in MPTP treated mice. Pharmacology and

Toxicology, 1994, 75, 36-41.

215. Parker, Adrian & Archer, T. Conflict behavior: Approach-approach, approachavoidance

and avoidance-avoidance. Encyclopedia of Human Behavior, Academic Press, 1994,

Vol. 1:665-673.

216. Rydenhag, B., Sjöström, A., Archer, T. & Conradi, N.G. A new operant

discrimination test procedure for resident rats. Physiology and Behavior, 1994, 55, 47-

51.

217. Ögren, S. O. & Archer, T. Effects of typical and atypical antipsychotic drugs on

two-way active avoidance. Relationship to DA receptor blocking profile.


1995

218. Archer, T., Dahlgren, L. & Järbe, T. U.C. Effects of dopamine depletion and social

housing upon spatial navigation and learning. MS to be revised.

219. Archer, T. & Fredriksson, A. MPTP treatment of mice: functional changes and their

modulation. Behavioural Pharmacology, 1995, Suppl. 7, 25-26.

220. Archer, T., Minor, B.G., & Post, C. Antagonism of 5-MeODMT analgesia by

DSP4: Effect of clonidine. Submitted, 1993.

221. Danysz, W., & Archer, T. Glycine and NMDA receptors: emerging problems of

physiological significance. Elsevier Trends Journals, 1993, 5, 34-37.

222. Danysz, W., Post, C., Minor, B. G., Behbebani, M. B., Schultzberg, M. & Archer.

T. Supraspinal mediation of 5-methoxy-N, N-dimethyltryptamine-induced analgesia.

Pharmacology & Toxicology, submitted

223. Järbe, T. U.C. & Archer, T. 5-Hydroxytryptamine 1A Agonists and DRL 72-sec.

schedule performance. To be submitted.

*224. Mohammed, A.K., Luthman, J., Magnusson, D., Jonsson, G., Archer, T., &

44

Winblad, B. Behavioral deficits induced by neonatal dopamine depletion are modified

by enriched environment. Manuscript submitted

225. Danysz, W., Minor, B.G., Post, C., Behbehani, M., & Archer, T. 5-Methoxy-

N,Ndimethyltryptamine induced analgesia: Effects of route of administration and cell

recording. Submitted. 1993.

226. Archer, T. Antinociception and 5-HT 1A receptor sensitivity after

treatment with desipramine, zimelidine and mianserin in rats. Nordic Journal of

Psychiatry, 1993, 48, 33-44.

227. Wultz, B., Sagvolden, T., Moser, M-B., Moser, E.I. & Archer, T. The

spontaneously hypertensive rats as an animal model of attention-deficit hyperactivity

disorder: Effects of reduced central noradrenaline levels in hyperac

tivity and on reactivity to methylphenidate. Behavioural Pharmacology, 1991, 00, 00-

00.

228. Ögren, S. O. & Archer, T. & Johansson, C. Serotonin and active avoidance

learning. Behavioural Neuroscience, 1993, 00, 0-00.

229. Ögren, S. O., Archer, T. & Johansson, C. Effects of 5-HT depletion on 1-way and

2-way acquisition. Psychopharmacology, 1994, 00, 00-00.

230. Archer, T., Bassen, M., Fredriksson, A. & Luthman, J. Effects of dopamine

agonists upon motor activity in MPTP-treated mice and 6-OHDA-treated rats. Spanish

Journal of Neurology, 89, 12-16.

231. Fredriksson, A. & Archer, T. Synergistic interactions between COMT-/MAOinhibitors and

L-Dopa in MPTP-treated mice. Journal of Neural Transmission, 1995, 102, 19-34.

1977-1995 = 147.

1996

232. Palomo, T., Archer, T. and Beninger, R.J. Dopamine disease states: From Parkinson's

disease to Schizophrenia. In: Dopamine Disease States, R.J. Beninger, T. Palomo & T.

Archer (Eds.)., Madrid University Press, 1996, pp.1-6.

233. Archer, T., Bassen, M., Peters, D., Luthman, J. and Fredriksson, A.

45

Dopaminergic-glutamatergic balance in the forebrain: functional studies of movement

disorders in rats and mice. In: Dopamine disease states, T. Palomo, T. Archer & R.J.

Beninger (Eds)., Madrid Univ. Press, 1996, pp. 117-154.

234. Fredriksson, A., Bassen, M. & Archer, T. MPTP-induced deficits in learning and

motor activity: Possible neuroprotective effects in parkinsonism. In: Dopamine disease

states, T. Palomo, T. Archer & R.J. Beninger (Eds)., Madrid Univ. Press, 1996, pp. 83-

116.

235. Klint, T., Bassen, M., Vlastos, H., Dahlgren, L. & Archer, T. Antipsychotic or

potential antipsychotic compounds alter MK-801 effects upon motor activity and maze

learning in male rats: Comparison with 5-HT antagonists. In: Dopamine disease states,

T. Palomo, T. Archer & R.J. Beninger (Eds)., Madrid Univ. Press, 1996, pp. 155-180.

236. Fredriksson, A., Bassen, M., Cervini, M. A., Post, C., Archer, T. & McArthur, R.

Effects of dopamine agonists upon locomotor function in denervated mice and rats:

Comparison with cabergoline. In: Dopamine disease states, T. Palomo, T. Archer &

R.J. Beninger (Eds), Madrid Univ. Press, 1996, pp. 181-210.

237. Luthman, J., Radesäter, A-C., Bassen, M. and Archer, T. Functional and neurochemical

responses to interventions in the developing dopamine system. In: Dopamine Disease

States, R.J. Beninger, T. Palomo and T. Archer (Eds), Madrid Univ. Press, 1996, pp.

337-358.

238. Palomo, T., Beninger, R.J. and Archer, T. Neurotoxicity and functional concomitants in

neurodegenerative brain disorders. In: Dopamine Disease States, R.J. Beninger, T.

Palomo and T. Archer (Eds), Madrid Univ. Press, 1996, pp. 569-605.

239. Fredriksson, A. & Archer, T. Alpha-phenyl-tert-butyl-nitrone (PBN) reverses age-related

maze learning preformance and motor activity deficits in mice. Behavioural

Pharmacology, 1996, 7, 1-9.

240. Fredriksson, A., Archer, T. & Eriksson, P. Modulation of diazepam-induced

changes in motor activity and marble-burying by neonatal treatment with diazepam.

Submitted to Environmental Toxicology & Pharmacology.

241. Klint, T., Bassen, M., Vlastos, H., Dahlgren, L. & Archer, T. Effects of

antipsychotic or putative antipsychotic compounds on alterations induced by MK-801

upon motor activity and maze learning performance in male rats. Submitted to

Behavioural Pharmacology.

46

242. Luthman, J., Bassen, M., Fredriksson, A. & Archer, T. Functional changes

induced by neonatal 6-hydroxydopamine lesions: Effects of dose levels on behavioural

parameters. Behavioural Brain Research, 1997, 82, 213-221.

243. Fredriksson, A., Gentsch, C. & Archer, T. COMT-inhibitor - L-DOPA interactions

and motor activity in MPTP-treated mice. To be submitted to Journal of Neural

Transmission.

244. Fredriksson, A., Ericsson, P. & Archer, T. Alpha-phenyl-tert-butyl-nitrone (PBN)

reverses age-related learning performance and motor activity deficits in C57/BL6 mice.

Journal of Neural Transmission, 1997, 104, 579-592.

245. Fredriksson, A., Danielsson, B. R. G., Dencker, L. & Archer, T. Prenatal

coexposure to metallic mercury vapour and methylmercury produce additive

behavioural changes in adult rats. Neurotoxicology & Teratology, 1996, 7, 129-134.

246. Teiling-Gårdlund, A., Fredriksson, A., Dahlgren, I.L., Danielsson, B., Lewander,

T., & Archer, T. Effects of prenatal exposure to a novel antipsychotic compounds,

remoxipride, on behaviour in rat. To be submitted.

247. Westergren, S., Rydenhag, B., Archer, T. & Conradi, N. G. Effects of prenatal

alcohol exposure on activity and learning in Sprague-Dawley rats. Pharmacology,

Biochemistry & Behaviour, 1996, 55, 515-520.

248. Archer, T., Peters, D. and Lindholm, K-J. Psychopathy: Concepts, etiology,

epidemiology and treatment. Nordic Journal of Psychiatry, 36, 24245-24249.

249. Archer, T. and Fredriksson, A. Effects of acute/chronic, subthreshold/threshold doses of

L-Dopa in MPTP-treated mice: I Influence of competitive and noncompetitive NMDA

antagonists. In: Interactive monoaminergic Disorders, T. Palomo, R.J. Beninger and T.

Archer (Eds), Madrid Univ. Press, 1999. pp. 573-606.

250. Fredriksson, A. and Archer, T. Effects of acute/chronic, subthreshold/threshold doses of

L-Dopa in MPTP-treated mice: II Effects of MAO/COMT inhibitors. In: Interactive

monoaminergic Disorders, T. Palomo, R.J. Beninger and T. Archer (Eds), Madrid Univ.

Press, 1999. pp. 607-654.

251. Norlander, T., Bergman, H. and Archer, T. Effects of flotation REST on creative problem

solving and originality. Journal of Environmental Psychology, 1998, 18, 399-408.

252. Palomo, T., Beninger, R.J., & Archer, T. Interactive Monoaminergic Basis of

47

Anxiety and Depression. In: Interactive Monoaminergic Disorders, T. Palomo, R.J.

Beninger & T. Archer (Eds), Madrid University Press. 1999. pp. 35-46.

253. Palomo, T., Archer, T., & Beninger, R.J. Interactive Monoaminergic Basis of

Schizopsychotic Disorder. In: Interactive Monoaminergic Disorders, T. Palomo, R.J.


254. Archer, T., Beninger, R.J., & Palomo, T. Interactive Monoaminergic systems in

Movement Disorders. In: Interactive Monoaminergic Disorders, T. Palomo, R.J.


255. Beninger, R.J., Palomo, T., & Archer, T. Interactive Monoaminergic systems in

Substance abuse disorders. In: Interactive Monoaminergic Disorders, T. Palomo, R.J.

Beninger & T. Archer (Eds), Madrid University Press, 1999, pp. 199-212.

256. Fredriksson, A., Palomo, T., Chase, T.N. & Archer, T. Tolerance to a suprathreshold

dose of L-Dopa in MPTP mice: Effects of glutamate antagonists. Journal of Neural

Transmission, 1999, 106, 283-300.

257. Norlander, T., Nordmarker A., & Archer, T. Effects of alcohol and frustration on

experimentally induced Graffiti. Scandinavian Journal of Psychology, 1998, 39, 201-

207.

258. Fredriksson, A., Palomo, T., & Archer, T. Effects of MAO inhibitors upon MPTP

mice chronically-treated with suprathreshold doses of L-Dopa. Behavioural

Pharmacology, 2000, 11, 571-581.

259. Fredriksson, A., Palomo, T., & Archer, T. Effects of co-administration of

anticonvulsant agents and subthreshold/suprathreshold doses of L-Dopa upon motor

behaviour of MPTP-treated mice. Journal of Neural Transmission, 106, 889-909.

260. Norlander, T., Bergman, H., & Archer, T. Primary Process in Competitive Archery

Performance: Effects of Flotation REST. Journal of Applied Sports Psychology, 1999,

11, 194-209.

261. Norlander, T., Dahlin A., & Archer, T. Health in Women: effects of life events, social

support and personality. Psychological Reports, 2000, 96, 76-78.

262. Nordmarker A., Norlander, T., & Archer, T. The effects of alcohol intake and

induced frustration upon experimental graffiti. Social Behaviour and Personality,

2000, 28, 15-28. in press.

263. Jiménez-Arriero, M.A., Ponce, G., Huidobro, J., Rubio, G., Archer, T., & Palomo, T.

48

Clinical evidence of naltrexone efficacy in the treatment of alcohol dependence. In:

Interactive Monoaminergic Disorders, edited by T. Palomo, R.J. Beninger & T. Archer.

Madrid University Press, 1999, pp. 275-290.

264. Schröder, N., Archer, T., Eriksson, P., Izquierdo, I & Fredriksson, A. Neonatal iron

exposure induces neurobehavioural dysfunctions in adult mice. XIII Reuniao Anual da

Federacao de Sociedades de Biologia Experimental, Caxambu, MG, Brazil, pp.16-18,

1998.

265. Fredriksson, A., Schröder, N., Eriksson, P., Izquierdo, I., & Archer, T. Neonatal iron

exposure induces neurobehavioural dysfunctions in adult mice. Toxicology and

Applied Pharmacology, 1999, 159, 25-30.

266. Fredriksson, A., Palomo, T., & Archer, T. Clonidine mobilization of L-Dopa-tolerant

MPTP mice. In: Catecholamine Disease States, edited by T. Palomo, R.J. Beninger & T.

Archer. Madrid University Press, 1999, pp. 29-41.

267. Norlander, T., Erixon, A., & Archer, T. Psychological Androgyny and Creativity:

Dynamics of Gender-role and Personality trait. Journal of Social Behaviour and

Personality, 2000, 28, 423-435.

268. Fredriksson, A., Eriksson, P., Ankarberg, E., Palomo, T., & Archer, T. Neonatal Nicotine

administration influences ethanol-induced behaviours. Alcohol, 2000, 21, 1-9.

269. Wästlund, E., Norlander, T., & Archer, T. Exploring cross-cultural differences in

selfconcept: A meta-analysis of SDQ1. Cross Cultural Research, 2001, 35, 280-302.

270. Svensson, N., Norlander, T., & Archer, T. Group versus Individual Performance of

Creative Tasks. The Korean Journal of Thinking and Problem Solving, 2002, 12, 15-34.

271. Norlander, T., Gård, L., Lindholm, L., & Archer, T. New Age: Exploration of outlook-

on-life frameworks from a phenomenological perspective. Mental Health, Religion and

Culture, 6, 1-20.

272. Archer, T., & Fredriksson, A. Effects of clonidine and alpha-adrenoceptor antagonists on

motor activity in DSP4-treated mice I: Dose-, Time- and Parameter-dependency.

Neurotoxicity Research, 2000, 1, 235-247.

273. Fredriksson, A., & Archer, T. Effects of clonidine and alpha-adrenoceptor antagonists on

motor activity in DSP4-treated mice II: Interactions with apomorphine. Neurotoxicity

Research, 2000, 1, 249-259.

274. Palomo, T., Archer, T., & Beninger, RJ. Catecholamines in Brain Disease States. In

49

Catecholamine Disease States, edited by T. Palomo, RJ Beninger & T. Archer, Madrid

University Press, Madrid, pp. xx-xx, 2000.

275. Norlander, T., Kjellgren, A., & Archer, T. The Experience of Flotation-REST as a

Function of Setting and Previous Experience of Altered State of Consciousness.

Imagination, Cognition and Personality, 2001, 20, 41-57.

276. Archer, T., Palomo, T., & Fredriksson, A. Functional expressions of noradrenergic

receptor changes following denervation with DSP4: Interactive and parametric effects

of clonidine. In Neurodegenerative Disorders, edited by T. Palomo, RJ Beninger & T.

Archer, Editorial Sintesis, Madrid, pp.181-212, 2001.

277. Archer, T., & Fredriksson, A. Restoration and putative protection in Parkinsonism. In

Neurodegenerative Disorders, edited by T. Palomo, RJ. Beninger & T. Archer,

Editorial Sintesis, Madrid, pp.609-665, 2001.

278. Archer, T., & Fredriksson, A. The role of a2-adrenoceptor agonists upon MPTP-induced

deficits. Catecholamine Disorders, 2002, xx, 000-000.

279. Fredriksson, A., Schröder, N., & Archer, T. Neurofunctional deficits in mice induced

by postnatal iron exposure: dose, time and MPTP interactions. In Neurodegenerative

Disorders, edited by T. Palomo, RJ. Beninger & T. Archer, Editorial Sintesis, Madrid,

pp. 449-480, 2001.

280. Palomo, T., Jhamandas, K., Beninger, R.J., & Archer,T. Neurotoxicity and

neurodegeneration: implications for neuropsychiatric disorders. In Neurodegenerative

Disorders, edited by T. Palomo, RJ. Beninger & T. Archer, Editorial Sintesis, Madrid,

pp. 23-30, 2001.

281. Fredriksson, A., Danysz, W., Quack, G., & Archer, T. Effects of co-administration of

memantine and amantadine with sub/suprathreshold doses of L-Dopa upon the motor

behaviour of MPTP-treated mice. Journal of Neural Transmission, 2001, 108, 167-187.

282. Archer, T., & Fredriksson, A. Restoration and putative protection of MPTPinduced

functional deficits. Neurotoxicity Research, 2000, 2, 251-292.

283. Jiménez-Arriero, M.A., Ponce, G., Huidobro, J., Rubio, G., Archer, T., &

Palomo, T. Clinic evidence of naltrexone on long-term alcohol dependent

treatment.Alcoholism: Clinical and Experimental Research, 2000, 17, 51-64.

284. Kjellgren, A., Sundequist, U., Norlander, T., & Archer, T. Effects of flotation-REST on

muscle tension pain. Pain Research & Management, 6, 181-189.

50

285. Fredriksson, A., Schröder, N., Eriksson, P., Izquierdo, I., & Archer, T. Maze

learning and motor activity deficits in adult mice induced by iron exposure during a

critical postnatal period. Developmental Brain Research, 2000, 119, 65-74.

286. Fredriksson, A., Schröder, N., Eriksson, P., Izquierdo, I., & Archer, T. Postnatal

iron and adult MPTP induced neurodegeneration and functional deficits in mice.

Parkinsonism & Related Disorders, 2001, 7, 97-105.

287. Norlander, T., & Archer, T. Predicting performance outcome in ski and swim

§ championship: Discriminant effectiveness of mood, perceived exertion and

dispositional optimism. Perceptual and Motor Skills, 94, 153-164.

288. Schröder, N., Fredriksson, A., Izquierdo, I., & Archer, T. Memory deficits in adult

rats following postnatal iron administration. Behavioural Brain Research, 124, 77-85.

289. Beal, M.F., Palomo, T., Kostrzewa, R.M., & Archer, T. Neuroprotective and

neurorestorative strategies for neuronal injury. Neurotoxicity Research, 2000, 2, 251-

292.

290. Archer, T., & Fredriksson, F. Effects of a-adrenoceptor agonists in chronic morphine

administered DSP4-treated rats: Evidence for functional cross-sensitization.

Neurotoxicity Research, 3, 411-432.

291. Archer, T., Palomo, T., & Kostrzewa, R.M. Neurotoxicity and substance abuse:

further fuel for regulatory dilemma. Neurotoxicity Research, 2001, 3, 1-6.

51

292. Pramling, N., Norlander, T., & Archer, T. Moral expression in six-to-seven yearold

children’s stories in Sweden, Hungary and China: a phenomenological study.

Childhood, 2001, 8, 361-382.

293. Norlander, T., Kjellgren, A., & Archer, T. Effects of Flotation- versus Chamberrestricted

environmental stimulation technique (REST) on creativity and realism under Stress and

Non-stress conditions. Journal of Environmental Psychology, accepted for

publication.

294. Palomo, T., Beninger, R.J., & Archer, T. Substance dependence disorders:

interactive and neurotoxic potential. In Advances in Neurosciences and Clinical

Realities: Substance Abuse Disorders, edited by T. Palomo, R.J. Beninger, M.A.

Jimenez-Arriero and T. Archer, pp. 25-48. Editorial Sintesis, 2001.

295. Palomo, T., Beninger, R.J., Jhemandas, K.H., & Archer, T. Neurodegenerative

diseases of the brain: genetic and environmental factors. In Neurodegenerative

Disorders, edited by T. Palomo, R.J. Beninger and T. Archer, pp. 213-224,

Editorial Sintesis, 2001.

296. Palomo, T., Beninger, R.J., Jhemandas, K.H., Kostrzewa, R.M., Beal, M.F., &

Archer, T. Protective and restorative strategies in the neurodegenerative

disorders. In Neurodegenerative Disorders, edited by T. Palomo, R.J. Beninger

and T. Archer, pp. 481-500, Editorial Sintesis, 2001.

297. Pramling, N., Norlander, T., & Archer, T. Conceptualization of the Unknown by

6-, 9- and 14-year-old children: Search for a 'heffalump'. Childhood, 2001, 10,

379-392.

298. Löfqvist, A.H., & Archer, T. A theoretical framework for the understanding of

psychosomatic reactions. Manuscript submitted for publication.

299. Rubio, G., Jiménez-Arriero, M.A., Ponce, G., Archer, T., & Palomo, T.

Neurobiological basis of primimg: its importance in alcoholism. In Advances in

Neurosciences and Clinical Realities: Substance Abuse Disorders, edited by T.

Palomo, R.J. Beninger, M.A. Jimenez-Arriero and T. Archer, pp. Xx-xx. Editorial

Sintesis, 2001.

300. Wästlund, E., Norlander, T., & Archer, T. Internet blues revisited: A replication

and extension of Kraut et al. (1998) Internet Paradox study. CyberPsychology

and Behaviour, 2001, 4, 385-391.

52

301. Löfqvist, A.H., & Archer, T. Functional somatic syndromes - a matter of stress

response patterns. Journal of Chronic Fatigue Syndromes, in press.

302. Fredriksson, A., Palomo, T., McArthur, R., & Archer, T. Effects of acute

administration of DA agonists on locomotor activity: MPTP versus neonatal

intracerebroventricular 6-OHDA treatment. Neurotoxicity Research, in press.

303. Palomo, T., Gorriti, M.A., Ponce, G., Archer T., & Jimenez Arriero, M.A. From

basic research on the tetrahydrocannabinoids to the study of alterations associated

with consumption. In Advances in Neurosciences and Clinical Realities: Substance

Abuse Disorders, edited by T. Palomo, R.J. Beninger, M.A. Jimenez-Arriero and T.

Archer, pp. 197-223. Editorial Sintesis, 2001.

304. Norlander, T., Blom, A., Archer, T. Role of High School Teachers in Swedish

Psychology Education: Phenomenological Circumstances. The Qualitative

Report, 2001 7, 1-15.

305. Dal-Pizzol, F., Klamt, F., Frota, M.L.C., Andrades, M.E., Caregnato, F.F.,

Schröder, N., Quevedo, J., Izquierdo, I., Archer, T., & Moreira, J.C.F. Neonatal

iron exposure induces oxidative stress in adult Wistar rats. Molecular Brain

Research, 2001, 130, 109-114.

306. Mohammed, A.H., & Archer, T. Effects of housing conditions on functional

development in rats.Pharmacology, Biochemistry & Behavior, manuscript

invited for publication.

307. Folkesson, P., Nyberg, C., Archer, T., & Norlander, T. Football referees'

experience of threat and violence: Effects of age, experience and life orientation

on outcome of coping strategy. Aggressive Behaviour, 2002, 28, 317-327.

308. Norlander T., Bood, S-Å., & Archer, T. Performance during stress by different

occupational groups: Affective personality, Age and regularity of physical exercise.

Social Behaviour and Personality, 2002, 30, 495-508.

309. Archer, T., Palomo, T., & Fredriksson, A.F. Restorative effects of glutamate

antagonists in experimental parkinsonism. Amino Acids, 2002, 23, 71-85.

310. Fredriksson, A., & Archer, T. Functional alteration by NMDA antagonist: Effects of

L-Dopa, neuroleptic drugs and postnatal administration. Amino Acids, 2002, 23,

111-132.

311. Archer, T., Palomo, T. & Fredriksson, A. Neonatal 6-hydroxydopamine-induced

53

hyperactivity: Blockade by dopamine reuptake inhibitors and effect of acute

damphetamine. Neurotoxicity Research, 2002, 4, 247-266.

312. Archer, T., Palomo, T., & Fredriksson, A. Functional deficits following neonatal

dopamine depletion and isolation housing: circular water maze acquisition under

pre-exposure conditions and motor activity. Neurotoxicity Research, 2002, 4,

503-522.

313. Archer, T., Palomo, T., & Beninger, R.J. Structural and functional neuroimaging as

an avenue towards the understanding of brain abnormalities in health and disease. In

Advances in Neurosciences and Clinical Realities: Substance Abuse Disorders, edited

by T. Palomo, R.J. Beninger, M.A. Jimenez-Arriero and T. Archer, pp. 197-223.

Editorial Sintesis, 2002.

314. Palomo, T., Beninger, R.J., & Archer,T. Neuroimaging in psychiatry. Advances in

Neurosciences and Clinical Realities:neuropsychiatry, edited by T. Palomo, R.J.

Beninger, M.A. Jimenez-Arriero and T. Archer, pp. 197-223. Editorial Sintesis, 2002.

315. Fredriksson, A., Schröder, N., & Archer, T. Neurobehavioural deficits following

Postnatal iron overload: I Spontaneous motor activity. Neurotoxicity Research,

2003, 5, 53-76.

316. Fredriksson, A., Schröder, N., & Archer, T. Neurobehavioural deficits following

Postnatal iron overload: II Instrumental learning performance. Neurotoxicity

Research, 2003, 5, 77-94.

317. Palomo, T., Archer, T., Beninger, R.J., & Kostrzewa, R.M. Neurodevelopmental

liabilities of substance abuse. Neurotoxicity Research, 2002, 4, 267-279.

318. Palomo, T., Kostrzewa, R.M., Archer, T., & Beninger, R.J. Neurodevelopmental

liabilities in Schizophrenia and Affective disorders. Neurotoxicity Research, 2002, 4,

397-408.

319. Fredriksson, A., & Archer, T. Effect of postnatal iron administration on MPTPinduced

behavioural deficits and neurotoxicity: behavioural enhancement by LDopa-MK-801.


320. Palomo, T., Beninger, R.J., Kostrzewa, R.M., & Archer, T. Sites of movement

disorder: Genetic and environmental agents in developmental perturbations.


321. Archer, T., Palomo, T., McArthur, R., & Fredriksson, A. Effects of acute

54


6hydroxydopamine. Neurotoxicity Research, 2003, 5, 95-110.

322. Norlander, T., Bergman, H., & Archer, T. Relative constancy of personality

characteristics and efficacy of a 12-month training program in facilitating coping

strategies. Social Behaviour and Personality, 2002, 30, 773-784.

323. Archer, T., & Fredriksson, A. Antihypokinesic effect of a2-adrenoceptor agonists

upon MPTP-induced behavioural deficits. Journal of Neural Transmission, 2002,

110, 183-200.

324. Archer, T. Environmental agents and vulnerability in cognitive deficits. In Advances in

Neurosciences and Clinical Realities: Genetic-environmental neurovulnerability in

psychiatry, edited by T. Palomo, R.J.Beninger, Jimenez-Arriero and E. Huertas. Pp.

151-179 .Editorial Sintesis, 2003.

325. Fredriksson, A., Archer, T., Alm, H., Gordh, T., & Eriksson, P. Neurofunctional

deficits and potentiated apoptosis by postnatal NMDA antagonist administration.


326. Fredriksson, A., Archer, T., Alm, H., Gordh, T., & Eriksson, P. Neurofunctional

deficits and potentiated apoptosis by neonatal administration of ethanol. Submitted.

327. Fredriksson, A., Eriksson, P., Alm, H., & Archer, T. Neurofunctional deficits and

potentiated apoptosis by postnatal MK-801 treatment. Submitted

328. Kristensson, P., Gustafsson, A., & Archer, T. Harnessing the creative potential

among users. Journal of Product Innovation Management, 2004, 21, 4-14.

329. Bood, S.Å., Archer, T., & Norlander, T. Affective personality as determinant of

factors influencing stress experience. Individual Differences Research, 2004, 2,

26-37.

330. Janson, L., Archer, T., & Norlander, T. Timing in sports performance:

psychophysiological analysis of technique in male and female athletes. Athletic

Insight, 2003, 10, 1-10.

331. Janson, L., Archer, T., & Norlander, T. Case studies of muscle activity in running.

Submitted.

332. Kjellgren, A., Norlander, T., Sundequist, U., & Archer, T. Altered consciousness in

Chamber-REST and Flotation-REST: Experience of Experimental Pain and

Subjective Stress. Social Behaviour and Personality, 2004, 32, 103-116.

55

333. Norlander, T., Moås, T., & Archer, T. Noise and stress in primary and secondary

school children: stress reduction and increased concentration ability through a short

but regular exercise and relaxation program. School Effectiveness and School

Improvement, 2005, 16, 91-99.

334. Perrin-Wallqvist, R., Archer. T., & Norlander, T. Adolescent’s fire-setting awareness

under boredom: relation to personality variables. Psychological Reports, 2004, 94,

863-871.

335. Wästlund, E., Reinikka, H., Norlander, T. & Archer, T. Effects of VDT and paper

presentation on consumption and production of information: Psychological and

physiological factors. Computers in Human Behavior, 2005, 21, 377-394.

336. Archer, T., and Fredriksson, A. Neonatal Iron and Adult MPTP administration

induced motor behaviour deficits and brain iron concentrations in mice. submitted

337. Fredriksson, A., & Archer, T. Hyperactivity Following Postnatal NMDA Antagonist

Treatment: reversal by D-amphetamine-induced. Neurotoxicity Research, 2003, 5,

401-416.

338. Norlander, T., von Schedvin, H., & Archer, T. Thriving as a function of Affective

Personality and Occupation: Relation to Personality Factors, Coping Strategies and

Stress. Anxiety, Stress, and Coping, 2005, 18, 105-116.

339. Esbjörnsson, H., Lithell, P., Wästlund, E., Jansson, B., & Archer, T. Perfectionism,

Subjective Stress, Anxiety/Depression, and Optimism as determinants of Affective

Personality type. Submitted.

340. Fredriksson, A., Eriksson, P., & Archer, T. Environmental agents inducing functional

deficits after postnatal treatment: Effects of acute Psychostimulant administration.

Acta Paediatrica, revised manuscript under preparation.

341. Fredriksson, A., & Archer, T. Neurobehavioural deficits associated with apoptotic

neurodegeneration and vulnerability for ADHD. Neurotoxicity Research, 2004, 6,

435-456.

342. Svensson, J., Diez, M., Engel, J., Wass, C., Tivesten, Å., Jansson, J-O., Isaksson, O.,

Archer, T., Hökfelt, H., & Ohlsson, C. Endocrine, liver-derived insulin-like growth

factor-I (IGF-I) is of importance for spatial memory learning in mice. Journal of

Endocrinology, 2006, 189, 617-627.

343. Fredriksson, A., Eriksson, P., & Archer, T. Postnatal iron-induced motor behaviour

56

alterations following chronic neuroleptic administration in mice. Journal of Neural

Transmission, 2006, 113, 137-150.

344. Pålsson, E., Klamer, D., Wass, C., Archer, T., Engel, J., & Svensson, L. The effects

of phencyclidine on latent inhibition in taste-aversion conditioning: Differential

effects of preexposure and conditioning. Behavioural Brain Research, 2004, 157, 139-

146.

345. Klamer, D., Pålsson, E., Wass, C., Archer, T., Engel, J., & Svensson, L. Antagonism

of nitric oxide synthase inhibitor, L-NAME, of the effects of phencyclidine on latent

inhibition in taste aversion conditioning. Behavioural Brain Research, 2005, 161, 60-

68.

346. Janson, L., Archer, T., & Norlander, T. Achievement of timing at the highest

competitive level: the necessity of a ‘driving conviction’. Athletic Insight, 2005, 7,

37-49.

347. Palomo, T., Archer, T., Beninger, R.J., & Kostrzewa, R.M. Neurodevelopmental

aspects of substance abuse. In Neurodevelopmental Liabilities in Brain Disease

States, edited by R.J. Beninger, T. Palomo, R.M. Kostrzewa & T. Archer, pp. 3-22.

Fundacion Cerebro y Mente, Madrid, 2003.

348. Palomo, T., Kostrzewa, R.M., Archer, T., & Beninger, R.J. Neurodevelopmental

liabilities in schizophrenia and affective disorders. In Neurodevelopmental

Liabilities in Brain Disease States, edited by R.J. Beninger, T. Palomo, R.M.

Kostrzewa & T. Archer, pp. 235-254. Fundacion Cerebro y Mente, Madrid, 2003.

349. Palomo, T., Beninger, R.J., Kostrzewa, R.M., & Archer, T. Brain sites of movement

disorder: genetic and environmental agents in neurodevelopmental perturbations. In

Neurodevelopmental Liabilities in Brain Disease States, edited by R.J. Beninger, T.

Palomo, R.M. Kostrzewa & T. Archer, pp. 557-596. Fundacion Cerebro y Mente,

Madrid, 2003.

350. Archer, T., Palomo, T., & Fredriksson, A. Neonatal 6-hydroxydopamine-induced

hypo/hyperactivity: blockade by dopamine reuptake inhibitors and effect of acute

Damphetamine. In Neurodevelopmental Liabilities in Brain Disease States, edited by

R.J. Beninger, T. Palomo, R.M. Kostrzewa & T. Archer, pp. 207-234. Fundacion

Cerebro y Mente, Madrid, 2003.

351. Archer, T., Palomo, T., & Fredriksson, A. Functional deficits following neonatal

57

dopamine depletion and isolation housing: circular water maze acquisition under

pre-exposure conditions and motor activity. In Neurodevelopmental Liabilities in

Brain Disease States, edited by R.J. Beninger, T. Palomo, R.M. Kostrzewa & T. Archer,

pp. 399-428. Fundacion Cerebro y Mente, Madrid, 2003.

352. Archer, T., Palomo, T., McArthur R., & Fredriksson, A. Effects of acute


intracerebroventricular 6-OHDA treatment. In Neurodevelopmental Liabilities in Brain

Disease States, edited by R.J. Beninger, T. Palomo, R.M. Kostrzewa & T. Archer, pp.

623-644. Fundacion Cerebro y Mente, Madrid, 2003.

353. Fredriksson, A., & Archer, T. Postnatal iron treatment followed by subchronic

haloperidol alters motor behaviour in mice. Neurotoxicity Research, 2006, 10,

123-129.

354. Palomo, T., Archer, T., Kostrzewa, R.M., & Beninger, R.J. Gene-environment interplay

in schizopsychotic disorders. Neurotoxicity Research, 2004, 6, 1-10.

355. Palomo, T., Beninger, RJ., Kostrzewa, RM., & Archer, T. Gene-environment interplay

in affect and dementia: emotional modulation of cognitive expression in personal

outcomes. Neurotoxicity Research, 2004, 6, 159-173.

356. Palomo, T., Beninger, RJ., Kostrzewa, RM., & Archer, T. Gene-environment

interplay in Alcoholism and other substance disorders: expressions of heritability and

factors influencing vulnerability. Neurotoxicity Research, 2004, 6, 343-361.

357. Palomo T., Archer, T., Beninger, RJ.,& Kostrzewa, RM. Gene-environment interplay

in neurodegeneration and neurogenesis. Neurotoxicity Research, 2004, 6, 415-434.

358. Karlsson, E., & Archer, T. Relationship between personality characteristics and affect:

Gender and affective personality. Individual Differences Research, 2007, 5, 44-58.

359. Agerström, J., Möller, K., & Archer, T. Influence of affective personality and level of

perfectionism on moral reasoning: Effect of gender. Journal of Personality and Social

Psychology, 2006, 34, 1259-1276.

360. Helldin, L., Karilampi, U., Norlander, T., & Archer, T. Functional determinants of

cognitive performance and symptom profile in a cohort of schizophrenic patients.

Psychiatry Research, 2006, 40, 738-745.

361. Helldin, L., Kane, J., Karilampi, U., Norlander, T., & Archer, T. Remission in

58

prognosis of functional outcome: a new dimension in the treatment of patients with

psychotic disorders. Schizophrenia Research, 2007 Jul; 93(1-3):160-8.

362. Helldin, L., Kane, J., Karilampi, U., Norlander, T., & Archer, T. Remission and

cognitive ability in a cohort of patients with schizophrenia. Journal of Psychiatric

Research, 2006 Dec;40(8):738-45.

363. Helldin, L., Kane, J., Karilampi, U., Norlander, T., & Archer, T. The influence of cognitive

ability for the attainment of remission by a cohort of patients with schizophrenia

spectrum disorder. Under review.

363. Karilampi, U., Helldin, L., Hjärthag, F., Norlander, T., & Archer, T. Cognitive

functioning in male and female schizophrenic outpatients and healthy volunteers:

Influence of learning performance level. Archives of Clinical Neuropsychology, 2007,

22, 161-174.

365. Karilampi, U., Helldin, L., Norlander, T., & Archer, T. Cognitive and daily functioning in a

cohort of schizophrenic outpatients: Gender and level of performance. Under review.

366. Archer, T., & Palomo, T. In memory or Ken ‘Kakeu’ Hodson: a man for all seasons. In:

Gene-environment Interplay in Neuropsychiatric Disorders, (Eds. T. Palomo, RJ.

Beninger, RM. Kostrzewa & T. Archer), Cerebro y Mente Publications, Madrid, pp.

xxiii-xxv.

367. Helldin, L., Kane, J., Karilampi, U., Norlander, T., & Archer, T. Experience of quality of

life and attitude to care and treatment in patients with chronic schizophrenia spectrum

disorder: role of remission. International Journal of Psychiatry and Clinical Practice,

2008, 12(2):97-104. doi: 10.1080/13651500701660007.

368. Archer, T., & Fredriksson A. Influence of noradrenaline denervation upon MPTP-induced

deficits in mice. Journal of Neural Transmission, 2006, 113, 1119-1129.

369. Svensson, N., Archer, T., & Norlander, T. Validation of the Swedish version of the

Regressive Imagery Dictionary: Effects of alcohol and emotional-enhancement on

primarysecondary process relations. Creativity Research Journal, in press.

370. Andersson-Arntén, A-C., Jansson, B., & Archer, T. Influence of affective personality type

upon coping behaviour, mood and self-reported stress. Individual Differences

Research, in press.

371. Pagels, P., Lidman, U., & Archer, T. Influence of brisk, daily exercise upon blood lipid and

affective health profiles in Swedish adults. Under review.

59

372. Svensson, L., Zhang, J., Pålsson, E., Klamer, D., Wass, C., Archer, T., & Engel, JA.

Neuronal development following early exposure to iron. Submitted

373. Pålsson, E., Klamer, D., Wass, C., Fejgin, K., Archer, T., & Engel, JA. Acute behavioural

effects of PCP: Lack of influence by aripiprazole. Submitted.

374. Archer, T., & Fredriksson, A. Iron influence upon dopaminergic and noradrenergic

contributions to movement disorder and psychotic behaviour. In Comorbidity in

Neuropsychiatric Disorders, edited by T. Palomo, R.J. Beninger, R.M. Kostrzewa & T.

Archer. Cerebro y Mente Publications, Madrid, 2007, pp. Xx-xx, in press.

375. Fredriksson, A., and Archer, T. Postnatal iron overload destroys NA-DA functional

interactions. Journal of Neural Transmission, 2007, 114, 137-150.

376. Archer, T. Comorbidity influences in neuropsychiatry: symptom plasticity constraints on

etiology and treatment. European Journal of Psychiatry, 2005, 19, 197-207.

377. Hellström P, Edsbagge M, Archer T, Tisell M, Tullberg M, Wikkelsø C. The

neuropsychology of patients with clinically diagnosed idiopathic normal pressure

hydrocephalus. Neurosurgery. 2007, 61(6):1219-26; discussion 1227-8.

378. Kjellgren, A., André, H., Johansson, I., & Archer, T. Acute smoking and nociception:

effect of gender. Under review.

379. Wass, C., Archer, T., Pålsson, E., Fejgin, K., Klamer, D., Engel, J., & Svensson, L. Effect of

phencyclidine and nitric oxide dependent mechanisms on spatial learning and memory

in rats. Behavioural Brain Research, 2006, 171, 147-153.

380. Archer, T., & Beniniger RJ. Movement disorder neurodevelopment and

neurobehavioural expression. Journal of Neural Transmission, 2006, 5-12.

381. Palomo, T., Kostrzewa, R.M., Beninger, R.J., & Archer, T. Comorbidity implications in

brain disease: neuronal substrates of symptom profiles. Neurotoxicity Research, 2006,

10, 1-13.

382. Karlsson, E., & Archer T. Affective state, stress and Type A-personality as a function of

gender and affective personality. Social Behavior and Personality, 2008, 36, xx-xx.

383. Wass, C., Archer, T., Pålsson, E., Fejgin, K., Klamer, D., Axelsson, Å., Engel, J., &

Svensson, L. Phencyclidine affects memory in a Nitric oxide-dependent manner:

working and reference memory. Behavioural Brain Research, 2006, 174, 49-55.

http://www.ncbi.nlm.nih.gov/pubmed/18162901



60

384. Archer, T., & Karlsson, E. Cognition-mediated emotional processing as a consequence of

type of affective personality: the notion of empowerment reinforcement. Invited book

chapter.

385. Archer, T., & Fredriksson, A. Functional consequences of iron overload in

catecholaminergic interactions: the Youdim factor. Neurochemical Research, 2007, 32,

1625-1639.

386. Archer, T. The enigmatic department of psychology. In: Ett Ämne blir till Psychologi I

Göteborg – en kort historia med ett långt förflutet, 1956-2006 [The origins of

Psychology in Göteborg – a short story with a long history, 1956-2006], (Eds. C.

Falkhe, E. Hjelmquist, I. Lundberg, I. Nilsson, T. Tjus), 2006, Department of

Psychology, Göteborg, pp. 88-92.

387. Wästlund, E., Norlander, T., & Archer, T. The effect of page layout on mental workload:

a dual task experiment. Computers in Human Behavior, 24, 1229-1245.

388. Wästlund, E., & Archer, T. Short-term and long-term working memory loads derived

from computer-based primary and secondary tasks. Submitted.

389. Archer, T., Adriansson, L., Plancak, A., & Karlsson, E. Influence of affective personality

on cognition-mediated emotional processing: Need for empowerment. European

Journal of Psychiatry, 2007, 21, 248-262.

390. Archer, T., & Fredriksson A. Behavioural supersensitivity following neonatal 6-

hydroxydopamine: attenuation by MK-801. Neurotoxicity Research, 2007, 12, 113-

124.

391. Hill, F., Landberg, S., Walter, S., & Archer, T. An astonishing proximity to reality: a

phenomenological study of employment-seekers’ experience of the OPQ32i

questionnaire. Submitted.

392. Palomo, T., Kostrzewa, R.M., Beninger, R.J., & Archer, T. Treatment consideration and

manifest complexity in comorbid neuropsychiatric disorders. Neurotoxicity Research,

2007, Vol 12, 43-60.

393. Palomo, T., Kostrzewa, R.M., Beninger, R.J., & Archer, T. Genetic variation and shared

biological susceptibility underlying comorbidity in neuropsychiatry. Neurotoxicity

Research, 2007 Vol. 12, 29-42.

61

394. Archer, T. Symptom-profiles underlying maladaptive emotional-cognitive risk

behaviours: contributions of stress, negative affect, low self-image, impulsiveness,

external locus of control and temperament. Submitted

395. Palomo, T., Archer, T., Kostrzewa, R.M., & Beninger, R.J. Comorbidity of substance

abuse with other psychiatric disorders. Neurotoxicity Research, 2007, Vol. 12, 17-27.

396. Zöller, M., Karlsson, E., & Archer, T. Self-rated affect among adults presenting

psychiatric diagnosis. Individual Differences Research, 2009, 7, 14-28.

397. Karilampi, U., Helldin, L., & Archer, T. Global assessment of functioning (GAF) in a cohort

of schizopsychotic patients: relation to measures of cognitive performance. Submitted

398. Andersson-Arntén, A-C., Jansson, B., & Archer, T. Partnership relations and work stress

as predictors of health and illhealth. Submitted

399. Wass, C., Archer, T., Engel, J., Pålsson, E., Fejgin K., Svensson, L., & Klamer, D. Effects of

phencyclidine on cognitive flexibility: targeting the nitric oxide system. Submitted.

400. Raustorp, A., Archer, T., Svensson, K., Perlinger T & Alfredsson M. Physical self-esteem –

a five year follow-up study of Swedish adolescents. International Journal of

Adolescent Medical Health, 2009, 21, 497-507.

401. Archer, T., Adolfsson, B., & Karlsson, E. Affective personality as cognitive-emotional

presymptom profiles regulatory for self-reported health predispositions. Neurotoxicity

Research, 2008, 14, 1-25.

402. Archer, T., & Beninger, R.J. Werner J. Schmidt (1950-2007) pushing the envelope of

neuroscience: a true academician and complete gentleman. Neurotoxicity Research,

2007, 12, 1-4.

403. Wass, C., Fejgin K., Pålsson, E., Engel, J., Archer, T., Svensson L., & Klamer, D.

Phencyclidine-impaired social behaviour is improved by inhibition of nitric oxide

production. Submitted.

404. Hellström, P., Archer, T., Tullberg, M., & Wikkelsö, C. Neuropsychological effects of

shunt surgery in patients with clinically diagnosed idiopathic normal pressure

hydroencephalus (INPH). Neurosurgery, 2008, 63, 527-535.

405. Archer, T. Identifying Symptoms in Diagnostic Labyrinths: Adaptive Beacons from

Biomarkers and Genetic Polymorphisms. European Journal of psychiatry, 2008, 22, 9-

16.

406. Palomo, T., Beninger, R.J., Kostrzewa, R.M., & Archer, T. Focussing on symptoms in

62

neuropsychiatry: conscious and unconscious expression in brain dysfunction.


407. Palomo, T., Kostrzewa, R.M., Beninger, R.J., & Archer, T. Schizopsychotic

symptomprofiles and biomarkers: beacons in diagnostic labyrinths. Neurotoxicity

Research, 2008, 14, 79-96.

408. Edvardsson, A., Hedelin, L., & Archer, T. Self-directed talk by athletes: an avenue for

success in sport. Submitted.

409. Palomo, T., Beninger, R.J., Kostrzewa, R.M., & Archer, T. Affective status in relation to

impulsive, motor and motivational symptoms: personality, development and physical

exercise. Neurotoxicity Research, 2008, 14,151-168.

410. Andersson-Arntén, A., Rosén, S., Jansson, B., & Archer, T. Partnership relations mediate

work stress effects on health: effects on gender. Submitted.

411. Zöller, M., & Archer, T. Predicting stress in male and female psychiatric patients and

healthy volunteers. Social Behavior and Personality, 2009, 37, 1081-1094.

412. Karlsson, E., & Archer, T. Personal profiles determining quality of sleep in non-clinical

populations: role of gender. To be submitted.

413. Archer, T., Kostrzewa, R.M., Beninger, R.J., & Palomo, T. Cognitive symptoms facilitatory

for diagnoses in neuropsychiatric disorders: executive functions and locus of control.


414. Palomo, T., Beninger, R.J., Kostrzewa, R.M., & Archer, T. Symptom Veracity and

Diagnostic Veniality in Brain Dysfunction: Conscious and Nonconscious Expression in

Impulsiveness and Decision-making. In: “Beyond Neuropsychiatric Diagnosis:

Symptoms Not Disorders”, (T. Palomo, R.J. Beninger, R.M. Kostrzewa & T. Archer,

Eds.), 2009, pp. 3-37. F.P. Graham Publishing: Mountain Home, TN.

415. Palomo, T., Beninger, R.J., Kostrzewa, R.M., & Archer, T. Beyond neuropsychiatric

diagnosis: symptoms not disorders. In: “Beyond Neuropsychiatric Diagnotics:

Symptoms not Disorders” (T Palomo, RJ Beninger, RM Kostrzewa and T Archer, Eds.),

2009, pp. vii-xii, F.P. Graham Publishing: Mountain Home, USA.

416. Andersson-Arntén, A., & Archer, T. Sexual Satisfaction as a Function of Partnership

Attributes and Health Characteristics: Effect of Gender. In: Psychological Wellbeing (IE

Wells, Ed.), 2010, Nova Science Publishers Inc.: NY, Chapter 3, pp. Xx-xx.

63

417. Archer, T., Johansson, B., & Fredriksson, A. Exercise alleviates Parkinsonism: Clinical and

Laboratory Evidence. Acta Neurologica Scandinavica, 2011. DOI: 10.1111/j.1600-

0404.2010.01360.x, 2011.

418. Archer, T. Neurodegeneration in Schizophrenia. Expert Reviews in Neurotherapeutics,

2010, Jul;10(7):1131-41.

419. Archer, T., & Fredriksson, A. Physical exercise restores MPTP-induced deficits in mice:

standard long-term and progressive-incremental neurotoxin administration.

Neurotoxicity Research, 2010, 18, 313-27, 2010.

420. Archer, T. Effects of Physical exercise on Brain Disorder Conditions: Clinical and

Laboratory Studies. Manuscript invited, Neurotherapeutics.

421. Archer, T. Stages in the pathophysiology and eventual treatment of brain disorders.

European Journal of Psychiatry, 24, 5-8, 2010.

422. Archer, T., & Kostrzewa, R.M. Staging neurological disorders: expressions of cognitive

and motor disorder. Neurotoxicity Research, 18(2):107-11, 2010.

423. Archer, T. Effects of exogenous agents on brain development: stress, abuse and

therapeutic compounds. CNS Neuroscience & Therapeutics, 2011, 17, 470-489. DOI:

10.1111/j. 1755-5949-2010.0017.x.

424. Archer, T., Kostrzewa, R.M., Beninger, R.J., & Palomo, T. Staging perspectives in

neurodevelopmental aspects of neuropsychiatry: agents, phases and ages at

expression. Neurotoxicity Research, 2010, 18, 287-305.

425. Archer, T., Kostrzewa, R.M., Palomo, T., & Beninger, R.J.Clinical staging in the

pathophysiology of psychotic and affective disorders: facilitation of prognosis and

treatment. Neurotoxicity Research, 2010,18(3-4):211-28.

426. Archer, T., Beninger, R.J., Palomo, T., & Kostrzewa, R.M. Epigenetics and biomarkers in

the staging of neuropsychiatric disorders. Neurotoxicity Research, 2010, 18, 347-66.

427. Archer, T., Kostrzewa, R.M., Beninger, R.J., & Palomo, T. Staging neurodegenerative

disorders: structural, regional, biomarkers and functional progressions. Neurotoxicity

Research, 2011, Apr 15.DOI 10.1007/s12640-010-9190-2, 19, 211-234.

428. Adrianson, L., Ancok, D., Ramdhani, N., & Archer, T. Cultures influences on health,

affect, self-esteem and impulsiveness: an Indonesian-Swedish comparison.

International Journal of Research Studies in Psychology, 2011. DOI:

10.5861/ijrsp.2013.228.

64

429. Andersson-Arntén, A-C., Johansson C., & Archer, T. Influence of self-esteem and

impulsiveness upon motivation and affect in adolescents and young adults. Submitted

for publication.

430. Archer, T. Physical exercise alleviates debilities of normal aging and Alzheimer’s disease.

Acta Neurologica Scandinavica, 2011, xx-xx. DOI: 10.1111 / j.1600-

0404.2010.01412.x., 2011.

431. Braverman, E.R., Chen, T.J.H., Waite, R.L., Bowirrat A., Allen, C., Yelandi, S., Damle, U.,

Madigan, M., Giordan, J., Downs, B.W., DiNubile, N., Palomo, T., Archer, T., & Blum, K.

Neuroquantum theories of psychiatric genetics: can weak forces induce epigenetic

influence on future genomes? Journal of Neuroquantology, in press.

432. Karilampi, U., Helldin, L., Hjärthag, F., & Archer, T. Vigilance profiles and remission in

schizophrenia. Submitted for publication.

433. Archer, T., Fredriksson, A., Schulz, E., Kostrzewa, R.M. Influence of physical exercise on

neuroimmunological functioning and health: aging and stress. Neurotoxicity Research,

2011, 20, 69-83, DOI: 10.1007/s12640-010-9224-9.

434. Fredriksson, A., Stigsdotter, I.M., Hurtig, A., Ewalds-Kvist, B., & Archer, T. Running wheel

activity restores MPTP-induced functional deficits. Journal of Neural Transmission,

2011, 118, 407-420. DOI: 10.1007/s00702-010-0474-8.

435. Archer, T., & Fredriksson, A. Delayed exercise-induced functional and neurochemical

partial restoration following MPTP. Neurotoxicity Research, 2012, DOI: 10.1007/

s12640-011-9261-z.

436. Blum, K., Giordano, J., Morse, S., Madigan, M., Downs, BW., Waite R., Kerner, M.,

Damle, U., Braverman, E.R., Femino, J., Bailey, J., DiNubile, N., Miller, D., Archer, T.,

Simpatico, T. Understanding the high mind: humans are still evolving genetically. The

HOAB Journal, accepted for publication.

437. Archer, T., Moradi, S., Welin, A., Hakiminejad, N., & Andersson-Arntén, A.C. Physical

exercise, stress and affect. Submitted.

438. Archer, T., & Blum, K. Epigenetics in Neuropsychiatry. In OMICS: Biomedical

Perspectives and Applications, Chapter 25, D Barh,K Blumand MA Madigan (Eds.),

2011, CRC, San Diego.

439. Archer, T., & Bright, P. Functional and structural MRI studies on impulsiveness:

AttentionDeficit/Hyperactive Disorder and Borderline Personality Disorders. In

65

“Neuroimaging – Cognitive and Clinical Neuroscience” volume, Chapter 10, Editor: P.

Bright, 2012, pp. 205-228; InTech: Rijeka, Croatia. DOI: 10.5772/1815.

440. Archer, T., Oscar-Berman, M., & Blum K. Epigenetics in Developmental Disorder: ADHD

and Endophenotypes. Journal of Genetic Syndromes & Gene Therapy, 2, 1-10. DOI:

10.4172/2157-7412.1000104.

441. Archer, T., & Kostrzewa, R.M. Physical exercise alleviates ADHD symptoms: regional

deficits and developmental trajectory. Neurotoxicity Research, 2012, 21(2):195-209.,

DOI: 10.1007/s12640-011-9260-0.

442. Pagels, P., Raustorp, A., Archer, T., Lidman, U., & Alricsson, M. Influence of moderate,

daily physical activity upon body composition and blood lipid profile in Swedish adults.

Journal of Physical Activity & Health, 2012, 9(6):867-74.

443. Archer, T., Svensson, K., & Alricsson M. Physical exercise ameliorates deficits induced by

traumatic brain injury. Acta Neurologica Scandinavica, accepted for publication.

444: Archer, T. Influence of physical exercise on traumatic brain injury deficits: scaffolding

effect. Neurotoxicity Research, accepted for publication. DOI: 10.1007/s12640-011-

9297-0.

445. Karilampi, U., Helldin, L., & Archer, T. Cognition and global assessment of functioning in

male and female outpatients with schizophrenia spectrum disorders. Journal of

Nervous and Mental Disease, 2011, 199, 445-448.

446. Garcia, D., & Archer, T. Adolescent life satisfaction and well-being. Journal of

Alternative Medical Research, 2012, 4, 271-279.

447. Garcia, D., Kerekes, N., Andersson Arntén, A-C., & Archer, T. Temperament, character,

and adolescent’s depressive symptoms: focussing on affect. Depression Research and

Research, 2012.DOI: 10.1155/2019/925372..

448. Rylander, P., Heden, A., Garcia, D., & Archer, T. Will the Peer leader please stand up?

The Personality of the athletic Peer leader in elite and non-elite sport teams. Journal of

Research Studies in Psychology, 2013, 65–74. DOI: 10.5861/ijrsp.2013.451.

449. Archer, T., & Fredriksson A. The restorative effects of physical exercise and Milmed on

MPTP-induced deficits. Submitted.

450. Garcia, D., Kerekes, N.,& Archer, T. A will (Persistence) and a proper way leading to

happiness: self-directedness mediates the effect of persistence on Positive Affectivity.

Personality and Individual Differences, 2012,DOI: 10.1016/j.paid.2012.07.025..

66

451. Scharin, M., Archer, T., & Hellström, P. Affective Spectrum Disorders (AfSD) in an urban

Swedish adult psychiatric unit: a descriptive study. Depression Research and

Treatment, accepted for publication, 2012.

452. Scharin, M., Hulterström, I., & Archer, T. Family work in psychiatric outpatient care: a

brief introduction to methodology and theory. Submitted.

453. Scharin, M., Starmark, A., Archer, T., Voionmaa, K., Malmgren, H., & Hellström, P.

MADRS-S, an important tool in psychiatry: hierarchical versus dimensional approach.

Submitted.

454. Scharin, M., Nordlund, A., Archer, T., & Hellström, P. Mini WAIS, a method to assess

general intellectual function in psychiatric patients. Submitted.

455. Scharin, M., Archer, T., Nordlund, A., & Hellström, P. Global assessment of functioning,

a validity study of the self-report version. Submitted.

456. Heden, A., Andersson Arntén, A-C., & Archer, T. Exercise and affective status: opponent

process effect.

457. Garcia, D., Archer, T., Moradi, S., & Ghiabi, B. Waiting in vain: managing time and

customer satisfaction at call centers. PSYCHOLOGY, 2012, 3, 213-216. DOI:

10.4236/psych. 2012.32030.

458. Archer, T., Oscar-Berman, M., Blum, K., & Gold, M. Neurogenetics and epigenetics in

impulsive behavior: impact on reward circuitry impairments. Journal of Genetic

Syndromes & Gene Therapy, in press, DOI: org/10.4172/2157-7412.1000115.

459. Garcia, D., Ghiabi, B., Moradi, S., Siddiqui, A., Archer, T. The happy personality: a tale of

two philosophies. In: Psychology of Personality, (Ed. EF Morris and F-A Jackson),

2012. Pp. 41-59,New York: Nova Science Publishers Inc.

460. Blum K, Bagchi D, Barh D, Giordano J, Morse S, Downs BW, Waite RL, Downs JM,

Madigan M , Ross-Coker C, Archer T, Braverman ER. Sugar craving a world epidemic: Is

there a nutrigenomic solution? Journal of Functional Foods (in process).

461. Garcia, D., Archer, T., Moradi, S., Andersson Arntén, A. Exercise frequency, high

activation positive affect, and psychological well-being: beyond, age gender and

occupation. Psychology, 2012, 3, 328-336. DOI: 10.4236/psych.2012.*****.

462. Archer, T., Ricci, S., Garcia, D., & Rapp-Ricciardi, M. Neurodegenerative aspects in

vulnerability to schizophrenia spectrum disorders. Accepted Neurotoxicity Research,

doi: 10.1007/s12640-014-9473-0.

67

463. Archer, T., & Fredriksson, A. Physical exercise as intervention in Parkinsonism. In

Handbook of Neurotoxicity, (Ed. R.M. Kostrzewa), Springer.

464. Garcia, D., Archer, T., Sailer, U. The happy time perspective: the Zimbardo time

perspective inventory in relation to subjective and psychological well-being.

Submitted.

465. Garcia, D., Sailer, U., & Archer, T. Past, present, and future life satisfaction among young

adults. Submitted.

466. Archer, T., Karilampi, U., Ricci, S., & Rapp-Ricciardi, M. Neurotoxic vulnerability

underlying schizophrenia spectrum disorders. In Handbook of Neurotoxicity, (Ed. R.M.

Kostrzewa), Springer.DOI 10.1007/978-1-4614-5836-4_119, Springer

Science+Business Media, New York, pp. 2181-2205.

467. Archer, T., Ricci, S., & Rapp-Ricciardi M. Drug Abuse Neurotoxicity: Nicotine and Alcohol

as Developmental Stressors. In Handbook of Neurotoxicity, (Ed. R.M. Kostrzewa),

Springer, DOI 10.1007/978-1-4614-5836-4_119, Springer Science+Business Media,

New York, pp. 2003-2023.

468. Sandberg, K.W., Pan, Y., & Archer, T. Recall and recognition of user codes: PIP versus

PIN personal identification code. Submitted.

469. Lindahl, M., & Archer, T. Depressive expression and antidepressive protection: positive

affect, motivation and self-efficacy. Pychology (PSYCH) Journal, 2013, 4, 495-505. DOI:

10.4236/psych.2013.46070.

470. Ricci, S., Businaro, R., Ippoliti, F., Lo Vasco, V.R., Massoni, F., Onofri, E., Troili, G.M.,

Pontecorvi, V., Morelli, M., Rapp Ricciardi, M., Archer, T. Altered cytokine and BDNF

levels in Autism Spectrum Disorders: expression of immunoexcitotoxicity.

Neurotoxicity Research, accepted for publication, DOI: 10.1007/s12640-013-9393-4.

471. Archer, T., & Kostrzewa, R.M. The neurotoxic agency of stress: from perinatal to

adolescent induction. In: (Mal)adaptive Aspects of Developmental Stress, (Eds. G

Laviola and S Macri), Springer,DOI: 10.1007/978-1-4614-5605-6, Springer, New York,

pp. 1-20.

472. Josefsson, T., Lindwall, M., & Archer, T. Physical exercise intervention in depressive

disorders: meta-analysis and systematic review. Scandinavian Journal of Medicine and

Science in Sports, doi: 10.1111/sms.12050.

68

473. Archer, T., Ricci, S., Rapp-Ricciardi, M., Kostrzewa, R.M. Polluting agents in

Parkinsonism: I Transition metals. In Handbook of Neurotoxicity, (Ed. R.M.

Kostrzewa), Springer.

474. Al Nima, A., Archer, T., & Garcia, D. Adolescents’ happiness-increasing strategies,

temperament, and character: Mediation models on subjective well-being. Health,

2012, Health, 4, 802-810. DOI: 10.4236/health.2012.410124.

475. Archer, T., Rapp-Ricciardi, M., Ricci, S., Kostrzewa, R.M. Polluting agents in

Parkinsonism: I Organic Agents. In Handbook of Neurotoxicity, (Ed. R.M. Kostrzewa),

Springer.

476. Archer, T., Fredriksson, A. Pharmacogenomics and personalized medicine in Parkinson’s

disease. In: “Omics for Personalized Medicine”, (ed. D Barh et al), Springer.DOI

10.1007/978-81-322-1184-6_14, pp. 265-287, 2013.

477. Archer, T., Ricci, S., & Rapp Ricciardi M. Pharmacogenomics and personalized medicine

in Mood disorders. In: “Omics for Personalized Medicine”, (ed. D Barh et al),

Springer.DOI 10.1007/978-81-322-1184-6_15, pp.237-264, 2013.

478. Archer, T., & Johansson, B. Pharmacogenomics and personalized medicine in

Alzheimer’s disease. In: “Omics for Personalized Medicine”, (ed. D Barh),

Springer.DOI 10.1007/978-81-322-1184-6_16, pp. 289-308, 2013.

479. Archer, T., Oscar-Berman, M., Blum, K., & Gold, M. Epigenetic modulation of mood

disorders. Journal of Genetic Syndromes & Gene Therapy, Accepted for Publication.

480. Al Nima, A., Rosenberg, P., Archer, T., Garcia, D. Anxiety, affect, self-esteem, stress:

mediation and moderation effects on depression. PLOS ONE, 8(9): e73265.

doi:10.1371/journal.pone.0073265.

481. Schütz, E., Archer, T., & Garcia, D. Character profiles and adolescents’ self-reported

experiences. Personality and Individual Differences, 54 (2013) 841–844.

482. Al Nima, A., Archer, T., & Garcia, D. The happiness-seeking strategies scales and well-

being in a sample of Swedish adolescents. International Journal of Happiness and

Development, 1, 196-211.

483. Garcia D., & Archer, T. When reaching our potential predicts low values: a longitudinal

study about performance and organizational values at call centres. Journal of Service

Science and Management, 5, 313-317.

69

484. Archer, T., & Fredriksson, A. Fusion models and fusioning in Parkinsonism: protection

and restoration by wheel-running and Milmed. In R.M. Kostrzewa (ed), Handbook of

Neurotoxicity, DOI 10.1007/978-1-4614-5836-4_95, Springer Science+Business

Media, New York, 2013, pp. 2047-2063.

485. Archer, T., Andersson-Arntén A.C., Garcia, D.,& Rapp Ricciardi M. Factors governing

personal health and development: stress (distress) and empowerment. PanMinerva

Med, 2014, 56(Suppl. 1 to No. 1):101-111.

486. Kjell, O.N.E., Nima, A.A., Sikström, S., Archer, T & Garcia D. The Relationships between

Iranian and Swedish Adolescents' Personality Traits, Subjective Well-Being and

Psychological Well-Being. PeerJournal, accepted for publication.

487. Sailer, U., Nima, A.A., Archer, T., Garcia, D. Time perspective and well-being. Submitted.

488. Garcia, D., Archer, T., & Nima, A.A. Temperament and Character’s relationship to

subjective well-being in Salvadorian adolescents and young Adults. Journal of

Adolescence, accepted for publication.

489. Garcia, D., Ghiabi, B., Nima, A.A., & Archer, T. The end of happiness: temporal distance

and judgements of life satisfaction in Sweden, Iran, Spain and El Salvador.

International Journal of Happiness and Development, in press.

490. Nima, A., A., Archer, T., & Garcia, D. (2013). Predicting Performance at Call-centres:

Work Climate, Exercise Frequency & Virtues. International Society for the Study of

Individual Differences Meeting. Barcelona, Spain. Submitted.

491. Ödman, T., Ödman, N., Rabotchi, E., Archer, T.. Design experiments of a wireless

performance measuring system for difference sizes of mammals.International Journal

on Communications, Antenna and Propagation, Submitted.

492. Archer, T., & Fredriksson, A. The yeast product Milmed enhances the effect of physical

exercise on motor performance and dopamine neurochemistry recovery in MPTP-

lesioned mice. Neurotoxicity Research, accepted for publication. Doi:

10.1007/s12640-013-9405-4.

493. Ödman, T., Ödman, N., Rabitchi, E., Fredriksson, A., Linden, M.,& Archer, T. Wireless

measuring systems for rodent exercise and motor performance.

494. Schütz, E., Garcia, D., Archer, T. Personal profiles determining quality of sleep in

nonclinical populations: effect of gender. Submitted.

495. Archer, T., & Fredriksson, A. Amelioration of MPTP-toxicity by running exercise: co-

70

administration with Milmed yeast. Submitted.

495. Garcia, D., Rapp Ricciardi, M., & Archer, T. The productive and happy agent:

performance and positive emotions at call centres. International Journal of Happiness

and Development, 2014, X, 000-000.

497. Scharin, M., & Archer, T. The Gothenburg Model of Family Work in Psychiatry A Brief

Introduction to Methodology and Theory. Family Medicine & Medical Science

Research, 2:1, doi: 4172/2327-4972.1000103.

498. Onofri, E., Mercuri, M., Salesi, M., Rapp Ricciardi, M., Archer, T., Ricci, S. Cognitive

performance deficits and dysgraphia in Alzheimer’s disease patients.Neurology and

Neurophysiology, 2014, 5:4. DOI: 10.4172/2155-9562.1000223.

499. Schütz, E., Sailer, U., Al Nima, A., Rosenberg, P., Andersson-Arntén, A-C., Archer, T., &

Garcia, D. The affective profiles in the USA: Happiness, depression, life satisfaction and

happiness-enhancing strategies.PeerJ, 1:e156; DOI 10.7717/peerj.156.

500. Schütz, E., Archer, T., & Garcia, D. Affective state, stress and Type A personality as a

function of gender and affective profiles. International Journal of Research Studies in

Psychology, accepted for publication.DOI: 10.5861/ijrsp.2013.450.

501. Onofri, E., Mercuri, M., Salesi, M., Ferrara, S., Troili, G., Massoni, F., Simeoni, C., Rapp

Ricciardi, M., Ricci, S., Archer, T. Dysgraphia in relation to cognitive performance in

patients with Alzheimer’s disease.Accepted for publication, Journal of Intellectual

Disability – Diagnosis and Treatment, 2013, 1, 000-000.

502. Andersson Arntén, A-C., Al Nima, A., Schütz, E., Abd Algafoor, N., Moradi, S., Archer, T.,

Garcia, D. Police Personnel Affective Profiles: Differences in perceptions of the work

climate and motivation. Journal of Police and Criminal Psychology, accepted for

publication.

503. Garcia, D., Anckarsäter, H., Kjell, O.N.E., Rosenberg, P., Cloninger, C.R., Archer, T., &

Sikström, S. Personality and Adolescents’ narratives: Agentic and communal values are

predicted by the semantic representation of written narratives of positive and negative

life events. Accepted for publication.

504. Garcia, D., Nima, A.A., & Archer, T. International note: Temperament and character’s

relationship to subjective well-being in Salvadorian adolescents and young adults.

Journal of Adolescence 2013, 36, 1115-1119. DOI: 10.1016/j.adolescence.2013.08.018.

505. Moradi, S., Andersson Arnten, A-C., Archer, T., Garcia, D. Motivation as a mediator:

71

Internal and external factors fostering engagement.

506. Archer, T. Physical exercise intervention in Autoimmune disease. Autoimmune Diseases

and Therapeutic Approaches, accepted for publication.

507. Cipollone, D., Businaro, R., Ricci, P., Onofri, E., Massoni, F., Rapp-Ricciardi, M., Archer,

T., & Ricci, S. Biological Therapeutics and Pharmacovigilance in Italy. International

Journal of Autoimmune disorders & Therapy, 2015, DOI: 10.15344/ijadt/2015/102.

508. Jimmefors, A., Garcia, D., Rosenberg, P., Mousavi, F., Adrianson, L.,& Archer, T.

Locomotion (empowering) and assessment (disempowering) self-regulatory

dimensions as a function of affective profiles in high school students. International

Journal of School and Cognitive Psychology, Accepted for publication. 1: 103. DOI:

509. Archer, T., & Garcia, D. Physical exercise influences academic performance and well-

being in children and adolescents. International Journal of School and Cognitive

Psychology: 2014: DOI: 10.4172/1234-3425.1000e102.

510. Archer, T. Health benefits of physical exercise for children and adolescents. OMICS

Medical Journals: Novel Physiotherapies, 4: 203-207.DOI: 10.4172/2165-

7025.1000203, 2014

511. Moradi, S., Nima, A.A., Rapp Ricciardi, M., Archer, T., & Garcia, D. Exercise, character

strengths, well-being and learning climate in the prediction of performance over a six-

month period at a call center. Frontiers in Psychology, in press, 2014, 5, DOI:

10.3389/fpsyg. 2014.00497.

512. Garcia, D., Ghiabi, B., Rosenberg, P., Nima, A.A., & Archer, T. Differences in affective

profiles in Temperament and Character in Salvadorians: the self-fulfilling experience as

a function of agentic (self-directedness) and communal (cooperativeness) values.

Accepted for Publication, International Journal of Happiness and Development, 2014.

513. Archer, T., & Garcia, D. Physical exercise improves cognition in brain disorders:

Alzheimer’s disease. In: Diet and Exercise in Cognitive Function and Neurological

Diseases. Tahira Farooqui and Akhlaq A. Farooqui (Eds.), pp. 175-181. © 2015 John

Wiley & Sons, Inc.

514. Garcia, D., Nima, A.A., Rappe, C., Rapp-Ricciardi, M.,& Archer, T. The relationship

between the JobMatchTalent and the NEO PI-R: Construct validation of an instrument

designed for recruitment of personnel. Accepted for Publication, PLOS ONE.

72

515. Mousavi, F., Archer, T., Anckarsäter, H., & Garcia, D. Agency, communion, and

intelligence in the child and adolescent twin study in Sweden: Persistence, not self-

directedness or cooperativeness, is related to twins’ cognitive abilities. Frontiers in

Personality Science and Individual Differences, accepted.

516. Sailer, U., Rosenberg, P., Nima, A.A., Gamble, A., Gärling, T., Archer, T., & Garcia, D. A

happier and less sinister past, a more hedonistic and less fatalistic present and a more

structured future: Time perspective and well-being. PeerJ, Accepted for publication.

517. Garcia, D., Jimmefors, A., Adrianson, L., Rosenberg, P., & Archer, T. High school pupils’

achievement, self-regulation (locomotion and assessment), and psychological well-

being. PeerJ 3:e847. DOI: 10.7717/peerj.847.

518. Mousavi, F., Garcia, D., Archer, T., & Ewalds-Kvist, B. Swedish High-school Pupils’

attitudes to drugs in relation to drug usage, impulsiveness and other risk factors. PeerJ,

accepted for publication.DOI: 10.7717/peerj.410.

519. Archer, T., & Garcia, D. Physical exercise improves cognition and health in ADHD.

Submitted.

520. Archer, T., Garcia, D., & Cloninger, C.R. Personal attributes that endower empowerment

mediated by positive affect: resilience, intrinsic motivation, self-regulation, and

character. Submitted.

521. Garcia, D., Lindskär, E.,& Archer, T. Thinking outside the box about indicators of

wellbeing: agency, communion, and the positivity. International Journal of Happiness

and Development, accepted for publication.

522. Onofri, E., Mercuri, M., Donato, G., Rapp Ricciardi, M., Ricci, S., & Archer, T. Dysgraphia

and cognitive deficits in Alzheimer’s disease and Lewy Body Dementia.

523. Archer, T., Garcia, D., Kostrzewa, R.M. Exercise and dietary restriction for promotion of

neurohealth benefits.

524. Garcia, D., Lindskär, E., Archer, T. To schedule or not to schedule: Agentic and

cooperative teams at call centers. Frontiers in Psychology: Personality and Social

Psychology, 2014,DOI: 10.3389/fpsyg.2014.00999.

525. Rapp Ricciardi, M., Garcia, D..Åkerman, J., Archer, T., Andersson-Arntén, A-C.,

Ambjörnsson, A. Professional Group Development trainers’ personal characteristics and

affective profiles. Frontiers in Psychology: Personality and Social Psychology, accepted

for publication.

73

526. Lundblad, S., Hansson, B., & Archer, T. Affect-group intervention for alexithymia in

eating disorders. Journal of Emergency Mental Health: Mental Health and Human

Resilience, 2015, 17, 219-223. DOI: 10.4172/1522-4821.1000144.

527. Onofri, E., Ricci, S., Rapp Ricciardi, M., & Archer, T. Writing in Alzheimer’s disease

patients: personal, spatial and temporal orientation deficits. Submitted.

528. Garcia, D., MacDonald, S., & Archer, T. Two different approaches to the affective

profiles model: median splits (variable-oriented) and cluster analyses (person-

oriented). PeerJ, 2015, DOI: 10.7717/peerj.1380.

529. Garcia, D., Adrianson, L., & Archer, T. The dark side of The Affective Profiles: differences

in psychopathy, Machiavellianism, and narcissism. Sage Open, 2015, 1-14. DOI:

10.1177/2158244015615167.

530. Lange, E., Mannerkorpi, K., Cider, Å., Archer, T.,& Wentz, K. Physiological adaptation in

women presenting fibromyalgia: comparison with healthy controls. Clinical and

Experimental Psychology, 2017, 3:1. DOI: 10.4172/2471-1000147.

531. Archer, T., Josefsson, T., & Lindvall, M. Effects of physical exercise on depressive

symptoms and biomarkers in depression. CNS Neurological Disorders and Drug

Targets, 2014, Nov 30, 13, xxx-xxx. PMID: 25470398.

532. Garcia, D., & Archer, T. Positive affect and age as predictors of exercise compliance.

PeerJ, 2014, 2:e694. DOI: 10.7717/peerJ.694.

533. Archer, T., & Garcia, D. Exercise and dietary restriction for promotion of neurohealth

benefits. Health, 2015, DOI: 10.4236/***.2015.*****.

534. Rapp Ricciardi, M., Hoff, E., Schaller, J., Garcia, D., & Archer, T. Personal attributes

linked to empowerment that influence receptivity to coaching leadership. Submitted.

535. Archer, T., & Kostrzewa, RM. Physical exercise alleviates health defects, symptoms and

biomarkers in schizophrenia spectrum disorders. Neurotoxicity Research, 2015. DOI:

10.1007/s12640-015-9543-y.

536. Onofri, E., Mercuri, M., Salesi, M.L., Rapp Ricciardi M., & Archer, T. Cognitive

performance deficits and dysgraphia in Alzheimer’s disease patients. The Open

Conference Journal, accepted for publication.

537. Archer, T., & Garcia, D., & Fredriksson, A. Restoration of MPTP-induced deficits Exercise

+ Milmed® Co-treatment. PeerJ 2014, 2:e531.DOI 10.7717/peerj.531.

74

538. Blum, K., Braverman, E.R., Archer, T., Thanos, P.K., Badgaiyan, R., Febo, M., Dushaj, K.,

Li, M., & Gold, M.S. Neuroquantum theories of psychiatric genetics: can physical forces

induce epigenetic influence on future genomes? NeuroQuantology, 2015. DOI:

10.14704/nq.2015.13.1.799.

539. Winge, H., Archer, T., & Garcia, D. Job Match: an instrument for workforce recruitment

and development. Personality and Individual Differences, 2014, 60, S34-S36. DOI:

10.1016/j.paid.2013.07.074.

540. Rapp Ricciardi, M., Schaller, J., Garcia, D., & Archer, T. Coaching leadership training in

high-tech settings. International Journal of Mentoring and Coaching, 2015, Vol. 13(3),

xx-xx.

541. Nordmarker, A., Hjärthag, F., Perrin-Wallqvist, R., Archer, T. Graffiti – expressionism and

vandalism: gender, affective status, and impulsiveness among adolescents. Psychology

(Psych) Journal, accepted for publication.

542. Archer, T., Businaro, R., Rapp Ricciardi, M. Physical exercise benefits that delay the

advance of aging. Submitted.

543. Nordmarker, A., Perrin-Wallqvist, R., Archer, T. Graffiti, for Joy (elation) and

Confirmation. An interview study with graffitists in Adolescence. Submitted.

544. Onofri, E., Mercuri, M., Archer, T., Rapp Ricciardi, M., Massoni, F., & Ricci, S. Effect of

cognitive fluctuations on handwriting in Alzheimer patient: a case study. Accepted for

publication in Journal Acta Medica.

545. Massoni, F., Ricci, P., Rapp Ricciardi, M., Luzi, E., Archer, T, Ricci, S. Quality of life during

chemotherapy: implications for social and legal medicine. European Journal of

Oncology, 2015, 20, 73-80.

546. Lundblad, S., Garcia, D., Hansson, B., Archer, T. Emotional well-being in Anorexia

nervosa: Negative affect, sleeping problems, use of mood-enhancing drugs and

exercise frequency. Archives of Depression and Anxiety, 1, 2015, 1-5.

547. Archer, T. Exercise as therapy: Health and Well-being. Journal of Intellectual Disability-

Diagnosis and Treatment, 2015, 3, 76-81, DOI: 10.6000/2292-2598.2015.03.02.5.

548. Archer, T. Epigenetic changes induced by exercise. Reward Deficiency Syndromes

Journal, 2015, DOI: 10.17756/jrds.2015-011.

549. Archer, T. Exercise alleviates Autism Spectrum Disorder Deficits. Autism Open Access,

2015, doi.org/10.4172/2165-7890.1000150.

http://dx.doi.org/10.1016/j.paid.2013.07.074

75

550. Garcia, D., Andersson-Arntén, A.A., & Archer, T. Character, responsibility and well-

being: influences on mental health and constructive behavior patterns. Frontiers in

Psychology, 2015, doi: 10.3389/fpsyg.2015.01079.

551. Fahlgren, E., Nima, A.A., Archer, T., & Garcia, D. Person-centered osteopathic practice:

Personality, Ill-being and Well-being among osteopathic patients in Sweden PeerJ

2015, 3:e1349. DOI: 10.7717/peerj.1349.

552. Mousavi, F., Rozsa, S., Nilsson, T., Archer, T., Anckarsäter, H., Garcia, D. Personality and

intelligence: persistence not self-directedness, cooperativeness or self-transcendence,

is related to twins’ cognitive abilities. PeerJ, 2015, 3:e1195. DOI: 107717/peerj.1195.

553. Garcia, D., Lundblad, S., & Archer, T. Time perspective, personality, and temporal life

satisfaction among anorexia nervosa patients. Submitted.

554. Lindskär, E., Ryberg, F., Mousavi, F., Rosenberg, P., Archer, T., & Garcia, D. Affective

profiles motivation to exercise, basic psychological needs in exercise, and propensity to

exercise during a six-month period. Submitted.

555. Garcia, D., Schütz, E., & Archer, T. Differences in happiness-increasing strategies

between and within affective profiles. Frontiers, submitted.

556. Archer, T., & Kostrzewa RM. Exercise and nutritional benefits in PD: Rodent Models and

Clinical Settings. In: RM Kostrzewa and T Archer (Eds.) Neurotoxin Modelling of Brain

Disorders – Life-long Outcomes in Behavioral Teratology. Springer.

557. Archer, T. Noradrenergic-dopaminergic interactions due to DSP4 – MPTP neurotoxin

treatments: iron connection. In: RM Kostrzewa and T Archer (Eds.) Neurotoxin

Modelling of Brain Disorders – Life-long Outcomes in Behavioral Teratology.

Springer.

558. Lundblad, S., Magnusson, J., Hansson, B., & Archer, T. Cognitive-affective status in

anorexia nervosa: self-image and absence of positive emotions. Clinical and

Experimental Psychology, accepted for publication.

559. Archer, T. Physical exercise as an epigenetic factor determining behavioral outcomes.

Clinical and Experimental Psychology, 2015, 1: e101. doi:10.4172/cep.1000e101.

560. Archer, T. Exercise influences in depressive disorders: symptoms, biomarkers and

telomeres. Clinical Depression, 2015, 1: e101. DOI: 10.4172/cdp.1000e101.

561. Archer, T., & Garcia, D. Exercise intervention in traumatic brain injury. Trauma & Acute

Care, 2015, 1, 1-3.

76

562. Garcia, D., Ghiabi, B., Nima, A.A., & Archer, T. The end of happiness: temporal distance

and judgements of life satisfaction in Sweden, Iran, El Salvador and Spain.

International Journal of Happiness Development, in press.

563. Archer, T., Jansson, B., & Olsen, K. Effects of age upon leadership attributes from

recruitment instrument: a selective developmental trajectory. Clinical and

Experimental Psychology, 2015. DOI: 10.4172/cep.1000006.

564. Haddad, B., Ångman, M., Garcia, D., & Archer, T. Dark Triad, sociosexual orientation and

religiousness: an association and moderation study. Clinical and Experimental

Psychology, accepted for publication.

565. Onofri, E., Mercuri, M., Archer, T., Rapp Ricciardi, M., & Ricci, S. Six months follow-up of

AD patients’ Dysgraphia and Cognitive Dysfunction: legal medical consideration.

Clinical Interventions in Aging, Accepted for publication.

566. Archer, T., & Garcia, D. Attention-deficit/hyperactive disorder: Focus upon aberrant N-

methyl-D-aspartate receptor systems. In: RM Kostrzewa and T Archer (Eds.)

Neurotoxin Modelling of Brain Disorders – Life-long Outcomes in Behavioral

Teratology. Springer.

567. Zöller, M.E.T., & Archer, T. Emotional disturbances expressed by deaf patients: Affective

deaf syndrome. Accepted for publication, Clinical and Experimental Psychology.

568. Blum, K., Febo, M., Fahlke, C., Archer, T., Berggren, K., Demetrovics, Z., Dushaj, K., &

Badgaiyan, R. Hypothesizing balance endorphinergic and glutaminergic systems to

treat and prevent relapse to reward deficiency behaviors: coupling D-phenylalanine

and N-acetyl-L-cysteine (NAC) as a novel therapeutic modality. Clinical Medical

Reviews and Case Reports, 2015, 2:8. ISSN: 2378-3656.

569. Sailer, U., Archer, T., Al Nima, A., & Garcia, D. A question of time and affect: the

affective profiles model, psychological well-being, and Zimbardo’s notion of time

perspective. Submitted.

570. Jimmefors, A., Garcia, D., Al Nima, A., & Archer, T. Affective profiles and self-regulatory

mode: Locomotion (empowering), assessment (disempowering), and well-being: the

benefits of time and locomotion. In preparation.

571. Archer, T., & Kostrzewa, R.M. Neuroteratology and animal modeling of brain disorders.

In: RM Kostrzewa and T Archer (Eds.) Neurotoxin Modelling of Brain Disorders – Life-

long Outcomes in Behavioral Teratology. Springer.

77

572. Archer, T., & Garcia, D. Affective profiling to determine propensity for empowerment or

disempowerment: protective attributes or afflictive proclivities in depressive states.

Clinical and Experimental Psychology: doi: 10.4172/cep.1000e102.

573. Garcia, D., Sailer, U., Al Nima, A., & Archer, T. Questions of time and affect: a person’s

affectivity profile, time perspective, and well-being. PeerJ, 2016, DOI:

10.7717/Peerj.1826.

574. Archer, T. Physical exercise and its impact on psychology. Clinical and Experimental

Psychology, 2015, 1:1, DOI: 10.4172/cep.S1-e001.

575. Archer, T. The influence of physical exercise on well-being and health. Journal of

Psychiatry and Psychology: Well-being, Empowerment and Affective Profiles, 2016,

accepted for publication.

576. Archer, T., Ricci, S., Massoni, F., & Rapp-Ricciardi, M. Cognitive benefits of exercise

intervention. Current Psychiatry Reviews [La Clinica Terapeutica], 2016, 167, 1945-

1963. DOI: 10.7417/CT.2016.1965.

577. Zöller, M.E.T., Schütz, E., & Archer, T. Motor impulsivity in affective deaf syndrome.

Journal of Psychology and Psychiatry Research: Well-being, Empowerment and

Affective Profiles, 2016, accepted for publication.

578. Crusco M., Luzi, E., Massoni F., Susi, B., Rapp-Ricciardi, M., Archer, T., & Ricci, S. Falling

accidents and risk assessment in Italian Hospital environment. Submitted.

579. Corsi M, Di Raimo T, Di Lorenzo C, Rapp-Ricciardi M, Archer T, Ricci S, Businaro R

Cognitive disability in Alzheimer’s disease and its management. Clin Ter. 2016 Sep-

Oct;167(5):e123-e126. doi: 10.7417/CT.2016.1955.

580. Crusco, M., Massoni, F., Luzi, E., Ricci, P., Pelosi, M., Rapp-Ricciardi, M., Archer, T., Ricci,

S. Gambling behavior and the necessity for novel interventions in Public Health with

non-substance addiction. Submitted.

581. Ferrara, R., Ansermet, F., Massoni, F., Petrone, L., Onofri E, Ricci, P., Archer, T., & Ricci,

S. Autism Spectrum Disorder and Intact Executive Function. Clin Ter. 2016 Sep-

Oct;167(5):e96-e101. doi: 10.7417/CT.2016.1951.

582. Ippoliti, F., Corbosiero, P., Canitano, N., Massoni, F., Rapp Ricciardi, M., Archer, T., &

Ricci, S. Work-related Stress, Over-nutrition and Cognitive Disability. Clin Ter. 2017 Jan-

Feb;168(1):e42-e47. doi: 10.7417/CT.2017.1981.

78

583. Massoni, F., Ricci, P., Crusco, M., Onofri, E., Petrone, L., Ricci, L., Rapp Ricciardi, M.,

Archer, T., & Ricci, S. Psychopathology and neoplastic disease: medico-social and

medico-legal considerations. La Clinica Therapeutica. 2017, 168(1):e48-e53. DOI:

10.7417/CT.2017.1982.

584. Di Lorenzo, C., Businaro, R., Corsi, M., Pinto, A., Coppola, G., Pierelli, F., & Archer, T.

Ketogenic diet and Alzheimer’s disease: mechanisms mediating the ketogenic diet

effects. Submitted.

585. Massoni, F., Ricci, P., Onofri, E., Donato, G., Rapp Ricciardi, M., Archer, T., & Ricci, S.

Quality of life in dementia sufferers: diet and exercise in an evaluatory role. Submitted.

586. Garcia, D., Lindskär, E., Moraga, F.R.G., Schȕtz, E., Archer, T., Cloninger, K., & Al Nima, A.

Who is Sleeping Beauty? Quality of sleep and adolescent’s sleep-psychophysiological-

emotional-personality profile. Asian Journal of Health Psychology, 2017, 2, 7-24.

587. Archer, T., & Businaro, R. Amelioration of symptoms and biomarkers of dementia: the

dual approach of diet and exercise.

588. Garcia, D., Ryberg, F., Al Nima, A., Andersson Arnten, A.C., & Archer, T. Autonomy and

responsibility as a dual construct: Swedish Police Personnel’s Stress, Energy and

Motivation. International Journal of Police Science and Management, accepted for

publication.

589. Onofri, E., Mercuri, M., Rapp Ricciardi, M., & Archer, T. Physician’s judicial role within

medical practices.

590. Archer, T. Amelioration of symptoms and biomarkers of Alzheimer’s disease by physical

exercise. Clinical and Experimental Psychology, 2016, DOI: 10.4172/2471-

2701.1000e105.

591. Garcia, D., Drugge, A., Blixt Samuelsson, H., Storm, U., Archer, T., & Cloninger, K. The

need for holistic interventions in schools: the promotion of healthy and sustainable

personal development among children. Clinical and Experimental Psychology, 2016,

2:2, DOI: 104172/2471-2701.1000129.

592. Archer, T., & Garcia, D. Selective diets for dementia disorders. Clinical and

Experimental Psychology, 2016, 2:2. DOI: 10.4172/2471-2701.1000127.

593. Hansson, B., Lundblad, S., Torgersson, J.S., Lindroos, A.K., & Archer, T. Anorexia nervosa

and obesity: a mental health comparison. Archives of Anxiety and Depression, 2016,

015-018.

79

594. Garcia, D., Kjell, O.N.E., Sikström, S., & Archer, T. Using language and affective profiles

to investigate differences between individuals. Clinical and Experimental Psychology,

2016, 2:2. DOI: 10.4172/2471-2701.1000123.

595. Garcia, D., & Archer, T. Affectivity profiling in relation to exercise: six months exercise

frequency, motivation, and basic psychological needs fulfillment. Submitted.

596. Archer, T., Amato, C., & Garcia, D. Neurohealth manifestations rendered by physical

exercise and diet. Journal of Diversity and Equality in Health and Care, 2016, 13, 257-

260.

597. Archer, T. Aspects of cognition failure by HIV-infected individuals: amelioration through

exercise. HIV: Current Research, 2016, 1:1. DOI: 10.4172/hicr.1000e101.

598. Archer, T., & Jacobsson, C. Exercise for Neurodegeneration-related disorders. Journal of

Chronic Diseases and Management, 2016, 1, 1001.

599. Jacobsson, C., Åkerlund, M., Graci, E., Cedstrand, E., Archer, T. Teacher team

effectiveness and teacher’s well-being. Clinical and Experimental Psychology, 2016,

2:2. DOI: 10.4172/2471-2701.1000130.

600. Archer, T., & Garcia, D. Exercise improves physical health and symptom profiles in

schizophrenia spectrum disorder. Submitted.

601. Archer, T. Epigenetic influences upon autism spectrum disorder. Autism-Open Access,

2016, 6, 5. DOI: 10.4172/2165-7890.1000192.

602. Garcia, D., Ryberg, F., Al Nima, A., & Archer, T. Autonomy and responsibility as dual

construct: Swedish police personnel’s stress, energy and motivation. Submitted.

603. Archer, T., & Garcia, D. Epigenetic influences on anxious and depressive behaviors:

BDNF links. JSM Anxiety & Depression, 2016, 1, 1015.

604. Archer, T., & Garcia, D. Physical exercise ameliorates symptoms of anxiety and

depression. Sports Medicine and Rehabilitation, 2017, 1: 4.1.

605. Archer, T., & Garcia, D. Exercise in anorexia nervosa: complexity of pathology and

health. Clinical and Experimental Psychology, 2016, 2:3. DOI: 10.4172/2471-

2701.1000e107.

606. Archer, T., & Garcia, D. Exercise influences upon stress-resilience and resilient health.

Kenkyu Journal of Neuropsychology & Stress Management, 2016, 1, 100101.

607. Garcia, D., Medeiros da Costa Daniele, T., & Archer, T. A Brief Measure to Predict Exer-

cise Behavior: The Archer-Garcia Ratio. Submitted.

80

608. Archer, T. Physical exercise improves health domains in HIV patients: ‘Lifting a Burden’.

HIV: Current Research, 2016, 1:2, 1000e102.

609. Ghandchi, B., Garcia, D., & Archer, T. Electromagnetic fields and human beings: a per-

son-centred approach to human technology. Clinical and Experimental Psychology,

2016, 2:3. DOI: 10.4172/2471-2701.1000138.

610. Archer, T. HIV co-morbidities and multi-morbidities. HIV: Current Research, 2016, 1:2,

1000e102.

611. Archer, T. Ageing in Health and Disorder. Submitted.

612. Archer, T., Andersson-Arnten, A.C., Olsen, K., & Jansson, B. Age and gender influence

upon self-reported leadership attributes during recruitment. Clinical and Experimental

Psychology, 2016, 2:3. DOI: 10.4172/2471-2701.1000140.

613. Jacobsson, C., Lidberg, J., & Archer, T. Consultants’ versus Managers’ – perceptions of a

group development intervention program. Clinical and Experimental Psychology,

2016, 2: 3. DOI: 10.4172/2471-2701.1000141.

614. Archer, T. Lifestyle in the elderly: exercise and dietary assets. MOJ Gerontology and

Geriatrics, 2017, .

615. Archer T. HIV-prevention: Hindrances, obstacles and constraints. HIV: Current

Research, 2016, 1:2, 1000e103.

616. Archer T. Exercise-diet combinations for enduring health advantage. Journal of

Nutrition & Food Sciences, 2016, 6:6. DOI: 10.4172/2155-9600.1000e131.

617. Archer T. Ageing, obesity, sedentary lifestyle: constituents for poor health and

performance. International Journal of Nutritional Sciences, 2016, 1(3), 1011.

618. Archer, T., Garcia, D., & Moradi, S. The enigmatic influence of video-internet gaming:

liabilities and assets over the lifespan. Sports Medicine and Rehabilitation Journal,

2016, 1, 1008-1017.

81

619. Garcia, D., Schütz, E., MacDonald, S., & Archer, T. Clinical and Experimental Psychology,

2016, 2:3. DOI: 10.4172/2471-2701.1000139.

620. Blum, K., Gold, M., Demetrovics, Z., Archer, T., Thanos, P.K., Baron, D., Badgaiyan, R.D.

Substance use disorder (SUD) a biodirectional subset of Reward Deficiency Syndrome

(RDS): Psychological and Neurobiological Constructs. Frontiers Bioscience, accepted

for publication.

621. Garcia, D., Al Nima, A., Lindskär, E., Jimmefors, A., & Archer, T. Questions of self-

regulation and affect: Affectivity, locomotion, assessment, psychological well-being.

Asian Journal of Health Psychology, accepted for publication.

622. Archer, T., & Abedini, Y. Regional dysregulation and aberrant functional connectivity in

ADHD. Journal of Neuroscience and Neuropsychology, 2016, 1(1), xx-xx.

623. Archer, T. Exercise as buttress against Parkinson’s disease. Submitted.

624. Rapp Ricciardi, M., & Archer, T. Designed mentorship, career development, learning and

psychological growth across generations: A study of a mentoring program in an

International Industrial Company. Clinical and Experimental Psychology, 2016, 2: 4.

DOI: 10.4172/2471-2701.1000144.

625. Andersson-Arntén, A-C., Jansson, B., Olsen, K., & Archer, T. Self-reported attributes of

police chiefs compared to civil leadership: Inner drive, Tolerance to stress and

Enterprise. Journal of Forensic Research, 2017, 8, 1-4. DOI: 10.41.72/2157-

7145.1000367.

626. Åkerlund, M., Henrysson-Eidvall, S., Jacobsson, C., & Archer, T. Leadership – a team

process that develops through context awareness.

627. Ferrara R, Ansermet F, Massoni F, Petrone L, Onofri E, Ricci P, Archer T, Ricci S. Autism

Spectrum Disorder and intact executive functioning. Clin Ter. [Clinical Therapeutics]

2016 Sep-Oct;167(5):e96-e101. doi: 10.7417/CT.2016.1951.

628. Garcia, D., & Archer, T. Empowerment (Character, Motivation, and Regulatory mode),

Positive Affect and Resilience. Journal of Happiness & Well-Being, 2017, 4,

629. Archer, T. Exercise as a Buttress against Parkinson’s disease. Journal of Neurology and

Experimental Neural Science, 2016, JNENS-107.

630. Archer, T., Arnten, A-C., Olsen, K., & Jansson, B. Self-reported attributes associated with

cognition and motivation as a function of gender. Clinical and Experimental

Psychology, 2016, 2: 4. DOI: 10.4172/2471-2701.1000146.

https://www.ncbi.nlm.nih.gov/pubmed/27845486

https://www.ncbi.nlm.nih.gov/pubmed/27845486

82

631. Andersson-Arntén, A-C., Huth, C.C., Colwell, J., & Archer, T. Unconditional respect:

change of mindset for effective and safe policing. Submitted.

632. Wentz, K., & Archer, T. Work load and heart rate in fibromyalgia: the hub within “pain

gaps” and clinical pain. Submitted.

633. Archer, T. Educational-exercise stimulation by video-gaming. BAOJ Psychology, 2017,

2:1, 2:020.

634. Wentz, K., & Archer, T. Pain and physiological adaptation in women presenting

fibromyalgia. Journal of Pain Management Therapy, 2016, 1(1), 28-30.

635. Archer, T., Badgaiyan, R.D., & Blum, K. Physical exercise interventions for drug addictive

disorders. Journal of Reward Deficiency Syndrome & Addictive Science, 2017. DOI:

10.17756/jrdsas.2017-036.

636. Archer, T., & Rapp Ricciardi, M. Physical Exercise for life-long health. Clinical and

Experimental Psychology, 2017, 3:2. DOI: 10.4172/2471-2701.1000e150.

637. Archer, T. Cognition and Intervention in Traumatic Brain Injury. Clinical and

Experimental Psychology, 2017, 3:2. DOI: 10.4172/2471-2701.1000e108.

638. Archer, T., & Wentz, K. Internet video gaming: symptoms, epidemiology,

neurophysiology and interventional aspects. Journal of Child & Adolescent Behavior,

2017, 5:3. DOI: 10.4172/2375-4494.1000345.

639. Archer, T. BDNF signaling ameliorates neurodegenerative disorders. EC Neurology,

2017, 7.2, 36-39.

640. Archer, T. HIV-infection prediction and co-morbid risks for cancer. HIV: Current

Research, 2017, 2:2, 125. doi: 10.4172/2572-0805.1000125.

641. Archer, T. Trauma, traumatization and adverse environments in war and armed-conflict.

Clinical and Experimental Psychology, 2017, S1:1, 1-5. DOI: 10.4172/2471-

2701.1000S1-001.

642. Archer, T. BDNF integrity in ageing and stress. Gerontology and Geriatrics, 2017, 1(6),

00031.

643. Archer, T. Fetal Alcohol Spectrum Disorder Attrition of the Developing Individual.

Submitted.

644. Garcia, D., Granjard, A., Lundblad, S., & Archer, T. A dark past, a restrained present, and

an apocalyptic future: Time perspective, personality, and life satisfaction among

anorexia nervosa patients. PeerJ, 2017 accepted for publication.

83

645. Archer, T., & Kostrzewa, R.M. Synthetic cathinones: Neurotoxic health hazards and po-

tential for abuse. In: Synthetic cathinones: Novel Addiction and Stimulatory Psycho-

active Substances, 2017, Chapter 1. Springer Neurotoxicity Book Series, Springer.

646. Archer, T. HIV-infection and cardiovascular health hazards. HIV: Current Research,

2017, 2:2.

647. Archer, T. Childhood adversity as the harbinger for future affective disorders and health

problems. J Child Psychology, 2017, 1, 3-4.

648. Archer, T. Health benefits for ageing: positive affect and life satisfaction, exercise and

coping, and telomere length. Submitted.

649. Wentz, K., & Archer, T. Exercise induced autonomic disengagement and pain in women

presenting FM and healthy women: analgesis and blood pressure. Clinical and


650. Wentz, K., & Archer, T. Fibromyalgia as a variant of hogh-performing PTSD: negative

affect, emotional integrity counter play and functional impairment. Journal of

Neuropsychology and Stress Management, 2017, 1, 1-9.

651. Andersson-Arntén, A-C., & Archer, T. Trust in law enforcement. Advances in

Biotechnology & Microbiology, 2017, 6(3): AIBM.MS.555689.

652. Wentz, K., & Archer, T. Blood pressure in women presenting fibromyalgia as a function

of pain and avoidance disparities. Journal of Psychology and Cognition, 2017, 2, 223-

230.

653. Archer, T. Adverse childhood exprience detrimental to health and function. Journal of

Psychology and Cognition, 2017, 2, 214-217.

654. Andersson-Arntén, A-C., Jansson, B., Olsen, K., & Archer, T. Self-reported attributes of

police chiefs compared to civil leadership: Tolerance; Social interest and communica-

tion. Journal of Forensic Science & Criminology, 2017, 5(4), 408-414.

655. Jacobsson, C., Nissling, L., Skår, L., Archer, T. The effect of teambuilding on team

development: A quasi-experiment within a Swedish State Authority. Clinical and


84

656. Garcia, D., Ryberg, F., Andersson-Arntén, A-C., Archer, T. Autonomy and responsibility

as a dual construct: Swedish police personnel’s stress, energy and motivation. Police

Science & Management, 2017, 19, 195-204. DOI: 10.1177/1461355717714002.

657. Wentz, K., Gyllensten, K., & Archer, T. Recording Recovery Opportunities at Work and

Functional Fatigue After Work: Two Instruments Adapted to the Swedish Context. Sub-

mitted.

658. Archer, T., & Rapp Ricciardi, M. Stress, affective status and neurodegenerative on-

slaughts. In: Personality and Brain Disorders: associations and interventions, D. Gar-

cia, R.M. Kostrzewa and T. Archers (Eds.), Springer, 2018.

659. Archer,T., & Businaro, R. Exercise Health Insurance for Ageing. Submitted.

660. Archer, T. Cognitive health and brain plasticity due to physical exercise. Submitted.

661. Archer, T. Cognitive health progression with physical exercise. Submitted.

662. Archer, T. Exercise for cardiovascular integrity and plasticity during ageing. Submitted.

663. Rapp Riciardi, M., Widh, J., Barbieri, B., Amato, C., & Archer. T. Dark Triad, Locus of

Control and Affective Status among Individuals with an Entrepreneurial Intent. Journal

of Entrepreneurship Education, 2018, 21, XX-XX.

664. Archer, T. Aspects of Cognition/Health Failure by HIV-infected Individuals: Amelioration through

Exercise. HIV: Current Research, 2018, 1:1, 1000e101.

665. Archer, T., & Kostrzewa, RM. Synthetic cathinones: neurotoxic health hazards and potential for abuse. In:

JB Zawilska (Ed.), Synthetic Cathinones: Novel Addictive and Stimulatory Psychoactive Substances,

2018, Springer: Switzerland.

666. Archer, T., Andersson Arntén, A-C., & Schutz, E. Longitudinal aspects of cognitive-emotional deficits in

internet gambling behavior. Submitted.

667. Archer, T. Addictive behavior on the internet: a quagmire for the young and unsuspecting. Submitted.

668. Archer, T., & Zöller, M. "Traumatization and Trauma Cases: Childhood Adversity and Deafness". Trauma

Cases and Reviews, 2018, 4:060. DOI: 10.23937/2469-5777/1510060.

669. Rapp-Ricciardi, M., Dahlgren, A., Barbieri, B., Amato, C., Lundquist, M., Archer, T., & Garcia, D. Locus of

control, affectivity, and the dark triad - a comparative study of entreprneurs, individuals with an entre-

preneurial intent and non-entrepreneurs. Submitted.

85

670. Adrianson, L., Amato, C., Rapp Ricciardi, M., Archer, T., & Garcia, D. Affectively motivated: Affective pro-

files, motivation, stress and energy. Accepted for publication.

671. Jansson, B., Olsen, K., & Archer, T. JobMatchTalent construct validity: correlations with IPIP scales. Clinical

and Experimental Psychology 4:3. DOI: 10.4172/2471-2701.1000197.

672. Jansson, B., Olsen, K., & Archer, T. JobMatchTalent construct validity: exploratory factor analysis. Interna-

tional Journal of Psychology & Behavior Analysis, 4: 150. DOI: 10.15344/2455-3867/2018/150.

673. Archer, T. Physical exercise to determine resilience: hormesic processes arising from physiologic perturba-

tion. Journal of Public Health and General Medicine, Vol 1, 1-10.

674. Archer, T. Psychological and Somatic Stress-Personality Interactions, Clinical and Experimental Psychol-

ogy, accepted.

675. Archer, T. Milmed as health intervention at several sites and conditions, submitted.

677. Archer, T. Sleep benefits of physical exercise. Submitted.

678. Sandberg, KW., & Archer, T. Recall and Recognition of user codes: PIP versus PIN personal identification

codes, Clinical and Experimental Psychology, 2018,.

679. Archer, T. Physical exercise and cognition among women: mobilization of consolidatory biomarkers. Sub-

mitted.

680. Archer, T., Businaro, R. Exercise for cardiovascular integrity and plasticity during ageing. Submitted.

681. Andersson Arntén AC., Jansson, B., Olsen, K., & Archer, T. Variations in Police leadership: experiential am-

biguity. Journal of Criminology and Forensic Science, 2018, 1(4): 180017. in press.

682. Archer, T., & Rapp Ricciardi, M. Predictors of work-ability over the lifespan. Submitted.

[email protected]

International Peer Review Journal articles: 435 published/in press.

Number of different journals: 163 International Scientific Peer-review

Journals

International Peer-review Journals that TA has published in:

1. Physiology and Behavior

2. Bulletin of Environmental Contamination and Toxicology

3. Animal Learning and Behavior

4. Physiological Psychology

86

5. Behavioral and Neural Biology

6. Quarterly Journal of Experimental Psychology

7. Neuroscience Letters

8. Scandinavian Journal of Psychology

9. Journal of Comparative and Physiological Psychology

10. Psychopharmacology

11. Experimental Animal Behaviour

12. Pharmacology, Biochemistry & Behavior

13. Trends in Pharmacological Sciences

14. British Journal of Pharmacology

15. Acta Pharmacol. et Toxicol. 16. Behavioral Neuroscience

17. Brain Research

18. European Journal of Pharmacology

19. Behavioural Brain Research

20. Journal of Neural Transmission

21. Developmental Brain Research

22. Pharmacology & Toxicology

23. New Trends in Experimental and Clinical Psychiatry

24. Drug and Alcohol Dependence

25. Hümertz - Pain – Doleur

26. Anesthesia and Analgesia

27. Nordic Journal of Psychiatry

28. Neurotoxicology and Teratology

29. Progress in Neuro-Psychopharmacology & Biological Psychiatry

30. Behavioral Pharmacology

31. Alzheimer Actualities

32. Neuropharmacology

33. Journal of Psychopharmacology

34. Developmental Pharmacology and Therapy

35. Acta Pathologica, Microbiologica et Immunologica Scandinavica

36. Polish Journal of Pharmacology

37. Journal of Amino Acids

38. Encyclopedia of Human Behavior

39. Spanish Journal of Neurology

40. Journal of Environmental Psychology

41. Journal of Applied Sports Psychology

42. Psychological Reports

43. Social Behaviour and Personality

44. Toxicology and Applied Pharmacology

45. Journal of Social Behaviour and Personality

46. Alcohol 47. Cross Cultural Research

48. The Korean Journal of Thinking and Problem Solving

49. Mental Health, Religion and Culture

50. Neurotoxicity Research

51. Imagination, Cognition and Personality

87

52. Alcoholism: Clinical and Experimental Research

53. Pain Research & Management

54. Parkinsonism & Related Disorders

55. Perceptual and Motor Skills

56. Childhood

57. Advances in Neurosciences and Clinical Realities: Substance Abuse Disorders

58. CyberPsychology and Behaviour

59. Journal of Chronic Fatigue Syndromes

60. The Qualitative Report

61. Molecular Brain Research

62. Aggressive Behaviour

63. Journal of Product Innovation Management

64. Individual Differences Research

65. Athletic Insight

66. School Effectiveness and School Improvement

67. Computers in Human Behavior

68. Anxiety, Stress, and Coping

69. Journal of Endocrinology

70. Psychiatry Research

71. Schizophrenia Research

72. Journal of Psychiatric Research

73. Archives of Clinical Neuropsychology

74. Creativity Research Journal 75. Neurosurgery and Neurology

76. Neurochemical Research

77. International Journal of Adolescent Medical Health

78. Neurosurgery

79. Acta Neurologica Scandinavica

80. Expert Reviews in Neurotherapeutics

81. CNS Neuroscience & Therapeutics

82. International Journal of Research Studies in Psychology

83. Journal of Neuroquantology

84. The HOAB Journal 85. Biomedical Perspectives and Applications

86. Journal of Genetic Syndromes & Gene Therapy

87. Journal of Physical Activity & Health

88. Journal of Nervous and Mental Disease

89. Journal of Alternative Medical Research

90. Depression Research and Research

91. Journal of Research Studies in Psychology

92. Personality and Individual Differences

93. PSYCHOLOGY

94. Journal of Functional Foods

95. Pychology (PSYCH) Journal 96. Scandinavian Journal of Medicine and Science in Sports

97. Health

98. PLOS ONE

88

99. International Journal of Happiness and Development

100. Journal of Service Science and Management

101. PeerJournal 102. Journal of Adolescence

103. Family Medicine & Medical Science Research

104. Autoimmune Diseases and Therapeutic Approaches

105. Journal of Intellectual Disability – Diagnosis and Treatment

106. Frontiers in Personality Science and Individual Differences

107. International Journal of School and Cognitive Psychology

108. OMICS Medical Journals

109. International Journal of Happiness and Development. 110. PanMinerva Med. 111. Frontiers in Psychology: Personality and Social Psychology

112. Neurology and Neurophysiology

113. Journal of Emergency Mental Health and Human Resilience

114. CNS Neurological Disorders and Drug Targets

115. International Journal of Autoimmune Disorders & Therapy

116. The Open Conference Journal 117. Journal of Police and Criminal Psychology

118. Journal Acta Medica

119. NeuroQuantology

120. Reward Deficiency Syndromes Journal 121. Archives of Depression and Anxiety

122. Autism Open Access

123. SageOpen

124. Trauma & Acute Care

125. Clinical Depression

126. International Journal of Mentoring and Coaching

127. Clinical and Experimental Psychology

128. European Journal of Oncology

129. Clinical Interventions in Aging

130. Clinical Medical Reviews & Case Reports

131. Current Psychiatry Reviews 132. Journal of Diversity and Equality in Health and Care

133. International Journal of Psychiatry and Clinical Practice 134. Journal of Chronic Diseases and Management. 135. Kenkyu Jornal of Neuropsychology & Stress Management 136. JSM Anxiety and Depression 137. HIV: Current Research 138. Diversity and Equality in Health and Care 139. Archives of Anxiety & Depression 140. Journal of Nutrition & Food Sciences 141. Frontiers Bioscience 142. Asian Journal of Health Psychology 143. International Journal of Nutritional Sciences 144. Sports Medicine and Rehabilitation Journal 145. Clinical Therapeutics

89

146. Journal of Happiness & Well-being 147. Journal of Neurology and Experimental Neural Science 148. Journal of Neuroscience and Neuropsychology 149. La Clinica Terapeutica 150. Journal of Forensic Science 151. BAOJ Psychology 152. Journal of Pain Management Therapy 153. International Journal of Police Science and Management 154. EC Neurology 155. Journal of Child and Adolescent Behavior 156. MOJ Gerontology and Geriatrics 157. Advances in Biotechnology & Microbiology

158. Journal of Forensic Science & Criminology 159. Police Science & Management 160. Journal of Psychology and Cognition

161. Journal of Entrepreneurship Education

162. International Journal of Psychology & Behavior Analysis

163. Journal of Public Health and General Medicine

Gamla Manus som vi ej har samt ej accepterade MS. *Archer, T., Söderberg, U., Jonsson, G., & Ross, S.B. Systemic DSP4 administration and

bilateral olfactory bulbectomy and aversive learning: A double dissociation. Manuscript, 1993. *Archer, T., Björklund, P.E., Fowler, C.J., Jonsson, G., Mohammed, A.K., Stenström, E., Tiger, G., Wahlström, G., & Winblad, B. Behavioral and neurochemical correlates of prenatal treatment of rats with methylazoxy-methanol.Manuscript, 1993. *Danysz, W., Fowler, C.J., Ahlenius, S., & Archer, T. LeChatelier's principle operates

after lesioning procedures in the brain: Implications for psychopharmacological research. Manuscript, 1993. *226. Mohammed, A.K., Jonsson, G., Winblad, B., & Archer, T. Altered extinction and

long-asting hyperactivity following prenatal treatment with methyl-azoxymethanol.Manuscript, 1993. Borras-Valls, Archer, T. & Larsson, K.The role of serotonin in the therapy of human

sexual dysfunction. (ins. till Nordic Journal of Psychiatry 940608, ej accepterad). Manuscript.

Curriculum Vitae - Pubtexto...University/University-Hospital/Courses Affiliations: 1981-1989...

Documents

Transcript of Curriculum Vitae - Pubtexto...University/University-Hospital/Courses Affiliations: 1981-1989...